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ABSTRACT
The development of a cell-free system in which adenovirus DNA 
synthesis can be initiated in vitro by using the viral genome or plasmids 
containing the origin of replication as template has led to the 
identification of the sequences important for origin function and the 
isolation and purification of the proteins required for viral DNA 
replication. In vitro studies on adenovirus types 2 and 5 have shown that 
their replication requires the formation of a large nucleoprotein complex. 
This is composed of three virally encoded proteins: adenovirus DNA 
polymerase, precursor terminal protein and DNA binding protein, and 
two cellular proteins nuclear factor I and nuclear factor III. While the 
presence of DNA helicases in other eukaryotic DNA replication systems 
have been well characterised, this was not the case for adenovirus DNA 
replication. Initial attempts to identify DNA helicase activity associated 
with any of the adenovirus replication proteins were unsuccessful. 
However, a novel DNA unwinding activity was found associated with the 
DNA binding protein (Ad.DBP). We examined the interaction of DBP 
with partial DNA duplexes and demonstrated that it could displace 
oligonucleotides annealed to single-stranded M13 DNA. In addition,
DBP could also unwind small fragments of fully duplex DNA. Unlike a 
DNA helicase, DBP promoted DNA unwinding was nucleoside-5'- 
triphosphate and Mg^ "^  independent and exhibited no directionality. The 
activity required saturating amounts of DBP and was both efficient and 
cooperative in nature.The helix-destabilising activity was shown to be 
situated in the C-terminal domain of the protein. These properties suggest 
a role for DBP in DNA replication in which DBP destabilises duplex 
DNA during origin unwinding and replication fork movement.
The second part of the thesis dealt with the characterisation of the 
putative "active site" of the adenovirus DNA polymerase. This 
experimental approach was prompted by data from earlier studies which 
indicated that DBP could increase the processitivity of the polymerase as 
well as its sensitivity to nucleotide analogue inhibitors. The "active site" 
was labelled with pyridoxal-5'-phosphate (PLP), a substrate binding site 
directed reagent for DNA polymerases. Treatment of Ad.5 DNA 
polymerase with PLP followed by reduction of the enzyme-PLP adduct 
resulted in irreversible inactivation of the polymerase activity while the 
3'“5’ exonuclease associated with Ad.5 DNA polymerase was minimally 
affected. Substrate protection studies indicate that PLP inhibition is 
complex. Neither template-primer nor substrate dNTP alone showed any 
protective effect from PLP mediated inhibition. However, the presence of 
both template -primer and complementary dNTP significantly protected 
against PLP inhibition. Comparative tryptic mapping of labelled 
enzyme, modified in the presence and absence of substrates by PLP 
reaction, on a C-18 reverse phase column, indicated the protection of one 
peptide from pyridoxylation in the presence of substrates. Amino acid 
sequence analyses found no sequence to be present in this peak.
1. The Adenoviridae
The Adenoviruses belong to the family Adenoviridae, a group of viruses 
containing DNA genomes. The adenoviridae family is divided into two 
genera depending on the host species they infect; Mastadenovirus, whose 
genus contains 78 or more serotypes, infect a wide range of mammals 
including cattle, monkeys, sheep, pigs, dogs and humans and 
Aviadenovirus, which contains 15 or more serotypes which infect a range 
of birds e.g. chickens, turkeys and ducks (Horwitz, 1990a, 1990b).
Human adenoviruses were first cultured and reported almost 
simultaneously by Rowe et al (1953) and Hillerman and Werner (1954). 
Rowe and colleagues discovered the viruses during attempts to establish 
tissue culture cell lines from tonsils and adenoidal tissues isolated from 
children with acute respiratory infections, Hillerman's group on the other 
hand discovered the virus in the same tissue types when carrying out 
epidemiological studies on U.S. Armed Forces recruits suffering from the 
same acute respiratory infections as the children in 1953. At present 41 
serotypes of adenovirus have been found to infect humans causing acute 
respiratory, gastrointestinal, ocular and urinary diseases. These viruses 
are ubiquitous in the human population infecting all ages, races and both 
sexes equally. Although the majority of adenovirus infections in man are 
seldom associated with fatal diseases, (the exception being the enteric 
adenovirus types 40 and 41 which are involved in acute diarrhoeal 
disease of infants), they are nevertheless considered important human 
pathogens. Initial studies on the structure and function of adenoviruses 
were maturated naturally by the result of clinical requirements. However, 
over the last 40 years their use as a tool in the elucidation of the 
molecular biology of eukaryotes has been recognised and exploited.
3
2. Virion Architecture.
The morphology of the adenoviriae virion is highly conserved throughout 
the genera. The virion consists of two major component structural 
complexes:- an icosahedral protein shell (capsid) which surrounds an 
inner core containing the viral DNA and at least two viral structural 
proteins. Overall the virion contains at least 11 viral proteins ranging 
from 3KDa-110KDa. Virion size, which is derived from its edge, (the 
distance between two pentons) was calculated for Adenovirus 5 to be 
52nm, giving an icosahedral diameter around the five fold axis of 
symmetry of approximately 75-88nm (Devaux et al, 1983). A schematic 
model illustrating the architecture of the adenovirus virion can be seen in 
figure 1.
2.1 The viral capsid.
The adenovirus capsid consists of 252 capsomeres which are composed 
of three viral proteins:- 240 hexons (viral protein II) whose organisation 
dictates the overall icosahedral structure of the capsid and 12 pentons, 
made up of a base and a fibre (III and IV, respectively), (Valentine and 
Periera, 1965).
Elucidation of the capsid structure after various treatments such as 
heating at 56^0, SDS or trypsin or deoxycholate treatments (Russell et al, 
1967 ; Laver et al.,1968) revealed that it dissociated into peripentonal 
hexons which surround each penton and planar 'groups of nine hexons' 
(GON’s). Under an electron microscope these GON's have a propeller 
like shape and are either left or right-handed depending on whether the 
inner or outer surface is visualised (Periera and Wrigley, 1974). Physical 
analysis has shown that the intact hexon is a trimer consisting of three
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Figure 1. Schematic model of the adenovirus particle.
The SDS-PAGE pattern of the virion polypeptides are shown along with 
their proposed locations (Russell and Precious, 1982).
identical subunits of lOSKDa (Gmtter and Franklin, 1974 ; Akusjarvi., et 
al, 1984),
Through the use of x-ray crystallography, a 3-D structure for the 
hexon has been obtained and revealed that the hexon trimer consists of 
two parts; a pseudo-hexagonal base 52A® high with a triangular top 64A^ 
high consisting of three 'towers' (Burnett et al., 1984). Each of the 
subunits consists of two domains named PI and P2 which consist of 13- 
barrel structures with loop-out regions between the strands. The three 
towers situated at the top of the structure, are formed from designated 
loops 11 and I4 from domains PI and P2 in adjacent subunits and loop 
12 from the third subunit which makes up the trimer (Roberts et al.,
1986). This interpretation of the trimeric structure shows that the three 
subunits of hexon make extensive contacts in both the base and the 
towers and explains its high resistance to dénaturation. Recently, 
comparative amino acid sequence studies of the predicated sequence of 
the hexons of Ad.2 and Ad.40 revealed that most of the differences 
between the serotypes are found in the loops which form the towers, 
consistent with the fact that the virion surface provides important type 
specific antigenic determinants (Toogood et al, 1989).
The pentocapsomere consists of a penton base and one or two 
(avian adenoviruses) thin projections, called fibres. The penton base 
consists of five subunits of III (85KDa) and the fibre, a trimer of the 
62KDa IV protein (Van Oosrum and Burnett, 1985 ; Ruigrok et al.,
1990). The fibre usually consists of a shaft 2nm in diameter varying in 
length between 9-13 nm depending on the serotype and is terminated by a 
knob-like stmcture 4nm in diameter. The interaction between the fibre 
and base are thought to be hydrophobic as they can be easily dissociated 
by guanidine or deoxycholate (Norrby, 1969).
The capsid structure relies on an additional protein named IX for capsid 
stabilisation. Studies by Colby and Shenk (1981) demonstrated that an 
Ad.5 mutant containing deletions in the gene for IX gave rise to virions 
which were more heat labile and gave individual hexons, not GON's, 
when dissociated. Further studies revealed that functional IX was 
essential for the packaging of mature viral genomes during infection 
(Ghosh-Choudhury et al, 1987). Combined E.M. analysis and x-ray 
crystallography of GON's and hexon structures, respectively, finally 
revealed that protein IX acted as capsid "cement", responsible for holding 
hexons of dissociated virions in the highly stable GON configuration 
(Furcinitti et al., 1989 ; Stewart et al., 1991 ; Stewart and Burnett, 1993). 
Viral proteins Ila (66KDa), VI (24KDa) and VIII (13KDa) are also 
known to be associated with the capsid.
2.2 The viral core.
Disruption of the adenovirus virion by treatment with 10% pyridine or 
0.5% deoxycholate removes the coat proteins leaving viral cores (Nermut 
et al., 1984). These viral cores are composed of viral DNA and four 
proteins; V, VII, Mu and the terminal protein (Chatteqee et al., 1986). 
VII which has a molecular weight of 18KDa has been shown ,even after 
various treatments with urea and acetone, to be closely associated with 
the viral DNA (Ginsberg, 1979). It is a highly basic protein with 
approximately 22% of its amino acid sequence as arginine, which is 
sufficient enough to neutralise the negative charge of the DNA's 
phosphate backbone. In contrast, the less abundant 45KDa protein V was 
found to be easily dissociated from the DNA-VII complex, even under 
relatively mild conditions (Vayda et al, 1983). Protein V has also been 
shown to be situated adjacent to the hexon, penton and Ilia ( Everitt, 
1975), possibly forming a shell on the surface of the cores (Brown et al,
1975 ; Nermut, 1979). In addition to V, VII and Mu, other proteins are 
present in the viral cores at a low copy number. One of these, the terminal 
protein (TP), is a 55KDa hydrophobic protein, which is covalently linked 
to the dCMP residue at the 5' end of each viral DNA strand. The role this 
protein plays in replication will be discussed further in section 6.
The mechanism by which viral proteins and DNA interact and 
package the genome has been and still is the subject of some controversy. 
Electron microscopic analysis of cores in various stages of relaxation had 
shown a "beads on a string" appearance or "rod-like elements" (Mirza 
and Weber, 1982). This along with micrococcal nuclease treatment data 
suggested two models for the organisation of the nucleocapsid; the 
continuous helix model, which proposes that the DNA is wrapped around 
a single helical filament made up of VII, and the discontinuous 
"nucleosome" model. Early microscopic analysis clearly favoured the 
discontinuous model, which proposes that DNA is packaged in 
nucleosome beads consisting of 6 VII molecules, with two turns of DNA 
per bead (164b.p.) and a spacer region of 30b.p. between the VII 
nucleosomes. The 4KDa Mu protein which is even more extremely basic 
than VIII (54% arginine) has been proposed as an accessory protein, 
helping VIII maintain the nucleosome structure. However, recent electron 
microscopic data along with Bal31 endonuclease activity assays on the 
DNA of subviral particle, has revealed the presence of distinct 
supercoiled domains within the DNA packaged inside the virion (Wong 
and Hsu, 1989). The data from these studies have been used to propose a 
new model in which the viral DNA is held in 8 supercoiled DNA 
domains (each domain contains 12% of the genome) by interaction with a 
central core protein, VII. This discontinuous helix model allows the 
prediction of the positions of the various parts of the genome within such 
a structure. Interestingly, the Ela and E4a promoters, being at the ends of
the genome, lie just outside the supercoiled regions potentially making 
them accessible to transcriptional proteins prior to complete dissociation 
of the virion, suggesting that a topological mechanism may exist for 
regulation of gene expression. More recently, proof for this theory has 
come from Wong and Hsu (1990) .They observed the presence of the 
supercoiled loops during compensatory supercoiling of portions of 
adenovirus DNA when the DNA double helix was unwound through the 
intercalation of ethidium bromide. Their observation that the packaging 
of adenovirus DNA into virus particles was inhibited by topoisomerase II 
inhibitors suggests that topoisomerase II may be involved in core 
assembly.
2.3 The Viral genome.
The majority of adenovirus serotypes have a linear, double-stranded 
DNA genome of approximately 35-36,000 base-pairs (35-36Kb) in 
length, with the human adenovirus genomes ranging between 34125b.p. 
in Ad. 12 (Sprengel et al, 1994) up to 35,937b.p. for Ad.2 (Roberts et al, 
1986). A distinct feature of the adenovirus genome is the presence of a 
55KDa protein linked to the ends of the genome. This terminal protein 
(TP) was shown to be covalently linked to the DNA by virtue of the 
resistance of the TP-DNA complex to proteolytic digestion, boiling and 
SDS treatment (Robinson et al, 1973; Sharp et al, 1976; Rekosh et al, 
1977). Further studies revealed that both the DNA-protein complex and 
deproteinised DNA were resistant to digestion with exonuclease VII (5'-3‘ 
specificity) and phosphatase and could not be labelled with 
polynucleotide kinase (adds nucleotides to the 5' ends of DNA).
However, they were found to be sensitive to digestion by exonuclease III 
(3-5') and labelling (at the 5' end) with terminal transferase (Camsi et al, 
1977; Sharp et al, 1976), indicating that TP was attached to the 5' ends of
the genome. The linkage between the TP and DNA was eventually shown 
to be a phosphodiester bond between the hydroxyl group of serine 625 
residue in the TP and the 5’ phosphate group of the terminal 
deoxycytidine of the genomic DNA (Desidero and Kelly, 1981). After the 
discovery of TP, debate centred on the origin of the terminal protein. 
Tr)/ptic peptide analysis by Green et al., (1979) demonstrated that the 
TP’s from five different serotypes were similar, suggesting some kind of 
common cellular origin for the protein. Experimental observations from 
Rekosh et al., (1981) then indicated that the TP's had different molecular 
weights, suggesting that TP was in fact a conserved viral protein. Debate 
continued until Stillman et al., (1981) identified a mRNA between 
coordinates 11-31.5 on the 1-strand of the adenovirus genome, that when 
translated in vitro gave a protein with a molecular weight of 87KDa. The 
protein was found to be identical to an 80KDa protein found attached to 
the 5' ends of in vitro synthesised viral DNA strands. Both the 87KDa 
and 80KDa proteins were found to be structurally related to the TP, 
indicating that the TP is synthesised as a precursor molecule (pTP). 
Further evidence for a precursor molecule came from studies involving a 
temperature sensitive Ad.2 mutant (Ad.2 tsl). This mutant virus cannot 
cleave viral precursor proteins to their mature forms at the non- 
permissive temperature, due to a defective viral protease. When analysed 
the Ad.2 tsl virions contained 80KDa, instead of 55KDa TP molecules 
(Stillman et al, 1981).
Electron microscopic studies on virions treated with 4M Guanidine 
revealed the existence of single stranded circles of adenovims DNA 
(Garon et al., 1972). These circles were found to be thermostable and 
disappeared after exonuclease III treatment. These observations led to 
suggestions that the adenovirus contained inverted terminal repeats 
(ITR's). Early estimates on the size of these ITR's, based on exonuclease
Ill digestion experiments showed that their size varied from serotype to 
serotype and put them between 350-14(X)b.p. long (Garon et al, 1972). 
However, nucleotide sequence analysis later showed these to be 
overestimates. The data revealed that the actual ITR size varied from 
63b.p. for chicken embryo lethal (CELO) virus (Alestrom et al, 1982) to 
165b.p. for Ad. 18 (Garon et al, 1982). Sequence analysis data on the 
ITR’s of several serotypes also revealed an asymmetric distribution of 
G/C and A/T base-pairs. Further investigations on the ITR of Ad.5 
revealed that the first 50b.p. of the 103b.p. ITR was composed of 72% 
A/T residues, whereas the second 50b.p. was only 27% A/T rich 
(Steenbergh et al., 1977). The ITR's within the human serotypes show a 
remarkable degree of homology, both Ad.2 and Ad.5 contain identical 
103b.p. long ITR's, (Shinigawa and Padmanabhan, 1979), whilst both 
Ad.7 and Ad.3 have 136b.p. ITR's which differ in only seven positions 
(Shinigawa and Padmanabhan, 1980).
Within all the human serotype ITR’s the sequence 5’- 
AT A AT AT ACCTT AT-3’ from nucleotides 9-22 has been found to be 
highly conserved (Tolun et al, 1979). This region, contained within the 
minimal origin of replication (bases 1-18 of the adenovirus origin) is very 
sensitive to base changes. This conserved domain was found to consist of 
two regions separated by a region in which single base changes could be 
tolerated. The latter spans bases 12-16 and any single base change in this 
region had no effect on in vitro DNA replication levels. However, any 
base change in the two critical flanking regions had a serious deleterious 
effect on DNA replication (Temperley et al, 1991; reviewed in Challberg 
and Kelly, 1989). There are other blocks of high sequence homology 
within the ITR's of various serotypes which have been shown to bind 
cellular factors during DNA replication.
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Using the nucleotide sequence of the Ad.2 genome which had been 
determined as 35,937b.p. (Roberts et al, 1986) and data from a variety of 
techniques, including in vitro transcription/translation, DNA-RNA 
hybridisations, R-loop and SI mapping (Weinman et al, 1983), a detailed 
map of the organisation of the Ad.2 genome was built up. Within the 
genome are 10 transcription units which are usually described as early or 
late depending on whether they are transcribed before or after DNA 
replication has begun. However, due to the complexity of adenoviral 
transcriptional regulation, the units are now generally referred to as pre- 
early, early, intermediate and late. The two DNA strands of the genome 
are classified by the direction of transcription along them; the strand 
transcribed to the left is termed the 1-strand (GC-rich) and the strand 
transcribed to the right the r-strand (A-T rich), (Bachenheimer et al,
1977). 69% of the viral genes are transcribed from the 1-strand. A 
schematic transcriptional and translational map of the Ad.2 genome, 
divided into transcriptional units, their mRNA’s and the proteins they 
encode are shown in figure 2 .
3. Adenovirus viral transcription.
Adenoviral transcription from viral promoters is first detected 45 minutes 
post infection (p.i.) with the viral genes being transcribed from nine 
initiation sites by the host cell RNA polymerase II (and RNA polymerase 
III in the case of the viral associated RNA’s) in the nucleus of the infected 
cell.The primary mRNA transcripts are capped at their 5’ end with mO 5' 
pppN and polyadenylated at their 3’ end, before entering the cytoplasm 
where translation takes place and at least 50 viral proteins are synthesised 
(Philipson et al., 1971). The 5' cap and the 3’ tail addition are thought to 
be important in maintaining mRNA stability and as a signal for the 
transport of processed nuclear transcripts into the cytoplasm. The
11
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Figure 2. Transcription and Translation map of adenovirus type 2.
By convention the r-strand is transcribed from left to right and the 1-
strand is transcribed from right to left. The viral polypeptides are
designated by roman numerals for the virion structural components and i
kilodaltons for non-structural virus-coded translation products (Horwitz, 
1990a).
regulation of gene expression is fundamental to the progression of the 
adenovirus lytic cycle and is exerted at a number of levels with 
transcriptional control being paramount. The order and amounts in which 
the primary transcripts are synthesised is critical and then each must be 
processed to give its progeny mRNA’s at the appropriate levels. The 
transportation of the mRNA’s out of the nucleus and their stability in the 
cytoplasm are also subject to differential control (Sharp et al., 1984).
3.1 Early transcription.
The first mRNA transcripts to be detected are those transcribed from the 
pre-early Ela transcription region (Nevins et al, 1979). Ela transcripts 
can be detected as early as 45 mins p.i. and usually reach a maximum at 3 
hour p.i. The Ela region lies on the r-strand between map units 1.3 and 
4.6 and transcribes 3 mRNA’s with sedimentation coefficients of 13s, 12s 
and 9s, respectively. The mRNA’s produced share common 5' and 3’ 
ends, differing only in their site of splicing, from which they are 
produced by separate splicing events from a precursor mRNA 
(Perricaudet et al., 1979). At early times during infection the predominant 
mRNA’s transcribed from Ela are the 13s and 12s species which give rise 
to polypeptides of 289 and 243 amino acids, respectively. They differ 
only in a 46 amino acid internal conserved region (CR3) which is unique 
to the 289R species (Moran and Mathews, 1987). From nucleotide 
sequence analysis both the 13s and 12s mRNA were predicted to 
transcribe proteins with molecular weights of 31.9 and 26.5KDa, 
respectively (Perricaudet et al, 1979). However, in practice the proteins 
were found to be heterogeneous, with greater apparent molecular weights 
than predicted, probably due to various post-translational modifications 
such as phosphorylation (Yee and Branton, 1985 ; Harlow et al., 1986). 
The 9s mRNA gives rise to a protein with a molecular weight of 28KDa.
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The proteins encoded from the Ela region are involved in both 
transcriptional regulation and cellular transformation. Ela products have 
been shown to increase the transcription level of other early viral 
promoters such as, Elb, E2, E3 and E4, up to 50-fold whilst only 
increasing its own level 5-fold (Berk et al, 1986; Jones and Shenk, 1979). 
Ela proteins can also stimulate transcription from cellular promoters 
such as the heat shock 70 protein, globin promoters (Svesson et al., 1984) 
as well as viral promoters such as HSVI glycoprotein, thymidine kinase 
(Everett and Dunlop, 1984) and the HTLVI and II promoters (Chen et al, 
1985).
Ela products can also have a negative effect on transcription by 
repressing the level of transcription from some promoters. E la has been 
shown to be involved in the repression of the SV40 and polyoma early 
promoters (Veliech and Ziff, 1985). The 46R region of E la which is 
unique to the 289 amino acid protein has been shown to be vital in 
transactivation function (Moran and Mathews, 1987). Green et al., (1988) 
demonstrated that a synthetic peptide comprising the 46R region was 
sufficient enough to stimulate transcription from several adenovirus 
promoters. The promoters activated by Ela share no common sequence 
homology. This lack of a Ela recognition site in the promoters led to the 
view that E la activated transcription by a number of indirect means, i.e. 
either through an increase in the amount of cellular factors such as ATP 
and MLTF, which are known to have a role in transactivation, during 
adenovirus infection (Flint and Shenk, 1989). Alternatively, Ela may 
activate existing cellular transcription factors, an example being TFIIIC 
which is activated by phosphorylation in adenovirus infected cells. 
Support for this theory came from studies which showed that infection of 
cells with an adenovirus mutant unable to express the 289R protein did 
not result in phosphorylation of TFIIIC (Hoeffler et al., 1988). However,
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such a mutant would have also been unable to synthesise other early 
proteins, so the lack of activation of TFIIIC may have represented an 
indirect consequence of the E la defective phenotype.
Recent evidence has also pointed to a direct role for Ela 
transactivation, as part of a transcriptional initiation complex. Evidence 
from Ptashne et al (1988) revealed that a number of cellular transcription 
factors were composed of two functionally distinct domains, an N- 
terminal DNA binding domain and a C-terminal transcriptional activation 
domain, which can bind to other components of both the transcription and 
replication machinery. This concept was applied to Ela by Lillie and 
Green , (1989) who found that a hybrid protein, comprising the Gal4 
DNA-binding domain and the acidic transcription activating domain of 
Ela, transactivated transcription from E4 and Elb promoters with high 
efficiency when Gal4 binding sites were introduced into the promoters of 
the adenovirus genome. However, since Ela doesn't bind to any 
nucleotide element in these promoters, it would seem that E la influences 
the level of transcription by binding to a protein already bound at the 
promoter and not directly. This has been demonstrated in the case of the 
cellular transcription factor E2F (important for activation of genes 
required for and involved in S-phase functions), which undergoes a 
dramatic change in activity during adenovirus infection, mediated by Ela 
(Kovesdi et al., 1986). During this process, the 19KDa E4 gene product 
interacts with E2F enabling it to bind to the E2 promoter region so that 
transcription can proceed (Huang and Hearing, 1989 ; Bagchi et al., 1990 
; Raychaudhuri et al., 1990). In uninfected cells this DNA binding 
activity would normally be blocked by the retinoblastoma gene product 
(see below) which interacts directly with E2F (Bagchi et al., 1991 ; 
Bandara et al., 1991), resulting in the inhibition of E2Fs transcription 
activity. Ela when present disrupts this interaction thereby freeing E2F to
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bind to the E2 promoter along with the 19KDa E4 gene product. This 
results in a marked increase in the level of transcription.
Ela is also important in cellular transformation by adenoviruses. 
This process seems to occur as a sequential process, involving both Ela 
and Elb gene products, although Ela alone has the property of 
immortalising primary cells in culture (Van den Elsen et al., 1983). 
However, stable transformation of cells leading to tumour induction 
requires the presence of Elb, whose function can be substituted by other 
oncogenes including activating H-ras and the polyoma middle T-antigen. 
In addition Ela can be replaced by polyoma large T-antigen and the myc 
and p53 oncogenes (Ruley, 1983 ; Jenkins et al., 1984). Mutational 
analysis studies on Ela have shown tliat its transformation and 
transactivation activities are situated on different domains. The 
transformation properties have been mapped to two regions on Ela 
named CRl an CR2 (Schneider et al, 1987 ; Fahnestock and Lewis,
1989), which are common to both the 289R and 243R proteins. Several 
other groups have also shown Ela to be associated with various host cell 
proteins referred to as anti-oncogenes or tumour suppressors. Prominent 
amongst these proteins is pl05-RB, a product of the retinoblastoma gene 
(Harlow et al, 1986 ; Whyte et al, 1988a, 1989). The RB protein is 
thought to be a tumour suppressor protein as its corresponding loss of 
activity has been found in malignant cell types (Weichselbaum et al, 
1988). Interestingly, the regions of Ela involved in pl05-RB binding 
were mapped and correspond to those essential for cellular 
transformation (Whyte et al, 1988b, 1989). The oscillation of RB protein 
phosphorylation with the cell division cycle (Buchkovich et al., 1989 ; 
DeCaprio et al., 1992), binding of RB protein to oncoproteins like Ela, 
and the association of RB protein with potentially important cell cycle 
regulatory proteins may effect cell growth by affecting the cell division
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cycle.The RB protein is thought to play some role at a restriction point in 
the G1 phase of cell division, either to allow exit from the cell cycle or 
delay entry into S phase until a suitable growth status is achieved 
(reviewed in Goodrich and Lee, 1993). In conclusion, it therefore appears 
that an important part of Ela mediated transformation occurs by the 
direct interaction of Ela with proteins involved in the regulation of cell 
growth and division.
The next mRNA's to be transcribed are the Elb, E2, E3 and E4 
regions. These mRNA's are detected 1.5-2 p.i. and reach a maximum for 
E lb between 6-7 hours post infection and 3-4 hours post infection for E3 
and E4. E2 mRNA transcription reaches a maximum between 3-4 hours 
post infection. Elb which is located between m.u. 4.6-11.2 is transcribed 
from the r-strand and is activated by Ela. Four transcripts are produced; 
13s, 14s, 14.5s and 22s. All these mRNA's have common 5' and 3' 
termini (Virtanen and Petterson, 1985) and are produced by differential 
splicing of a single precursor. The 14s and 14.5s mRNA’s are identical to 
the 13s species with the addition of a third exon. The 22s mRNA contains 
two AUG’s which are used during translation to encode two proteins with 
molecular weights of 55KDa and 19KDa, with the latter encoded for by 
the 13s, 14s and 14.5s mRNA's (Bos et al, 1981). Additionally, all four 
mRNA's also contain the coding regions for IX, the 14.3KDa stmctural 
protein associated with the GON's hexons. However, the coding 
information for this protein is translated from an additional mRNA 
transcribed at intermediate (not early) times during infection Esche et al.,
1980). The precise functions of the Elb proteins are still unclear. It has 
been demonstrated that the 55KDa protein can bind to a 34KDa protein 
encoded by the E4 region, forming a 55-34KDa complex which has a role 
in the transport of late mRNA's from the nucleus to the cytoplasm (Pilder 
et al., 1986 ; Bridge and Ketner, 1990). As with Ela, the protein products
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from E lb are required for complete cellular transformation by 
adenoviruses (Van der Eb,, 1984). Both the 19KDa and the 55KDa 
proteins are involved in transformation. The 55KDa protein binds to p53, 
a cellular anti-oncogene protein found at elevated levels in transformed 
cells (Samow et al., 1982), like Ela, can co-operate with activated ras 
genes in the malignant transformation of primary cells (Eliyahu et al., 
1984 ; Parada et al., 1984). The Elb 55KDa protein is important for 
adenovirus transformation activity, as mutants in the 55KDa Elb gene 
are severely reduced in their ability to transform rodent cells ( reviewed 
in Shenk, 1989). Interestingly, the region of p53 which binds to Elb 
55KDa protein resides in the amino terminal acidic domain, which is 
associated with die transcriptional transactivating function of p53 (Fields 
and Jang, 1990 ; Raycroft et al., 1990 ; Unger et al., 1992). In fact, it has 
recently been demonstrated by Yew and Berk (1992) that the apparent 
binding of wild-type adenovirus type 2 Elb 55KDa and the equivalent 
adenovirus type 12 Elb 54KDa proteins to wild-type p53 severely 
inhibits the ability of p53 to mediate transcriptional transactivation, at the 
same time promoting transformation of rodent fibroblasts in conjunction 
with Ela. Mutants of Elb 55KDa and 54KDa which do not bind p53 
allow p53 to transactivate and are severely reduced in transformation 
potential in cooperation with Ela. The prevention of the normal tumour 
suppressor activity of p53 by Elb binding should result in a more actively 
dividing cell. Recently, Yew et al., (1993), using a fusion of Elb 55KDa 
and the Gal4 DNA-binding, have shown that Ela may prevent p53 
activity by acting as a direct transcriptional repressor that is targeted to 
p53 responsive genes by binding to p53.
Additional studies on cellular transformation, with a large number of 
point and deletion mutants of the pl9 gene, resulted in a range of mutant 
phenotypes which included degradation of all host cell and viral DNA,
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abnormal cytopathic effect and formation of large plaques (White et al,
1988). Transfection studies using p i9 expressing vectors indicated that 
the encoded 19KDa protein, (located within the nuclear, endoplasmic 
and plasma membranes, was associated with and profoundly disrupted 
the vimentin-containing intermediate filament network and the nuclear 
lamina (White and Capriani, 1989,1990). It has been proposed that 
anchorage independent growth of adenovirus transformed cells results 
from such altered stmctural organisation of intermediate filaments 
induced by the 19KDa protein. Additionally, modification of the nuclear 
lamina by the 19KDa protein could be important in maintaining the 
integrity of both cellular and viral DNA after infection as Elb defective 
virus was found to contain degraded DNA.
The E2 transcription region, located between map units 75.7-11.3, is 
transcribed from the 1-strand (Chow et al, 1979a, 1979b). During 
adenovirus infection E2 mRNA's are transcribed at early times from a 
promoter at map unit 75 which is dependent on Ela, then at later times 
from a promoter at map position 72 which is Ela independent.The E2 
transcripts are divided into two sets depending on the position at which 
they terminate. The transcripts terminate at two different poly- 
adenylation (polA) sites and are termed E2a and E2b. E2a mRNA's are 
transcribed early in infection fi*om a promoter at m.u. 75.4 and from a 
second promoter at 72.2, later in infection. Both terminate at a polA site 
at 62.4 (Baker et al, 1979). E2b mRNA's bypass this poly-A site and 
terminate at 11.3 (Stillman et al, 1981). All the E2 mRNA's share a 
common leader at m.u.68.8.
Only one protein is encoded by the E2a mRNA's, the 72KDa viral 
single stranded DNA binding protein (DBF). DBF is a multifunctional 
phosphoprotein and plays important roles in DNA replication, the control 
of early and late transcription and viral host range. DBF's role in DNA
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replication will be addressed in later sections. The role of DBF in early 
and late transcription is probably due to its ability not only to bind DNA 
(Van der Vliet and Sussenbach, 1975) and RNA (Cleghom and Klessig,
1990), but on its ability to regulate its own production (Nicholas et al., 
1982) as well as the transcription of the El and E4 region (Babich and 
Nevins, 1981). Limited proteolytic studies have demonstrated that DBF is 
preferentially degraded into a C-terminal domain and a highly 
phosphorlyated N-terminal domain (Schecther et al., 1980). The C- 
terminal region binds to DNA and is fully functional in DNA replication 
assays in vitro (Tsemoglou et al., 1985). Mutational studies on the N- 
terminal region of DBF indicate that this domain is not important for 
function in DNA replication, but in viral host range. Early studies by 
Klessig and Grodzicker, (1979) showed that human adenoviruses, which 
normally undergo an abortive infection in monkey cells, could replicate 
normally in these cells only when mutant N-terminal DBF was present. 
This was later found to be due to the presence of a functional fibre 
protein, not present in monkey cells infected with wild type virus 
(Anderson and Klessig, 1984).
Three mRNA’s are transcribed from the E2b region. Two of these 
mRNA's encode the 80KDa precursor terminal protein (pTF) and the 
140KDa DNA polymerase (Ad.Fol), which are present in infected cells as 
a stoichiometric complex and are required for DNA replication. The third 
mRNA encodes a 22.8KDa protein, whose function has not been 
identified as yet.
The E3 transcription unit maps from m.u. 76.8-85.9 on the r-strand 
(Berk and Sharp., 1978). Nine mRNA's are transcribed from this region 
through differential splicing of two precursor molecules. The E3 proteins 
produced are thought to be involved in the evasion of host cell antiviral 
defences, as well as the down regulation of epidermal growth factor
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receptor (EGF-R). So far only three proteins have been assigned to the E3 
region:- a 19KDa glycoprotein (Andersson et al., 1985 ; Burget et al., 
1987 ; Rawle et al., 1989) which has been shown to bind to class 1 major 
histocompatability complex antigen, preventing their transport to the cell 
surface; a 14,7KDa protein which prevents cytolysis by the tumour 
necrosis factor (TNF) in infected cells (Gooding et al., 1988), and a 
llKDa protein which down regulates the EGF-R, resulting in a 
subsequent decrease in the cellular metabolism of infected cells (Carlin et 
al., 1989 ; Tollefson et al., 1990).
mRNA transcripts from the E4 region are transcribed from the 1- 
strand between m.u, 99-91.3 (Berk and Sharp, 1978). A primary 
transcript is produced which is then spliced into 12 mRNA's all with 
identical 5' and 3' ends (Virtanen et al., 1984). Generation of mutants 
containing large deletions resulted in pleiotropic including defects in late 
protein synthesis, in late mRNA accumulation and the shutdown of host 
cell protein synthesis (Halbert et al., 1985). Data from DNA sequencing 
analysis on E4 mRNA's has revealed that the existence of seven open 
reading frames (ORF's) encoding proteins ranging from 6-34KDa in size 
(Fiyer et al., 1984 ; Virtanen et al., 1984).
E4 transcription is activated by a product of the Ela region (Jones 
and Shenk, 1979) and inhibited by the 72KDa DBF Elb product (Handa 
et al., 1983). Further studies have revealed that the 14KDa and 34KDa E4 
products are involved in the accumulation of late viral mRNA's and in the 
shutdown of host cell macromolecular synthesis (Huang and Hearing,
1989). As mentioned above , the 34KDa protein has also been found to 
be associated with the 55KDa protein encoded by Elb in infected cells 
(Samow et al., 1984) and is involved in the transport of late mRNA's 
from the nucleus to the cytoplasm (Filder et al., 1986). Another E4 
protein with a molecular weight of 19KDa can be found in complex with
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the cellular transcription factor E2F, with which it transactivates the level 
of transcription from the E2a promoter by increasing the DNA binding 
affinity of E2F for its recognition site (Marton et al., 1990).
3,2. Intermediate and late gene expression.
The E2b region, which codes for the viral proteins pTP and Ad.DNA Pol, 
is transcribed at intermediate times during infection from its own 
promoter between m.u. 23-30 and is terminated when mRNA production 
has finished (Lewis and Mathews, 1980). Two additional intermediate 
mRNA's are transcribed giving rise to two proteins; IX and IVa2, a 
50KDa protein involved in virion morphogenesis. Altliough these 
mRNA’s can be detected prior to DNA replication, maximal transcription 
occurs only after DNA replication (Crossland et al., 1983).
After the onset of DNA replication, transcription from early sites 
is increased 3-10 fold presumably due to an increase in the number of 
DNA templates (Shaw and Ziff, 1980). DNA replication also brings 
about a thousand fold increase in the activity of the major late promoter 
(MLP), from which the majority of mRNA's are transcribed. The ML? is 
situated on the r-strand at m.u. 16.5 (Ziff and Evans, 1978). The 5' ends 
of the mRNA's produced by the MLP consists of a 210b.p. tripartite 
leader sequence, which is spliced at numerous sites, to generate a large 
number of unique mRNA's. The mRNA's transcribed from the MLP are 
classified into five families named LI to L5, with each family sharing a 
common poly-A site (Evans et al., 1977). The primary transcript for the 
families extends to m.u. 99, although the last poly-A signal (for L5) is at
91.3 (Fraser et al., 1979).
LI transcripts are expressed at early times in infection generating 
3 mRNA's which share a poly-A site at m.u. 39.3 (Fraser et al, 1982) and
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5' cap sites at positions 29, 31 and 34, The transcripts also contain an 
additional leader sequence, containing an open reading frame between 
positions 21.5-23. The LI mRNA's encode two structurally related 
proteins with molecular weights of 52KDa and 55KDa whose function is 
unclear (Miller et al., 1980). The third mRNA codes for Ilia, a 66KDa 
protein found associated with the hexon in mature virions (Akusjarvi and 
Pettersson, 1981).
The L2 region generates 3 mRNA’s which are transcribed from 
map position 39, have 5’ cap sites at 39.4,44.1,45.9 and a poly-A signal 
at at m.u. 50 (Alestrom et al., 1984). The mRNA's encode for the 
important structural proteins: III (85KDa), VII (18.5KDa) and V 
(48.5KDa), (Miller et al., 1980 ; Akusjarvi and Petterson, 1981). All are 
structural components of the mature virion. III forming the penton base 
and VII and V constituting the two major proteins of the viral core. L2 
also contains a fourth open reading frame (ORF) which codes for a 
hypothetical polypeptide 85 amino acids long which is thought to be the 
precursor for protein Mu, a component of the viral core.
Region L3 transcribes 3 mRNA's with 5' cap sites at 50.1,52.3 
and 60.2 with a poly-A signal at 62.4. The mRNA's encode for a single 
precursor which gives rise to a precursor of VI, hexon (II) and a 23KDa 
viral endopeptidase which specifically cleaves a number of precursor 
proteins to generate mature viral proteins: VI, VII, VIII and the terminal 
protein (TP). Recent inhibitor profile studies have shown that the 23KDa 
protein is a cysteine protease, which cleaves the target amino acid 
sequence (M,L,I)XGX-G (Webster et al., 1989 ; Webster et al., 1993).
L4 transcribes four mRNA's which have a common poly-A signal 
at 78.5. Only 3 proteins have been assigned to three of the mRNA's: the 
mRNA's encode; a l(X)KDa multifunctional protein involved in hexon 
assembly and inhibition of host messenger translation (Gambke and
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Deppert, 1984 ; Adam and Dreyfus, 1987), a 33KDa non-structural 
protein whose function is unknown and a 26KDa precursor of VPVIII, a 
structural protein associated with the hexon (Miller et al., 1980).
L5 contains two major mRNA's transcribed between m.u. 86-91.3 
(Miller et al., 1980). These mRNA's differ from the other late transcripts 
by virtue of the fact that they contain leader sequences derived from map 
positions 72.2, 78,6 and 84.7, in addition to the tripartite leader sequence. 
These mRNA’s produced encode the IV fibre protein (Uhlen et al., 1982).
Two additional low molecular weight mRNA's are transcribed from 
the adenovirus genome late in infection and are designated virus 
associated RNA's I and II (VA RNA I AND II). These RNA’s are 
transcribed on the r-strand from two promoters at map positions 29.5 and
30.2, which are located within the non-coding region of LI. They are 
transcribed by RNA polymerase III and can form complex secondary 
stem-loop structures via base-pairing. Mutational studies on both the VA 
I and II promoters, demonstrated that the VA RNA II species was non- 
essential, whereas VA RNA I was essential, for the efficient translation 
of late viral transcripts (Thimmapaya et al., 1982). It seems that VA RNA 
I acts to facilitate late translation by maintaining the activity of the 
eukaryotic translational initiation factor eIF-2, which is inactivated when 
phosphorylated by a double stranded RNA activated kinase (DAI), 
(Akusjarvi et al., 1987). It is believed that VA RNA I achieves this by 
preventing the activation of the kinase, thus allowing translation to 
continue (O'Malley et al., 1989). Further studies on mutant VA RNA I 
molecules have revealed that it consists of two domains which have 
different functions, one mediates binding to DAI and the other directly 
interferes with DAI inactivation (Mellitis et al., 1990).
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4. Adenovirus DNA replication.
The initial impetus for studying adenovirus DNA replication in depth 
arose from the idea that analysis on the mechanism of replication of the 
small genomes of eukaryotic infecting DNA viruses could provide 
insights into the mechanisms involved in the replication of larger and 
more complex host cell genomes. To date adenovirus DNA replication 
has been extensively studied both in vivo and in vitro.
Adenovirus DNA replication can be detected 6-8 hours post infection, 
usually reaching a maximum after 19 hours. Replication takes place in 
the host cell nucleus and is found to be coincident with a complete 
shutdown (90%) of host cell DNA synthesis. After 24 hours, 
approximately 1Q5-1G6 new double stranded DNA daughter molecules 
are present, equalling the total DNA content of the host cell (Green et al.,
1970). Ultimately, only 20% of the progeny genomes are packaged into 
mature virions. A lot of the important mechanistic features of adenovirus 
DNA replication were elucidated by studies on viral DNA replication in 
vivo. However the development of in vitro assays capable of replicating 
DNA in vitro (Challberg and Kelly, 1979) has allowed tiie identification, 
purification and characterisation of three viral gene products and four 
host cell polypeptides that have been found to be necessary for the 
synthesis of the adenovirus genome.The in vitro systems have also led to 
the elucidation of important nucleotide sequences within the adenovirus 
genome important for DNA replication. The following sections will deal 
with the evolution of both the in vivo and in vitro Ad. DNA replication 
systems.
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4.1. Adenovirus DNA replication in vivo.
Most of the initial studies utilised both pulse-labelling and electron 
microscopic techniques to study the mechanics of adenovirus DNA 
replication in infected cells.
Initially, pulse-labelling studies were used and identified 
replicative intermediates in adenovirus infected cells which had been 
exposed to [^H] thymidine. When labelled DNA from these cells was 
examined by native sucrose gradient centrifugation, it was observed that 
a significant proportion of the DNA had a greater sedimentation rate than 
mature viral DNA (Pearson and Hanawalt, 1971). These premature viral 
DNA molecules also had a greater buoyant density in caesium chloride 
gradients suggesting the presence of single-stranded regions in the 
replicative intermediates (Pearson and Hanawalt, 1971; Robin et al., 
1973). This was confirmed when SI nuclease treatment abolished the 
difference in density (Pearson, 1975). When the same experiments were 
carried out under denaturing conditions, a wide range of DNA strands of 
various sizes were present in the intermediates (Pearson and Hanawalt,
1971).
Early electron microscopic analysis by various groups (Lechner and 
Kelly, 1977) revealed the presence of two classes of replicating 
molecules; Type I intermediates containing genomic length DNA, with 
between one and four single-stranded branch structures, and Type II 
intermediates which consist of linear molecules with a single-stranded 
region extending from one end. Early studies by Ellens et al., (1974) 
demonstrated that when adenovirus replication was synchronised after the 
release of a hydroxyurea block, branched (Type I) intermediates 
predominated early and unbranched molecules at later times. 
Investigations on the level of initiation of DNA replication in these
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intermediate molecules by partial dénaturation techniques (Lechner and 
Kelly, 1977 ; Revet and Benichou, 1981) revealed that the DNA 
molecules initiated with equal frequency at either end of the genome. The 
polarity of DNA replication in the intermediates was then determined by 
Lechner and Kelly (1977) who demonstrated that terminal transferase 
could add labelled dTTP residues to the termini of growing DNA 
molecules, forming poly (dT) tails.These tails were observed growing 
only at the branch points of Type I molecules and at double to single­
stranded transitions of Type II molecules, indicating that the daughter 
strands contained only one free 3 -OH group which is located at their 
growing points. The conclusion drawn from this was that both Type I and 
Type II DNA synthesis proceeded in a 5' to 3' direction.
A model for adenovirus DNA replication proposed by Lechner and 
Kelly, (1977) was improved on by the finding that the inverted terminal 
repeats (ITR's) of the displaced strands in the replicative intermediates 
could associate, giving rise to a single-stranded circle of DNA with a 
double-stranded region, known as a "panhandle" structure (Daniell,
1976). Supportive evidence for panhandle formation came from 
transfection studies by Stow (1982a) and Hay et al., (1984). Stow (1982a) 
showed that Ad.2 genomes with deletions within the left ITR would 
generate progeny virus with two intact ITR's after transfection into 
permissive cells. This evidence was substantiated by the work of Hay et 
al., (1984) using a linearised plasmid containing inverted repeats of a 
94bp E.coli DNA fragment with a 570bp Ad.2 terminal fragment at one 
end. After cotransfection of this plasmid into permissive cells with Ad.2 
wildtype DNA, progeny molecules an extra 0.5kb in length were 
generated. This indicated that during adenovirus infection the ITR's at 
each end do interact. Incorporation of this transfection data into the 
Lechner and Kelly model suggested that the ITR's at either end of the
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genome did indeed interact to form panhandle structures during 
infection. The bulk of in vivo data has indicated that adenovirus DNA 
replication initiated at the 5* end of each daughter strand, at an origin 
located at or near the termini of the parent DNA molecule and terminated 
at the opposite end of the genome with the concomitant displacement of 
the strand not being utilised as the template.
4.2. Adenovirus DNA replication in vitro.
The development of an adenovirus DNA replication system totally 
dependent on an exogenous template for initiation and elongation has 
made it possible to purify and develop functional assays for the 
individual components of the replication system. As well as allowing a 
precise breakdown of the major features of the replication pathway, the in 
vitro assays have confirmed many of the earlier models based on in vivo 
data.
Early in vitro studies were based on attempts to isolate Ad.2 replication 
complexes (replicating DNA and replication proteins) from infected 
nuclei. However these attempts were unsuccessfiil as the DNA isolated 
became fragmented during the isolation procedure (Frenkel, 1978). The 
complexes were prepared by various chemical treatments; e.g. Kaplan et 
al (1977) isolated a soluble extract containing replicating DNA by 
fractionation with ammonium sulphate. The isolated complexes required 
both Mg^" ,^ dNTP's and a large amount of the viral 72KDa DBF protein 
before they would synthesise DNA (Yamashita et al., 1977 ; Kaplan et 
al., 1977). However, a major drawback of these early assay systems was 
that the elongation of daughter DNA strands in vitro, could only proceed 
on molecules which had already been initiated in vivo. This fact 
combined with the short "half-life" of the complexes, after extraction.
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made these early in vitro systems unsuitable for further analysis of the 
replication mechanism.
A major breakthrough in the study of adenovirus DNA replication 
was the development by Challberg and Kelly (1979) of an in vitro 
replication system consisting of cell-free soluble extracts from the nuclei 
of Hela cells isolated from adenovirus type 5, Ad.5 DNA-protein 
template in the presence of both ATP and Mg2+. This represented the 
first working adenovirus DNA replication system in which both the 
initiation and elongation of DNA replication occurred entirely in vitro.
4.3. A model for the mechanism of adenovirus DNA replication :
**Protein-priming mechanism".
Replication of the linear 36Kbp adenovirus genome (reviewed: Hay and 
Russell, 1989 ; Stillman et al,, 1989) initiates via a protein-priming model 
first proposed by Rekosh et al, (1977), Initiation starts at the origins, 
which are located at the ends of the genome, by the covalent linkage of 
dCMP to the P-hydroxyl group of a serine residue in the terminal protein 
(TP) or to be more exact, in its precursor (pTP), by the adenovirus DNA 
polymerase (Ad.DNA pol). The polymerase then proceeds to synthesise 
a new strand starting from the 3'-0H end of the dCMP moiety (reviewed 
in Salas, 1991). The non-template strand is displaced during this reaction 
and the adenovirus DNA-binding protein (DBP) binds this displaced 
single-strand and protects it from nuclease digestion (Van der Vliet et al,
1977). The molecular ends of the totally displaced ssDNA may 
subsequently hybridise to each other via its long inverted terminal repeat 
(ITR) sequences (Hay et al, 1984). The resulting partially double­
stranded DNA, called a "panhandle”, contains a functional dsDNA origin 
sequence at its ends. Replication from this origin results in the formation 
of a fully duplex daughter molecule (Leegwater et al, 1988). However, it
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is not clear whether panhandle formation is an absolute requirement for 
second strand synthesis since it has been demonstrated in vitro that 
initiation can also take place on single-stranded templates (Kenny and 
Hurwitz, 1988). It is thought that the complex of DBP with the displaced 
ssDNA strand forms a preferred substrate for the incoming DNA 
polymerase. Late during infection, the precursor terminal protein is 
cleaved by a 23KDa virally encoded protease to its 55KDa mature 
terminal protein form. A schematic diagram of this model is shown in 
figure 3.
5. Ad.2 / Ad.5 DNA replication origins.
Mutational analysis of plasmids containing the terminal sequences for 
Ad.2 and Ad.5, which possess nearly identical origin sequences, in DNA 
replication assays (in vitro) revealed the existence of three different 
functional domains within the terminal 51 base-pairs of the viral genome 
important for efficient DNA replication. The first domain consists of the 
first 18 base-pairs of the genome and constitutes the minimal replication 
origin. This "core" region is very A-T rich and contains the sequence 5’- 
ATAATATACC-3' (between nucleotides 9 and 18) which is fully 
conserved in different adenovirus serotypes (Tamanoi and Stillman, 1983 
; Challberg and Rawlins, 1984). Base-pair changes within this conserved 
sequence greatly reduced the template’s ability to replicate. This 
conserved region between nucleotides 9 and 18 has been implicated in 
binding to the preterminal protein (Temperley et al., 1992). The second 
region comprises the region of DNA sequence between nucleotides 19-39 
and is the binding site for the cellular transcription nuclear factor I 
(Nagata et al., 1983). The presence of this domain, which is present in 
some, but not all adenovirus serotypes (except Ad. 4, Ad.9 and Ad. 11), 
increases the efficiency of initiation of replication. The third domain
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Figure 3. A model for adenovirus DNA replication with schematic 
representations of viral proteins shown.
Lines with arrow heads represent newly synthesised DNA. The arrow 
indicates the direction of synthesis.
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found between nucleotides 39 and 51 is highly conserved and 
corresponds to the nuclear factor III binding site. It is not essential, but 
stimulates the initiation of DNA replication (Pruijin et al., 1986). The 
roles of NF-I and NF-III in DNA replication will be discussed more 
thoroughly in a later section. The origin requirements for Ad.2 have also 
been defined in vivo using a system in which transfected plasmids 
containing cloned origin sequences are amplified in the presence of a full 
complement of viral replication proteins provided by co-transfected 
helper virus (Hay, 1984). This technique was initially developed for the 
isolation of other eukaroytic origins of replication, such as SV40 (Myers 
and Tjian, 1980) and HSV (Stow, 1982b). A series of plasmids 
containing deletions in the Ad.2 ITR were used in such an assay, with 
Ad.2 helper virus, and revealed that DNA molecules containing ITR 
sequences deleted to within 45bp of the terminus were replicated as 
efficiently as those containing a complete ITR sequence. However, 
plasmids containing ITR sequences containing ITR sequences deleted to 
within 36bp of the terminus were not replicated, demonstrating that all 
the sequences required for an origin of Ad.2 DNA replication in vivo are 
contained within the terminal 45bp of the genome which contains the 1- 
18 "core" domain and the NF-I recognition site (Hay, 1985a, 1985b). In a 
further study in which ITR's containing such deletions were reconstructed 
into viral genomes it was found that genomes containing deletions which 
removed the NF-I site were non-infectious whereas genomes containing 
the terminal 45bp were fully infectious (Hay and McDougall, 1986).
6. Viral proteins required for adenovirus DNA replication.
Three viral proteins are required for adenovirus DNA replication in vitro; 
the single-stranded DNA-binding protein (DBP), the adenovirus DNA 
polymerase (Ad.DNA pol) that forms a heterodimer complex with the
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third viral protein, preterminal protein (pTP). All three of these proteins 
are transcribed from the E2 region on the adenovirus genome. There are 
two spliced mRNA transcripts produced from this region ; E2a, which 
encodes DBP and E2b which transcribes a 22kb mRNA capable of 
encoding for both the pTP and Ad DNA pol. proteins. Both pTP and 
Ad.pol. are expressed at the same time during infection to help 
heterodimer formation which is needed for efficient DNA replication.
The roles of each of the proteins in adenovirus DNA replication will be 
discussed in the following sections.
6.1. Terminal protein and its precursor: Protein priming of DNA 
synthesis.
Using electron microscopy Robinson et al., (1973) identified the presence 
of a protein linked to the 5' termini of mature adenovirus DNA. The 
55KDa terminal protein (TP) identified was shown to be covalently 
linked to the viral DNA by viitue of the resistance of the DNA-protein 
complex to boiling and SDS treatment. However, early in vitro DNA 
replication studies indicated the presence of an 80KDa precursor terminal 
protein (pTP) covalently attached to the 5' end (Challberg et al., 1980). 
Analysis on an Ad.2 virus protease temperature sensitive mutant (H2tsl), 
which can replicate efficiently at its restrictive temperature, but whose 
progeny virions are not infectious, finally revealed that the 80KDa pTP 
was processed to the mature TP form late in virion assembly (Stillman et 
al., 1981). Furthermore, sequence analysis on the tiyptic peptide maps of 
both virion purified pTP and TP indicated a great deal of amino acid 
homology suggesting that the 80KDa species was indeed the precursor of 
the 55KDa terminal protein. Recent studies on the maturation of 
precursor terminal protein have revealed that this processing event is 
catalysed by a virally encoded 23KDa cysteine protease (present in all the
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adenovirus serotypes) that is activated by a virus coded disulphide-linked 
peptide (Webster et al., 1993). The involvement of precursor terminal 
protein (pTP) in the initiation of DNA replication was demonstrated by 
Lichy et al., (1981) when it was shown that a covalent complex between 
pTP and P^P] labelled dCMP, the 5' terminal nucleotide of the nascent 
strand, was formed in a cell free extract from infected cells in a reaction 
which required viral DNA-protein complex as template, MgCl2, ATP and 
dCTP. pTP capable of forming initiation complex was first purified from 
infected Hela extracts by DNA affinity chromatography (Enomoto et al.,
1981).They found it in a tightly bound complex with a 140KDa protein 
from which it could only be dissociated by sucrose density centrifugation 
under denaturing conditions in the presence of 1.7M urea (Lichy et al.,
1982). Closer investigation of the 140KDa protein confirmed that it was 
the adenovirus DNA polymerase (Field et al., 1984).
Further studies by Rijinders et al., (1983) using an antiserum 
raised against virion purified TP showed that it could inhibit both pTP- 
dCMP complex formation and the specific labelling of Ad. DNA-protein 
terminal fragments. The same anti-TP serum was shown to be ineffective 
against the polymerase activity of purified pTP-Pol complex. Van Bergen 
et al., (1983) then demonstrated using the same anti-TP serum that 
replication on a linearised plasmid containing the Ad.2 ITR's could be 
inhibited, indicating that inhibition was due to an effect on pTP and not 
the mature TP attached to the template. Although the role of pTP in the 
protein priming of Ad.2 DNA has been elucidated, the role played by the 
mature TP protein species in DNA replication is still unclear.
A role for pTP in the nuclear transport of adenovirus DNA 
polymerase has recently been found.Transfection studies by Zhao et al.,
(1988) revealed that pTP could facilitate the transport of wild type 
Ad.DNA polymerase into the nucleus through a direct interaction with
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pTP, Even mutant Ad.DNA polymerase without a nuclear localisation 
signal was transported into the nucleus when pTP was present. The 
formation of these protein-protein complexes in the cytoplasm most 
probably represents an important mechanism for the location of 
replication proteins to their required destinations in the cell.
Initial observations indicated that viral DNA infectivity was 
increased when TP was present (Sharp et al., 1976). This observation was 
reinforced when a number of in vitro DNA replication studies (Tamanoi 
and Stillman. 1982 ; Van Bergen et al., 1983 ; Guggenheimer et al., 1984) 
reported that TP free DNA was less efficient as a template for initiation 
and replication than TP containing DNA. Additionally, it was found that 
the initiation reaction didn't always occur at the termini in protein free 
templates, but at any 0  residues between nucleotide bases 4 and 8 in the 
ITR. These experimental observations suggested several roles for mature 
TP in adenovirus DNA replication: 1. TP could have a role in protecting 
progeny viral linear DNA from digestion by exonucleases; 2, Interaction 
with the preterminal protein( pTP), which is thought to play a part in the 
correct positioning of the replication proteins at the origin of replication 
(Pronk and van der Vliet, 1993); and 3. Strand unwinding of the DNA 
helix template which was confirmed by Kenny et al., (1988). Recent 
evidence suggests that only a small fragment of the TP is required for the 
enhancement of DNA replication in vitro. Pronk et al., (1992) 
demonstrated by employing a-chymotiypsin digestion that a considerable 
part of the TP N-terminus could be lost before the enhancement effect 
was compromised.
Recent evidence suggests that both TP and pTP can mediate the 
binding of adenovirus DNA to the nuclear matrix. Initial in vivo studies 
by Schack et al., (1990) demonstrated that unlike wild-type TP-DNA 
viral DNA with a mutant TP attached was defective in nuclear matrix
33
binding and subsequently not efficiently packaged into mature virions. 
This hypothesis gained support when in vivo and in vitro studies by 
Fredman and Engler, (1993) revealed that vaccina virus purified pTP 
could compete with both nuclear matrix bound pTP and TP-DNA. This 
has suggested that there are at least two ways in which the matrix might 
aid in DNA replication. One possibility is that the nuclear matrix plays a 
structural role, providing a locale at which both the replication proteins 
and viral DNA can interact. Alternatively, the matrix may play a role by 
providing access to required factors (enzymes) embedded within its 
stmcture. However, the role of the matrix is probably structural, since the 
in vitro DNA replication system of adenovirus was developed in the 
absence of proteins from the nuclear matrix.
6.2. Adenovirus DNA polymerase.
During the purification of precursor terminal protein from an Ad.2 
infected cytosolic extract (Enomoto et al., 1981) two protein species 
which were essential for DNA replication were isolated. These were; an 
80KDa species found to be preterminal protein and a 140KDa protein 
with a unique DNA polymerase activity distinguishable from various 
cellular DNA polymerase species (a, p and y). These two proteins 
copurified in a tight heterodimer complex which only separated into its 
component parts after fractionation on a glycerol gradient containing 
1.7M urea. This was confirmed by Lichy et al., (1982) who also 
demonstrated that the DNA polymerase activity resided in the 140KDa 
species and didn't require the 80KDa pTP protein species.
The viral origin of the DNA polymerase was first suggested from 
complementation experiments with a group of temperature sensitive E2 
transcription mutants of Ad.5 (Group N mutants ) defective in both the 
initiation and elongation of DNA replication in vivo (Stillman et al., 1982
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; Van Bergen et al., 1983). Furthermore, nuclear extracts prepared from 
cells which were subsequently infected with these mutant viruses were 
unable to support pTP-dCMP complex formation in vitro. However, upon 
addition of the 140KDa DNA polymerase, replicative activity was 
restored to the extracts (Stillman et al., 1982).
Once purified to homogeneity the DNA polymerase underwent 
rigorous biochemical characterisation. Comprehensive studies carried out 
by Field et al., (1984) revealed that both the pTP-dCMP and DNA 
polymerase activities were inactivated in the presence of N- 
ethylmaleimide (5mM) or by heating at 55°C for 15 minutes. These early 
studies also seemed to indicate that the virally encoded polymerase 
resembled the eukaryotic DNA polymerase a  as it used activated DNA 
(nicked) as a template and was sensitive to both cytosine p-D-arabinoside 
5'-triphosphate and sodium chloride. However, it differed from DNA 
polymerase a  when it was shown to be less sensitive to ddTTP and 
Aphidicolin. Further in vitro adenovirus DNA replication studies by 
Lichy et al., (1982) then revealed that both pTP-dCMP formation and 
chain elongation to the 26th nucleotide were unaffected in the presence of 
aphidicolin. However, extensive chain elongation was found to be 
affected by aphidicolin and resulted in the accumulation of DNA chains 
approximately lOkb in length (Nagata et al., 1983). The existence of an 
aphidicolin resistant viral polymerase was later confirmed when the E2b 
transcription region (containing both the pTP and pol mRNAs) was 
cloned and expressed in Cos cells. A 140KDa aphidicolin resistant DNA 
polymerase activity identical to that of the putative Ad.DNA polymerase 
was detected in extracts of transfected cells (Shu et al., 1987).
Fields et al., (1984) initially observed that the Ad. DNA polymerase 
could utilise a variety of homopolymer template-primers. Ad. DNA pol. 
could replicate on: poly d (C): oligo d (G), poly d (C): oligo r (I), poly d
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(T): oligo d (A), and poly d (T): oligo r (A), but not on poly d (G), poly d 
(I) or poly d (GC) templates.
The purified Ad.DNA pol. was also found to contain a 3’-5’ 
exonuclease activity whose probable function is to increase the fidelity of 
replication by removing mismatched nucleotides (Reha-krantz and 
Bessman, 1977). The exonuclease function which is shared with other 
viral and prokaryotic DNA polymerases (Bemad et al., 1989) was found 
to be 10-fold more active on single-stranded than duplex DNA (Field et 
al., 1984).
The presence of DBP was found to have a profound effect on both 
the DNA polymerase and exonuclease activities of the Ad. polymerase 
(Field et al., 1984) DNA synthesis on poly ( dT ) : oligo ( rA ) was 
stimulated 10-100 fold by the presence of DBP and a further 3-10 fold 
suggesting that it increased the processitivity of the Ad. polymerase. 
However, this effect was found to be template specific as DNA synthesis 
on activated DNA and poly ( dC ) : oligo ( dG ) were not affected by 
DBP. Other single-stranded binding proteins (SSB's) e.g. E.coli SSB 
were unable to substitute for Ad. DBP. Alternatively, it was found that 
Ad.DBP did not substitute for HSSB in stimulating the activity of human 
cellular polymerase a. These results were consistent with a reported 
specific cooperative interaction between DBP and the Ad.DNA 
polymerase (Lindenbaum et al., 1986). DBP is thought to act in this 
complex by stabilising the interaction between Ad. DNA polymerase and 
the DNA template. Indirect evidence for the formation of a physical 
complex came from work by Lindenbaum et al., (1986) who observed an 
increase in the thermostability of Ad.DNA pol in the presence of an 
excess of DBP. Although physical evidence of functional complexes 
between SSB's and DNA polymerases have been found in a variety of 
prokaryotes such as T4 and T7 (Huberman and Komberg, 1971; Reuben
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and Gefter, 1973) and eukaryotes like human SSB (Kenny et al, 1989, 
1990) it has not yet been possible to isolate an Ad DNA polymerase 
-DBP complex.
In addition to its polymerase function Ad.pol also possesses an 
intrinsic 3'-5’ exonuclease activity, common to many prokaryotic and 
eukaryotic DNA polymerases (Bemad et al., 1989). This exonuclease 
which is thought to have a role in the proof-reading of nascent DNA 
during elongation, was found to be inhibited up to 7-fold by the presence 
of DBP. The nature of inhibition by DBP was shown to be due to a direct 
effect upon the DNA polymerase rather than binding to and protecting 
the DNA (Lindenbaum et al., 1986).
Recent affinity chromatography studies by Bosher et al., (1990) have 
demonstrated that Ad.2 DNA polymerase can also interact with the 
cellular protein nuclear factor I (NF-I), which has been shown to 
stimulate the initiation of adenovims DNA replication between 5-30 fold 
(Mul and Van der Vliet, 1990). Only Ad.pol and the pTP-pol heterodimer 
complex protein species were observed binding to a matrix containing 
NF-I immobilised on sepharose. pTP alone did not bind to the NF-I 
affinity column. These same conclusions were reached by Chen et al., 
(1990) who found that an antibody raised against Ad.DNA polymerase 
precipitated two protein species; Ad. DNA pol and NF-I. This protein- 
protein interaction is thought to play a role in the assembly of the 
preinitiation nucleoprotein complex at the adenovirus DNA origin of 
replication. The pTP-pol heterodimer can recognise the 1-18 adenovirus 
"core" origin sequence on its own and bind to it without the aid of NF-I, 
but at much lower levels (Temperley and Hay, 1992). It is thought to do 
this through the ability of the polymerase to bind DNA. Mutational 
analysis by Joung and Engler, (1992), has identified two putative 
cysteine-histidine rich clusters in the Ad.2 DNA polymerase, that affect
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its DNA-binding and presumably polymerisation functions. N-terminal 
domain mutations in this enzyme had a moderate effect on both DNA 
synthesis and elongation, but failed to make the pTP-dCMP complex or 
bind DNA. C-terminal mutants had the greatest effect on both DNA 
synthesis, DNA-binding and pTP-dCMP complex formation.
Recent in vivo evidence by Ramadhandra et al., (1993) has shown 
that the Ad.DNA polymerase is a phosphoprotein with its activity 
modulated by both phosphoiylation and dephosphorylation events. Using 
both in vivo phosphorylation and tryptic peptide map analysis, they 
demonstrated that Ad.DNA polymerase from adenovirus infected Hela 
cells and a vaccinia virus vector were phosphorylated on identical 
peptides at Ser 67. The importance of phosphate group(s) on its 
replication initiation activity (in vitro) was shown when 
dephosphorylation of the Ad.DNA pol by calf intestinal alkaline 
phosphatase prior to its addition to the reaction resulted in a significant 
decrease in pTP-dCMP complex formation. Additionally, they have 
demonstrated that the polymerase is phosphorylated by a stably 
associated Histone HI kinase which exhibits properties similar to the 
cdc2 family of kinases (Ramachandra and Padmanabhan, 1993).
The adenovirus DNA polymerase shares regions of high amino acid 
sequence homology with a large number of DNA polymerases including 
several prokaryotic phage polymerases (bacteriophages T4 and (j) 29), 
eukaryotic polymerases (human DNA polymerase a) and viral 
polymerases (adenovirus, herpes simplex and vaccinia virus). Four 
conserved amino acid regions designated I-IV (I being the most 
conserved between species) have been found in the adenovirus DNA 
polymerase. The most conserved regions (I II ) are found in the C- 
terminal domain of the protein and have been implicated in metal binding 
(region I) and substrate binding (regions II and III ). However, it has to be
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pointed out that the functional importance of these regions in the 
adenovirus DNA polymerase is only based on sequence homology 
(Bemad et al., 1987) and comparison with regions in mutant HSV DNA 
polymerases that confer altered sensitivity to nucleotide analogues such 
as aphidicolin and acyclovir (Larder et al., 1987 ; Marcy et al., 1990).
6.3. Adenovirus DNA binding protein (DBP).
The relatively high abundance of DBP during the adenovirus infection 
cycle (maximum of 5x10^) helped make it become the first of the DNA- 
binding replication proteins to be identified and subsequently purified. 
Van der Vliet and Levine, (1973) initially reported the isolation of two 
polypeptide species of 72KDa and 48KDa from cells infected with Ad.5. 
No DBP was found in uninfected cell extracts. Further investigations 
revealed that the smaller of the two species was the proteolytic 
breakdown product of the larger (Levinson and Levine, 1977).These 
initial studies indicated that the two protein species bound specifically to 
single-stranded DNA (ssDNA), but not duplex DNA (ds DNA).
However, more in depth DNA binding studies revealed that only the 
72KDa full-length DBP species bound to both ssDNA and dsDNA 
(Fowlkes et al,, 1979 ; Schechter et al., 1980). DBP binding was also 
found to be specific for the termini of a linear DNA template, with closed 
circular DNA molecules not being bound to any great extent. However, 
EM studies by Kedinger et al., (1978) revealed that only the single­
stranded regions of DNA in replicative intermediates isolated from 
infected nuclei were coated with DBP, suggesting that in vivo the binding 
of DBP to DNA differed from that observed in vitro. More recent in vitro 
binding studies indicate that DBP can also bind to RNA (Cleghom and 
Klessig, 1986). Although DBP apparently has a molecular weight of 
72KDa this was subsequently shown to be an abenant electrophoretic
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mobility, with its true molecular weight as predicated from amino acid 
composition being around 59KDa (Kruijer et al., 1981).
The essential functional role played by DBP in adenovirus DNA 
replication was directly demonstrated in early in vitro systems where 
addition of anti-DBP antiserum was observed to inhibit elongation of 
nascent strands in isolated nuclei (van der Vliet et al., 1977). Further in 
vitro support for this idea came from the use of two temperature sensitive 
mutants of Ad.5: H5tsl25 and H5tsl07. Nuclear extracts from both of 
these mutants were found to be defective for full-length Ad.DNA 
replication on both exogenous and endogenous templates (Friefeld et al.,
1983). In both cases activity was restored by the addition of purified 
wild-type DBP.
Although the role of DBP in elongation has been well documented 
over the years by both in vivo and in vitro studies, its role in the initiation 
of adenovirus DNA replication is still unclear. Shortly after the 
development of an in vitro initiation system (Challberg and Kelly, 1979) 
it was demonstrated that the addition of DBP to crude infected cell 
extracts, had no effect on the formation of the pTP-dCMP complex 
indicative of successful initiation (Lichy et al., 1981). Friefeld et al., 
(1983) subsequently showed that extracts derived from temperature 
sensitive mutant H5tsl25 infected cells could in fact support pTP-dCMP 
complex formation to wild-type levels at the non-permissive 
temperature. These same extracts were unable to elongate on in vivo 
initiated DNA templates (Friefeld et al., 1983 ; Van Bergen and Van der 
Vliet, 1983). This suggested that DBP was dispensable for initiation but 
not elongation. However, more recent studies have observed a 
stimulatory effect on the level of initiation when DBP is present (Kenny 
and Hurwitz, 1988 ; Cleat and Hay, 1989 ; Mul and van der Vliet, 1993). 
The most likely explanation for these reported differences is that DBP
40
acts on initiation in a concentration dependent manner. At saturating 
concentrations DBP is probably inhibiting initiation by saturating the 
DNA template, thus preventing protein-protein interactions between the 
other replication proteins, required for their correct positioning at the 
origin of replication. A stimulatory effect at subsaturating concentrations 
could be due to a functional interaction between DBP and NF-I, a cellular 
DNA-binding protein which has also been found to stimulate the 
initiation of DNA replication. Evidence for the latter came from De 
Vries et al., (1985) who observed that NF-I’s ability to stimulate 
initiation in vitro was influenced by the concentration of DBP. 
Subsequent experiments demonstrated that the effect was cooperative in 
nature, suggesting that there was some kind of specific protein-protein 
interaction between the two proteins (Cleat and Hay, 1989 ; Stuiver and 
van der Vliet, 1990). However, no direct evidence for this interaction was 
found, either in vivo or in vitro. An alternative theory by Cleat and Hay,
(1989) explained the effect as a result of DBFs ability to alter the 
structure of the DNA it bound to, i.e. DBP binds and alters the structure 
of the DNA in a specific way that facilitates NF-I binding. Support for 
the latter has come from recent in vitro structural studies on the nature of 
d,s.DNA-DBP complexes. Using a combination of electron microscopy, 
hydroxyl footprinting and circular dichroism Stuiver et al., (1992) have 
demonstrated that DBP can remove the tertiaiy structure of d.s. DNA 
fragments upon binding. This led to the suggestion that the structure of 
the DBP-DNA complex could well alter the hydrogen bond positions in 
the major and minor grooves, causing a fine tuning of the contacts 
between NF-I and the nucleotide bases, leading to a change in the NF-I 
binding affinity.
Recent studies by Mul and Van der Vliet, (1993) have 
reinvestigated the effect of DBP on DNA replication with respect to the
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activities of both NF-I and Ad.DNA pol. They have proposed that DBP 
stimulates the initiation of Ad.DNA replication in two ways: by 
increasing the Vmax of the reaction at low NF-I levels, helping NF-I to 
bind DNA more easily, decreasing the Km of the polymerase for the 
initiator nucleotide dCTP. Km reduction could occur by DBP facilitating 
the unwinding of the replication origin, improving the presentation of 
important initiator nucleotides to Ad.DNA pol. or alternatively, DBP 
could induce a "better fit" for the initiator dCTP nucleotide in Ad.DNA 
pol. via either structural changes in the DNA or through a direct protein- 
protein interaction with the Ad.DNA polymerase. Indirect support for the 
former has come from earlier studies on Ad,DNA polymerase's 
sensitivity to the nucleotide analogue (s)-HPMPAapp (Mul et al., 1989). 
In these studies the sensitivity of Ad.DNA pol. for the drug was 
increased in the presence of DBP.
Partial chymotryptic digestion of purified DBP yields a C-terminal 
fragment of around 40KDa and a highly phosphorylated 27KDa N- 
terminal fragment (Klein et al, 1979) which are apparently functionally 
separate. Nucleotide sequence analysis on the C-terminal portion has 
revealed that it is conserved between all adenoviruses serotypes 
(Kitchingman et al., 1985 ; Vos et al., 1988). More detailed analysis on 
the C-terminal domain using temperature sensitive mutants of DBP 
revealed the presence of highly conserved "clusters" of amino acids 
which appear to be essential for DBFs functions in DNA replication. 
This supported earlier evidence by Ariga et al., (1980) and Friefeld et al.,
(1983), who both demonstrated that the C-terminal fragment alone was 
capable of binding DNA and stimulating DNA replication. Armed with 
this information, Neale and Kitchingman, (1990) created a series of 
mutants located in each of the three highly conserved regions of the C- 
terminal domain. These were all found to alter DBFs ability to bind to
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single-stranded DNA templates in vitro. Further investigation revealed 
the presence of a zinc binding motif within this domain (between amino 
acids 273 and 286) which when mutated destroyed all of DBFs functions 
(Eagle and Klessig, 1992). More recent studies using limited proteolysis 
and photo-crosslinking techniques have revealed that the two residues, 
Methionine 299 and Phenylalanine 418, also play an important part in 
DBFs ability to bind ssDNA (Cleghom and Klessig, 1992). The recent 
elucidation of the x-ray crystal structure of the C-terminal region 
(Tucker et al., 1994 Personal communication) should help in the further 
characterisation of DBFs role in DNA replication.
Mutations in the N-terminal domain do not seem to have the same 
effect on DBF's functions. Vimses carrying mutations in their N-terminal 
region have been shown to bind and replicate their DNA normally. 
However, the mutant viruses did show a change in their host range which 
was demonstrated as being due to the altered processing of the mRNA 
transcript encoding the fibre protein (Anderson and Klessig, 1984).
Sequence analysis on DBP from various serotypes has been completed 
and reveals that all appear to possess the characteristic two domain 
stmcture, with the N-terminal region showing the most variation between 
serotypes (30-40% at the amino acid level) and the C-terminal region 
being the most conserved (60-80%).
7. Cellular proteins involved in adenovirus DNA replication.
Limited initiation of DNA replication in vitro can occur in the presence 
of only the virally encoded pTP, Pol and DBP proteins (Rawlins et al.,
1984). However, the addition of a cmde nuclear extract of uninfected 
Hela cells was observed to restore efficient levels of initiation. This 
stimulatory effect was due to the presence of two cellular transcription 
factors, Nuclear factor I (NF-I) and Nuclear factor III (NF-III).
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Transfection experiments indicate that NF-I and not NF-III are needed for 
in vivo DNA replication (Hay, 1985a ; Hay 1985b). Full elongation of the 
adenovirus DNA in vitro also requires the presence of the additional 
cellular factor, Nuclear factor II  (N F -I I ) .
7.1. Nuclear Factor I (NF-I).
Early in vitro DNA replication studies by both Ikeda et al., (1981) and 
Lichy et al., (1982) demonstrated the need for an unknown component in 
uninfected Hela cell nuclear extract, for optimal initiation and elongation 
in the presence of infected cytosol or purified pTP-pol heterodimer and 
DBP. An initiation and elongation enhancing activity was subsequently 
purified from the nuclear extract by Nagata et al., (1982). This 'active’ 
fraction contained no detectable topoisomerase, nuclease, ATPase, RNA 
or DNA polymerase activities. The fraction contained a single major 
protein species with a molecular weight of 47KDa and was termed 
nuclear factor I (NF-I).
The early characterisation of NF-I concentrated on its ability to 
specifically bind the adenovirus origin. DNase I footprint analysis 
revealed that NF-I protected a region between nucleotides 17-48, which 
was subsequently found to be conserved between a number of adenovirus 
serotypes (Nagata et al., 1983 ; Rawlins et al., 1984 ; Leegwater et al.,
1985). Extensive mutagenesis and deletion analysis on this NF-I binding 
site revealed that the protein actually bound to a smaller core consensus 
binding sequence 5 -TGGC (N6) GCCAA-3' (Leegwater et al., 1985 ; 
Gronostajski et al., 1984,1987 ; De Vries et al., 1985). Méthylation and 
éthylation interference studies subsequently demonstrated that NF-I 
protected G and T residues in the major groove and on the phosphate 
backbone of the helix (De Vries et al., 1987). Further investigation 
revealed that the contacts made were similar in each of the two blocks of
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symmetrical sequence and that inversion or replacement of the entire NF- 
I binding site had no effect on the efficiency of Ad.2 DNA replication in 
vivo or in vitro (Adhya et al, 1986 ; Hay et al, 1988). This suggested that 
NF-I bound to its site as a dimer, making base contacts on one side of the 
helix only (De Vries et al, 1987). Extensive sequence homology searches 
have shown that NF-I binding sites are also present in the promoter 
regions of eukaryotic genes such as the chicken lysozyme gene 
(Borgmeyer et al., 1984), human IgM gene (Hennighausen et al., 1985) 
and viral regulatory regions such as the CMV immediate-early promoter 
(Hennighausen and Fleckstein, 1986) and the MMTV LTR promoter 
(Nowock et al., 1985). In most of these cases deletion of the NF-I sites 
from these upstream regulatory sites resulted in a reduction in the level of 
gene transcription. Correspondingly, a five fold stimulation of 
transcription in vitro was observed when NF-I sites were inserted 
upstream of the TATA box of the adenovirus major late promoter 
(Gronostajski et al., 1988).
A wide range of proteins with NF-I like activity have been isolated 
from various sources. Analysis of extracts from human cells using 
affinity chromatography identified a number of NF-I like proteins 
ranging in size between 52-66KDa (Rosenfeld et al., 1987). Limited 
proteolysis revealed that these proteins had similar polypeptide patterns 
suggesting that they were all members of the same family. In addition, 
mRNA transcripts encoding NF-I like proteins have been found in rat, 
hamster and pig (Paonessa et al, 1988 ; Gil et al, 1988 ; Meisterernst et 
al., 1989). On the basis of immunological cross-reactivity data, amino 
acid composition and proteolytic cleavage patterns it appears that the NF- 
I proteins are indistinguishable from CCAAT-binding transcription 
factors (CTF's), a family of proteins involved in cellular gene 
transcription. Analysis of the cDNA's from various human NF-I / CTF
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mRNA’s have shown that they all originate from a single gene, giving 
rise to multiple mRNA transcripts by differential splicing of a precursor 
molecule (Santoro et al., 1988 ; Meistemst et al, 1989). The NF-I proteins 
had virtually indistinguishable DNA binding activities and stimulated 
Ad.2/Ad.5 initiation of DNA replication in vitro. Mutagenesis studies 
on the cDNA of the largest NF-I protein (CTF-1) identified two 
functional domains: a highly conserved N-terminal protease resistant 
domain 158 amino acids in length, which contains the functions for 
DNA-binding, dimérisation and DNA replication (Santoro et al., 1988 ; 
Mermod et al., 1989 ; Gounari et al., 1990 ; Bosher et al., 1991), and a 
less highly conserved, proline rich C-terminal domain which contains a 
transcriptional activation function (Mermod et al., 1989).
Binding of the N-terminal domain to DNA is sufficient to stimulate the 
initiation of adenovirus DNA replication (Bosher et al., 1991). However, 
activation of transcription requires the presence of both domains.The C- 
terminal region is presumed to be important for interaction either directly 
with components of the transcriptional machinery such as theTATA 
binding protein, (TBP), RNA polymerase or with transcriptional activator 
proteins, e.g. Spl, AP-1. It has been demonstrated that transcriptional 
activation of a collagen type I promoter by transforming growth factor 
(TGFb) is mediated by an NF-I site, suggesting that it may be modified 
by an interaction with other transcription proteins into an active 
conformation allowing it to activate transcription (Rossi et al., 1988).
This hypothesis has gained more recognition recently as NF-I binding 
sites have been found in the enhancer regions of Human Papillomavirus 
Type 16 (Apt et al., 1993), Human polyoma JC virus (Kumar et al., 1993) 
and Mouse mammary tumour virus (Mink et al., 1992), In each of these 
cases addition of NF-I led to transcriptional activation, but only in the 
presence of other activators that also had binding sites in the enhancer
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regions. Although no direct physical evidence for protein-protein 
interactions between NF-I and these other activators exists it seems 
probable that these interactions play an important role in activation.
It is still not known if all the members of the NF-I/CTF family 
are exclusively involved with either DNA replication, transcription or 
both. However, it has been shown that an NF-I protein from chicken 
erythrocytes which can stimulate lysozyme transcription can also 
substitute for human NF-I in stimulating adenovirus DNA replication 
(Leegwater et al., 1986). This suggests that the NF-I/CTF proteins have a 
high degree of functional conservation amongst themselves, with their 
function in transcription and DNA replication being interchangeable.
The mechanism of stimulation of Ad. DNA replication by NF-I in 
vitro is complex (Mul et al., 1990). The degree of stimulation appears to 
be strongly dependent on the concentration of pTP-pol. At low pTP-pol 
concentrations, NF-I or NF-I-BD stimulated replication up to 50-fold, 
while at high concentrations stimulation was less than two-fold. This 
demonstrates that the in vitro need for NF-I can be overcome by high 
pTP-pol concentrations. This result provided an explanation for the 
different levels of stimulation by NF-I reported previously (Adhya et al., 
1986 ; De Vries et al., 1985) as well as a strong indication for a direct 
interaction between NF-I and pTP-pol (see next paragraph).
The orientation and spacing between the NF-I site and the 1-18 
core origin sequence is critical in adenovirus DNA replication. Insertion 
of additional sequence between these two sequence regions abolished 
NF-I mediated stimulation of DNA replication in vitro (Adhya et al., 
1986 ; Wides et al., 1987) and in vivo (Bosher et al., 1990). This 
suggested that a strict constraint on the spatial arrangement between the 
1-18 core sequence and the NF-I site existed which was necessary to 
allow specific protein-protein interactions between NF-I and other
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replication proteins. This was shown to be the case when both Bosher et 
al., (1990) and Chen et al., (1990) demonstrated that the Ad.DNA 
polymerase and NF-I made a specific protein-protein interaction on the 
adenovirus origin of replication. On the basis of their observations both 
concluded that the interaction between NF-I and Ad.DNA polymerase 
may serve to direct and stabilise the pTP-pol heterodimer complex into a 
preinitiation complex at the adenovirus origin of replication.
7.2. Nuclear Factor in  (NF-III).
The host encoded cellular factor NF-III was initially identified in Hela 
nuclear extracts through its ability to stimulate the initiation of 
adenovirus DNA replication in vitro in the presence of NF-I (Pruijin et 
al., 1986). Purified NF-III has a molecular weight of 92KDa and when 
bound to its recognition site in the adenovirus origin stimulates the level 
of initiation in vitro 3-7 fold (O'Neill and Kelly, 1988). Deletion of this 
site resulted in a 30% decrease in the efficiency of replication in vitro. A 
combination of DNase I footprinting and méthylation protection studies 
on Ad.2 identified the core binding site as, 5 -TATGATAA-3' which is 
situated between nucleotides 39 to 47 in the Ad.2 ITR. Mutational 
analysis has revealed that all of the bases within the recognition site are 
important as NF-III DNA-binding is reduced 2-10 fold when changed. 
This NF-III site which is partially conserved in human adenoviruses is 
not symmetrical and correspondingly it is believed that unlike NF-I, NF- 
III binds as a monomer (Pruijin et al., 1988). A direct relationship 
between NF-III DNA-binding and the level of initiation of DNA 
replication exists, i.e. Ad.2 contains a recognition sequence with a 
relative binding affinity 2.5 times lower than Ad.4 which contains the 
optimal binding site sequence 5 -TATGCAAAT-3' ; correspondingly this 
leads to a lower level of stimulation of DNA replication.
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NF-III also plays an active part in the regulation of transcription in many 
different systems. Sequence homology studies have shown it to be 
identical to members of the Octamer binding protein family a group of 
DNA binding proteins which recognise the consensus sequence 5'- 
TAATGARAT-3' (where R=A or G) and activate transcription. NF-III 
binds to its consensus sequence in a number of transcriptional regulatory 
gene elements e.g. the promoters of the IE genes of HSV, 
immunoglobulin ^H and promoters and in the histone 2B promoter. In 
the case of the herpes simplex virus genes, a functional interaction 
between NF-III and a HSV viral component Vmw65 (VP16), along with 
a cellular protein complex forming factor (CFF), leads to transcriptional 
activation of the herpes virus (O'Hare and Goding, 1988 ; Preston et al., 
1988 ; Amosti et al., 1993).
NF-III's membership of the Octamer binding protein family was 
recognised by O'Neill et al., (1989) and Pruijin et al., (1989) who 
demonstrated that NF-III was functionally similar to another protein 
which bound transcriptional promoters and enhancers termed Octamer 
transcription factor (OTF-1). Pruijin's work demonstrated that both NF- 
III and OTF-1 had indistinguishable mobilities on SDS PAGE gels and 
could stimulate Ad.2 DNA replication. Also, antisera raised against OTF- 
1 could recognise NF-III and inhibit its stimulation of Ad.2 DNA 
replication. Many more Octamer binding proteins have been found and 
identified as having a common, conserved DNA binding region known as 
the POU domain. NF-III contains this domain, which like the N-terminal 
domain of NF-I is sufficient for the in vitro stimulation of Ad.2 DNA 
replication (Veriijer et al., 1990).Transcriptional activation by NF-III 
requires additional protein regions either through self-dimerisation or 
interaction with other POU containing proteins, such as Pit-1 (Verrijer et 
al,, 1992). The actual POU domain can be subdivided into an N-terminal
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74 amino acid POU-specific domain and a C-terminal POU 
homeodomain (Strum and Herr., 1988). It has been demonstrated that the 
POU homeodomain binds to DNA and inhibits DNA replication, 
suggesting that the POU specific domain is ultimately responsible for the 
stimulation of DNA replication.
NF-III's function in the initiation of adenovirus DNA 
replication is still not as defined as it is for NF-I. This has been based on 
observations which show that efficient initiation in vitro can exist in the 
absence of NF-III provided that NF-I is present (Rosenfeld et al., 1987). 
This was confirmed by studies which demonstrated that mutant Ad.2 
viruses containing genomes with a deleted NF-III site were as infectious 
as wild-type virus with an intact NF-III site (Hay and McDougall, 1986). 
However, transfection assays on plasmids containing only an NF-III site , 
(no NF-I site) found that they could stimulate the basal level of Ad.2 
DNA replication when compared to plasmids containing only the 1-18 
core origin of replication (Hay et al., 1988). This confirmed in vitro 
replication studies by Mul et al., (1990) who found that both the NF-III 
and NF-I binding sites were needed for optimal stimulation of replication. 
Since the binding sites of the two proteins overlapped, this suggested that 
they could interact as a an NF-I / NF-III complex in a cooperative manner 
to stimulate DNA replication. However, since no evidence about any 
such an interaction exists it seems that both proteins can, by binding to 
their respective recognition sites, stimulate initiation independently and 
without steric hindrance (Mul et al., 1990). An alternative explanation 
that explains NF-III's ability to stimulate replication has been presented 
by Verrijer et al., (1991), who demonstrated that NF-III was able to bind 
the adenovirus DNA via its POU specific domain. This altered structure 
may enhance pTP-pol binding to the 1-18 "core" origin region of the 
genome. Alternatively, NF-III induced binding may position adjacently
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bound proteins which the POU specific domain can interact with, such as 
VP16 (O'Hare and Goding., 1988 ; Preston et al., 1988) in such a way as 
to allow functional protein-protein interactions.
7.3. Nuclear Factor II (NF-II).
The search for another host encoded replication factor was carried out by 
Nagata et al., (1983) based on the observation that the products of DNA 
synthesis on terminal protein containing DNA (TP-DNA) were only 25% 
of the size of full-length DNA. The factor was eventually purified from 
uninfected Hela nuclear extracts and was termed nuclear factor II (NF-II). 
SDS PAGE analysis revealed NF-II to be a 30KDa complex of two 
proteins with molecular weights of 15KDa and 17KDa. These purified 
NF-II preparations contained no detectable nuclease, ATPase, RNA or 
DNA polymerase activities, but contained Type I topoisomerase activity. 
NF-II which is not a sequence specific DNA binding protein like NF-I 
and NF-III, was found not to be required for the initiation of DNA 
replication or even in the elongation of short templates. However, it was 
required for the synthesis of full-length DNA strands. NF-II's function 
could be substituted by the lOOKDa eukaryotic topoisomerase I, 
suggesting that NF-II may be a different species of cellular topoisomerase 
or even a "core" subunit of topoisomerase I which has undergone 
proteolytic cleavage.
7.4. Factor pL.
Factor pL was Erst identified by Guggenheiner et al., (1984) who purified 
the 44KDa protein from uninfected Hela nuclear extracts on the basis that 
it was specifically required for the initiation of plasmids containing the 
adenovirus origin of replication. pL was found to have no effect on TP- 
DNA template replication, but was required for TP minus template
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replication. The purified protein contains a 5'-3' exonuclease function 
which is thought to stimulate the initiation of adenovirus DNA replication 
by rendering the 3’ end of the adenovirus genome single-stranded, 
allowing pTP-pol direct access to the 3' end. However, the use of 
partially single-stranded oligonucleotides as templates demonstrated that 
pL's function could be abolished (Kenny et al., 1988). This suggests that 
pL is unlikely to play a role in DNA replication in vivo, since it doesn’t 
affect the in vitro DNA replication of TP containing templates.
8. Adenovirus type 4 DNA replication.
Early transfection studies demonstrated that plasmids containing an Ad.2 
replication origin could be replicated efficiently when supported with 
either an Ad.2 or Ad.4 helper virus. However, plasmids containing Ad.4 
origin sequences were only found to be efficiently replicated when co­
transfected with Ad.4 helper virus genome.By comparison co­
transfection with Ad.2 helper virus gave around a 20-fold reduction in 
replication (Hay et al., 1985b). Sequence analysis of the replication 
origins of Ad.2 and Ad.4 revealed that whilst the 1-18 "core" domain of 
the origin is identical in both serotypes, Ad.4 possesses an A/T rich 
domain in place of an NF-I binding site. Furthermore it was demonstrated 
that Ad.4, in contrast to Ad.2, requires only the terminal 18bp of the viral 
genome for fully efficient DNA replication in vivo.Subsequent in vitro 
replication studies confirmed the in vivo observations when it was 
demonstrated using a crude Ad.4 infected Hela cell extract that linearised 
plasmid containing only the terminal 18bp of an adenovirus ITR could 
support initiation of DNA replication (pTP-dCMP complex formation) in 
vitro as efficiently as a template containing a complete AD.4 ITR (Harris 
and Hay, 1988). Recently, a combination of more extensive sequence 
analysis (Temperley et al., 1991) and in vitro replication studies using a
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purified Ad.4 infected Hela cell extract (Temperley and Hay, 1991) has 
identified two distinct regions within the adenovirus that are required for 
efficient DNA replication. Temperley et al., (1991) examined the effect 
of single base changes in positions 9 to 18 of the Ad.4 origin on DNA 
replication in vitro. Changes in the bases between 12 to 16 had little 
effect, whereas alterations at positions 9,10,11,17 and 18 all reduced 
the efficiency of initiation of DNA replication by between 50 and 90%. It 
was concluded that the region from 9 to 18 bp contained two sets of bases 
(separated by 5base-pairs) essential for DNA replication. The region 
between 9-18bp is thought to be part of the recognition site on Ad.4 for 
the pTP-pol heterodimer. Strong proof for this theory has come from 
studies on Ad.2 when Temperley and Hay, (1992) demonstrated that the 
region between 8 to 17bp was the recognition site for the Ad.2 pTP-pol 
heterodimer. The basis of the difference in origin sequence requirements 
between Ad2/5 and Ad4 is that Ad4 appears to be able to replicate its 
DNA without the need for auxiliary stimulatory functions provided by the 
binding of NF-I and NF-III. Ad.4 does not possess an NF-I recognition 
site although it does have a strong consensus binding site for NF-III 
located at the same position as in the Ad2/5 origin of replication. 
However, it has been unequivocally demonstrated that neither cellular 
factor stimulates Ad4 DNA replication even if their cognate binding sites 
are present in a reconstituted origin of replication (Hay et al., 1988).
Since it appears that NF-I and NF-III play auxiliary roles in Ad2/5 DNA 
replication, whereby the function of the viral replication proteins are 
enhanced or aided by their binding at the origin, the probability is that 
Ad.4 is able to replicate its DNA without them because its own 
replication proteins alone can perform the required functions. Ad.4 
therefore potentially provides a more simplified system in which to
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further study the molecular details of the mechanism of adenovirus DNA 
replication.
9. Simian Virus 40 DNA replication.
Studies on the DNA replication of SV40 have proven it to be an excellent 
model system for providing information on the mechanisms underlying 
cellular DNA replication.
The SV40 genome consists of a circular duplex DNA molecule of 
about 5000 base-pairs and contains a single origin of DNA replication. 
Replication takes place in the nucleus of the host cell where the genome 
is complexed with cellular histones to form a nucleoprotein complex 
(minichromosome) which is indistinguishable from cellular chromatin. 
Since SV40 only encodes a single viral protein involved in DNA 
replication, T-antigen (an 82KDa phosphoprotein), extensive use is made 
of the replication machinery in a manner which differs little from that of 
cellular DNA replication. In both SV40 and cellular DNA synthesis, 
initiation results in the creation of two replication forks that move bi- 
directionally from the origin. At each fork one of the two nascent strands 
(the leading strand) grows continuously, while the other, lagging strand 
grows discontinuously by joining together small 200bp segments of DNA 
(Okazaki fragments) that are independently initiated with RNA primers 
from DNA primase enzymes. Completion of replication occurs when two 
oppositely moving forks meet (reviewed; Hay and Russell, 1989, 
Fanning and Knippers, 1992).
Just as in the study of adenovirus DNA replication, the development 
of an efficient in vitro cell-free replication system in which SV40 DNA 
replication could be initiated and elongated, provided the opportunity for 
greatly accelerated progress in understanding the mechanisms involved in 
the replication process. This breakthrough came when Li and Kelly
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(1984) purified an "active" soluble extract from SV40 infected cells that 
could support initiation and elongation of an exogeneously added DNA 
template containing the SV40 DNA origin of replication. The system was 
found to be absolutely dependent on the presence of the viral T-antigen 
protein and the origin region of the SV40 genome. An important dividend 
from the systems development has been the identification and 
characterisation of the components of the cellular machinery involved in 
SV40 DNA replication.
9.1. The origin of SV40 DNA replication.
The SV40 origin of replication is a 64bp segment of the viral genome that 
has been found to contain all the nucleotide sequence elements required 
for initiation of viral DNA replication in vitro and in vivo. Extensive 
mutational analysis of base substitutions has revealed that the origin is 
complex, consisting of three distinct sequence domains essential for 
origin function. It is composed of a central sequence element containing 
four copies of the pentameric sequence 5 -GAGGC-3' organised as a 
palindrome, and serves as the binding site for the viral T-antigen (T-ag) 
(Tegtmeyer et al., 1983 ; Stillman et al., 1985). The primary role of this 
site is to bind T-ag and position it in the proper location and orientation 
for its subsequent function in DNA replication. It has been demonstrated 
that T-antigen binds to this sequence in the absence of ATP forming a 
range of oligomeric structures from monomers up to tetramers 
(Mastrangelo et al., 1985). The other two domains of the "core" region 
are located on either side of the T-ag binding site. On one side there is a 
17 base-pair A/T rich region which untwists upon ATP dependent T-ag 
binding. (Boroweic and Hurwitz, 1988a). On the other side of the site is a 
lObp imperfect palindrome sequence known as the "early palindrome" 
(Deb et al., 1986). This sequence element contains an 8bp purine-
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pyrimidine tract that opens upon T-ag binding (Borowiec and Hurwitz, 
1988b). All three sequences are required for SV40 DNA replication and 
there is some evidence that the spacing between them may be critical 
(Parsons et al., 1990).
The 64bp "core" region may be sufficient to support initiation, 
but sequences outside of the "core" can have a profound effect on the 
efficiency of the process. Of even greater importance, in vivo, are two 
auxiliary sequence components which flank the SV40 origin, Aux-1 
(another T-ag binding site, teimed site I) and Aux-2 (contains three Spl 
binding sites and three T-ag-binding sites). Aux-1, depending on 
experimental conditions, can stimulate SV40 DNA replication up to 70- 
fold, whereas Aux-2 can stimulate it up to 100-fold (Guo et al., 1991 ; 
Guo and DePamphilis, 1992). Maximum stimulation of SV40 DNA 
replication in vitro requires the presence of both sequences which are 
thought to be involved in the unwinding of the "core" region. Deletion of 
Aux-1 and Aux-2 reduced the efficiency of origin specific DNA 
unwinding when either T-ag containing cell extracts or purified T-ag was 
used (Gutierrez et al., 1990). This data suggested that both Aux-1 and 
Aux-2 facilitate the T-ag dependent unwinding of the SV40 DNA origin. 
This is thought to be due to the T-antigen's ability to form protein-protein 
interactions with the proteins that bind at the Aux sequences, promoting 
DNA unwinding by stabilising the initial unwound replicative 
intermediate (reviewed in DePamphilis, 1993).
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9.2. Initiation of SV40 DNA replication and bidirectional DNA 
synthesis:
T-antigen (T-ag).
Production of the SV40 large T-antigen is initiated soon after infection by 
the virus. The T-ag plays multiple roles during productive infection; it 
regulates the timing of the infection cycle, repressing transcription of its 
own gene, initiating viral DNA replication and stimulating the expression 
of viral capsid proteins. It also stimulates cell proliferation, cell 
transformation and the induction of tumours in animals (reviewed in 
Fanning and Knippers, 1992). Correspondingly, it has been shown to 
interact with cellular proteins implicated in cell growth control, such as 
the tumour suppressor p53 (Braithwaite et al, 1987), the retinoblastoma 
suppressor gene product (De Caprio et al., 1988 ), replication factor A 
(Domreiter et al, 1992) and the DNA polymerase a-primase complex 
(Smale and Tijian, 1986 ; Domeiter et al, 1990).
The large T-ag protein has three main roles in SV40 DNA 
replication. Firstly, it binds as a double hexamer to specific sequences 
("core") within the origin of replication, forming an ATP dependent 
initiation complex (Boroweic et al, 1990). This results in the structural 
distortion and local untwisting of the DNA at the origin. Secondly, it has 
an intrinsic DNA helicase activity which is required for bidirectional 
unwinding of the origin and extending unwinding during DNA synthesis 
(Dobson et al., 1987 ; Dean and Hurwitz, 1991). Last of all it guides the 
DNA polymerase a-primase complex into the unwound origin via 
specific protein-protein contacts with itself and RF-A. These interactions 
position the DNA pola-primase complex in an orientation suitable for 
subsequent full-length DNA synthesis (Collins et al, 1993).
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Replication Factor A (RP-A).
RP-A is a heterotrimeric protein complex consisting of 70KDa, 34KDa 
and llKDa subunits, and participates in the unwinding process as a result 
of its 70KDa subunits ability to unwind DNA strands and stabilise 
regions of ssDNA already created by T-ag and itself, (Georgaki, and 
Hubscher, 1993). The T-ag independent unwinding activity of the 70KDa 
subunit is thought to be facilitated through phosphorylation of the 32KDa 
RP-A subunit by the cdc2 family of kinases (Fotedar and Roberts, 1992). 
The importance of RP-A’s contribution to SV40 DNA replication was 
confirmed when kinetic analysis on in vitro DNA replication studies 
demonstrated that the presence of RP-A led to the elimination of a 10-15 
minute lag which usually preceded the start of DNA synthesis (Wobbe et 
al, 1986 ; Fairman and Stillman, 1988 ; Wold and Kelly, 1988). This 
indicated that unwinding of the origin of replication may be the rate- 
limiting step in initiating DNA synthesis and that RP-A is the only 
cellular protein known to be essential for this step. This preinitiation 
complex of T-ag and RP-A is then thought to be converted to an 
"initiation" complex by the recruitment of the cellular DNA pola-primase 
complex. This step is determined by specific protein-protein contacts 
between T-ag, RP-A and DNA pola-primase (Collins et al, 1993). The 
interactions between these proteins are thought to help in the suppression 
of unspecific priming events.
RP-A is also required during the elongation of SV40 DNA, to 
stimulate the activity of both the cellular DNA pola-primase complex 
(Kenny et al., 1989 ; Tsurimoto and Stillman, 1989a, 1991). RP-A 
stimulates DNA pola-primase activity through direct physical 
interactions with the 70KDa and 32KDa subunits (Fang and Newport, 
1994). These interactions are highly specific as both procaryotic and viral
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single-stranded proteins cannot be substituted for RP-A in complete 
replication reactions (Kenny et al, 1988) This specific interaction 
between ssDNA binding proteins and polymerases can be seen 
throughout procaryotic (E.coli and Bacteriophage T4 and T7) and 
eukaryotic (Adenovirus and Heipes Simplex vims) viral DNA replication 
systems. RP-A (via its 70KDa subunit) has also been shown to bind to 
and stimulate the activity of the cellular DNA polymerase 5. The 
stimulatory effect is complex as it requires the presence of at least two 
other accessoiy proteins: proliferating cell nuclear antigen (PCNA) and 
replication factor C (RF-C),which with RP-A are needed for optimal 
stimulation (Tsurimoto and Stillman,, 1989a, 1989b ; Kenny et al., 1989). 
DNA polymerase ô, unlike DNA polymerase a, is less dependent on RP- 
A originating from the same organism. Tsurimoto et al., (1990) 
demonstrated that SSB's from both E.coli and adenovims could substitute 
for RP-A derived from the same tissue.
Cellular DNA polymerases and processitivity factors.
Early in vivo SV40 DNA replication studies using inhibitors implied that 
cellular DNA polymerase a  was involved in the replication process 
(Krokan et al., 1979). Several lines of evidence suggested that this was 
also the case in vitro. Initial experiments (Ariga and Sugano, 1983 ; Li 
and Kelly, 1984) showed that replication in vitro was inhibited by 
aphidicolin, an inhibitor of DNA polymerase a, and N-ethyImaleimide, 
an inhibitor of polymerase a  and p. In contrast dTTP, an inhibitor of 
polymerases P and y, had no effect on replication. When the polymerase 
was purified from Hela cell extracts it was found to be tightly associated 
with a DNA primase activity (Murakami et al., 1986). Both of these 
activities are absolutely required for SV40 DNA replication in vitro 
(Murakami et al., 1986). The DNA pola-primase complex which has
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been implicated as the lagging-strand polymerase in SV40 DNA 
replication (Collins and Kelly, 1991 ; Murakami and Hurwitz, 1993), is a 
four subunit enzyme that exhibits both DNA polymerase and primase 
functions. These activities were first found in the DNA pola-primase 
complex of Drosophilia melanogaster (Cotterill et al., 1987a, 1987b). 
DNA pola-primase influences SV40 DNA replication through the 
different functions its subunits contain. The largest of these is the 
180KDa subunit A. This subunit contains the DNA polymerase catalytic 
activity and forms a physical interaction with the viral T-ag protein 
(Domreiter et al., 1990,1993). Early in vitro SV40 DNA replication 
assays revealed that RP-A associated with both the DNA pol a-primase 
complex and the T-antigen (Domreiter et al., 1992) in a trimeric complex. 
The interaction between T-ag and the DNA pol a-primase was found to 
be significantly important as the physical coupling of these two 
components of the replication apparatus increases the efficiency with 
which new DNA chains are initiated (Collins and Kelly, 1991 ; Erdile et 
al., 1991 ; Melendy and Stillman, 1993). Absence of any one of these 
components leads to the abolishing of SV40 DNA replication.
The B-subunit(s) of polymerase a  was initially purified and 
sequenced from Drosophilia melanogaster (Conaway and Lehman, 1982). 
Only recently has the B-subunit of human polymerase a  been cloned and 
expressed in large enough amounts to use in characterisation studies. 
Collins et al., (1993) demonstrated that purified human B-subunit protein 
was capable of binding to the viral T-antigen as well as subunit A 
(Catalytic domain) of the DNA polymerase a. Addition of exogenous 
subunit B protein was found to greatly enhance the formation of the 
complex between the catalytic domain of DNA polymerase a  (subunit A) 
and the viral T-antigen. These physical interactions were shown to be 
functionally important when it was demonstrated that T-ag stimulated the
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activity of the DNA polymerase a  catalytic subunit on model templates 
only in the presence of subunit B. This suggested that subunit B was 
acting as a molecular tether whose function was to couple the DNA pola- 
primase complex to the unwinding apparatus. This would increase the 
efficiency of initiation of the first DNA chains at the origin and facilitate 
the subsequent priming and synthesis of DNA chains on the lagging 
strand template by holding the polymerase within the domain of the DNA 
template after it has dissociated from the terminus of a newly synthesised 
DNA strand (Wang, 1991 ; Collins et al, 1993).
All DNA polymerases require a 3'-hydroxyl terminus of a pre­
existing primer for polymerisation (reviewed in Komberg, 1980), To date 
DNA polymerase a  is the only eukaryotic polymerase with a tightly 
associated primase. The primase activity of the DNA pola-primase 
complex resides in its two smallest subunits C (53KDa) and D (48KDa) 
(Kaguni et al., 1983 ; Tseng et al., 1983 ; Cotterill et al., 1987b). The role 
of the primase is centred on the lagging strand template where it 
synthesises short base-paired RNA primer strands. These are then "filled 
in" by the catalytic subunit (A) of DNA polymerase a  during elongation 
(Roth, 1987).
A second cellular DNA polymerase, DNA polymerase Ô, is involved 
in the synthesis of SV40 DNA. It consists of a 125KDa catalytic 
polypeptide with an associated 48KDa subunit (function unknown) and 
possess a 3-5' exonuclease activity (Byrnes et al., 1976). Its role was 
initially suggested from work on the identification and purification of the 
36KDa proliferating cell nuclear antigen factor (PCNA), which was 
found to be essential for SV40 DNA replication in vitro (Mathews et al,, 
1984 ; Prelich et al., 1987a). Further in vitro studies revealed that the low 
processitivity of DNA polymerase Ô on long single-stranded templates 
could be increased by the addition of exogenous PCNA ( et al., 1987b).
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This implied that both the polymerase and PCNA had essential roles in 
SV40 DNA replication.
PCNA’s role in SV40 DNA replication was revealed in an in depth 
study which compared the structure of in vitro SV40 replication products 
formed both in the presence and absence of PCNA (Prelich and Stillman, 
1988). The data from these studies demonstrated that PCNA was not 
required during the initiation of SV40 DNA replication and in the 
formation of primary nascent strands at the replication origin. However, 
subsequent elongation in the absence of PCNA resulted in the shutdown 
of leading strand synthesis and the production of short DNA 
products,which dissociated from the template. This implied that PCNA 
was required for co-ordinated leading and lagging strand synthesis.
A second factor called replication factor C (RF-C) was also identified 
and found to be associated with only the elongation phase of SV40 DNA 
replication. Its omission from an in vitro DNA replication reaction had 
the same effect on the SV40 DNA replicative products as the omission of 
PCNA (Tsurimoto and Stillman, 1989b). Further investigations revealed 
that both PCNA and RF C recognise and bind to the lagging strand 
polymerase complex at the replication origin forming a "primer 
recognition" complex (Tsurimoto et al., 1990). This complex is thought 
to play a crucial role in blocking the DNA pola-primase complex and in 
initiating leading strand synthesis from the nascent DNA fragment 
synthesised by the lagging strand DNA polymerase complex (reviewed in 
Bambara and lessee, 1991). Recently, a third polymerase species (Pol e) 
has been found and is thought to be involved in the elongation of the 
lagging strand. However, its existance is still controversial (reviewed in 
Bambara and lessee, 1991).
Using the type of assay where SV40 DNA replication is reconstituted 
entirely from purified proteins which can be excluded or omitted,
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Figure 4. Model for initiating leading- and lagging-strand synthesis 
with two DNA polymerases.
The first line of the figure shows the unwound complex stage, followed 
by five subsequent stages: 1. primer RNA synthesis with primase 
(Priming), 2. first Okazaki fragment synthesis with polymerase a , 3. 
switching of DNA polymerases at the 3' end of this first Okazaki 
fragment, and finally, 4. leading- and 5. lagging-strand synthesis by 
polymerase 6 and a. Factors involved are DNA helicase (T antigen in the 
case of SV40), RF-A, polymerasea-primase, RF-C, PCNA and 
polymerase Ô. The factors are introduced according to their entry into the 
reaction. The roles of the topoisomerases are not indicated (taken from 
Wang, 1991).
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Tsurimoto and Stillman, (1990) have proposed a "polymerase switching" 
model for the initiation of bidirectional DNA replication and subsequent 
elongation of leading and lagging strand strands.
"Polymerase switching" model for the mechanism of SV40 DNA 
replication.
The model (see figure4) proposes that DNA polymerase a-primase 
primer synthesis ensues from the unwound origin site generated by T- 
antigen (helicase function), RF-A and DNA topoisomerase action. 
Addition of both RP-A and RF-C facilitates DNA pol a-primase priming 
and lagging strand synthesis to some degree, based on their known 
stimulation of DNA pol a-primase activity. PCNA addition to the nascent 
Okazaki fragment at the origin induces the ATP-independent binding of 
RF-C and DNA polmerase Ô to the 3’ terminus, displacing DNA 
polymerase a  for another cycle of Okazaki fragment synthesis on the 
lagging strand. Leading strand synthesis is then mediated by the RF-C / 
PCNA / DNA polymerase ô complex. The dissociated DNA pol a- 
primase complex then returns to the next priming site on the lagging 
strand by interaction with T-antigen and continues to copy the lagging 
strand template discontinuously.
10. Herpes Simplex virus DNA replication.
The herpesviruses are a large group of DNA containing viruses which 
have been isolated from humans and many different animal species. The 
most extensively characterised of all the groups members are human 
HSV-1 and HSV-2. Like all heipesviruses HSV can maintain a latent 
infection (its genome being harboured in the neurons of sensory ganglia) 
and replicate lytically in the epithelial cells of an infected individual as
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well as in a wide variety of cultured mammalian cells. The HSV-1 
genome contains a linear double-stranded DNA of approximately 
152kbp, which has been completely sequenced and found to encode over 
70 distinct proteins (M^Geoch et al., 1988) including all those required 
for the replication of its genome. The HSV-1 genome consists of two 
components: a long (L or Ul ) and short (S or Us) unique sequence each 
of which is flanked by inverted terminal repeats. During the course of 
viral replication both L and S invert relative to each other via a 
recombination mechanism leading to reorganisation, or isomérisation, of 
the genome. Since both the L and S sequence components can be in one 
of two orientations, purified replicated viral DNA consists of an 
equimolar population of four possible isomers soon after infection 
(Jenkins and Roizman, 1986 ).
To date no cell-free system for HSV DNA replication has been 
described, therefore most of our present knowledge has been derived 
ft'om in vivo studies on replicative intermediates. These intermediates 
were found to have two characteristics; firstly, replicating viral DNA 
pulsed-labelled with [^H] thymidine has a higher sedimentation 
coefficient than unit length viral DNA (Jacob and Roizman, 1977) and 
secondly that the same DNA is "endless", i.e. the molecular termini of 
mature viral DNA are fused together forming concatmer structures (Jacob 
et al, 1979). On the basis of these in vivo observations it was proposed 
that parental HSV DNA was circularised shortly after entry into the host 
cell, via complementary single nucleotide 3' overhangs at the genome 
termini, with subsequent replication probably taking place by a rolling 
circle mechanism, generating linear progeny genomes as linear 
concatamers of tandemnly repeated virus genomes (Jacob et al., 1979).
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10.1. The HSV origins of DNA replication.
The HSV-1 genome has three origins of replication: two identical copies 
of Oris located within the repeated elements of the unique short segment 
of the viral genome and a single copy of OriL near the centre of the 
unique long segment of the viral genome. The functional significance of 
three separate origins of replication in the HSV genome is not clear. 
Mutant viruses lacking either one copy of Oris or OriL have been isolated 
and have no obvious defect in growth (Longnecker and Roizman, 1986). 
Based on the observation that transfected plasmids containing viral 
origins of replication are amplified in HSV infected cells, the sequence 
requirements for origin function were defined. The most extensive of 
these studies was carried out on plasmids containing Oris. Minimally, 
Oris is comprised of a 75bp segment of sequence containing a 44bp 
palindromic sequence of which the central 18bp are composed entirely of 
A/T base-pairs (Stow and McMonagle, 1983). The termini of the 44bp 
palindrome contains a lObp sequence composed of overlapping inverted 
partial repeats. These lObp sequences are homologous and are termed 
Box I and Box II. In addition, a third 40bp homologous partial inverted 
repeat, Box III, exists and is located to the left of the palindrome and is 
also required for Oris function.The minimum sequences required for the 
function of Oris correspond well to the region of highest similarity with 
OriL. However, OriL does contain a more extensive palindromic region 
of 144bp (Weller et al, 1985). Mutational analysis on the Oris sequence 
revealed that deletion of the central A/T rich region in the palindrome 
completely abolished DNA replication, as did replacement of the central 
A/T region with an equal number of GC base-pairs (Lockshon and 
Galloway, 1988). Both arms of the palindrome contain a binding site for 
the HSV origin binding protein, a product of the UL9 virus gene (Weir et
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al., 1989). The role of this protein in DNA replication will be discussed in 
the following section. There is also evidence that regions of sequence 
flanking the core region have a modest effect on the extent of DNA 
replication, when measured in a plasmid amplification assay (Stow et al., 
1982b ; Stow and McMonagle, 1983). However, more recent evidence 
by Su and Knipe (1987) found no evidence suggesting that these 
upstream regulatory elements had any direct effect on origin function.
10.2. HSV genes required for DNA replication.
For many years the use of virus mutants (usually temperature sensitive 
mutants) has provided the major experimental approach to determining 
whether specific viral gene products play a role in HSV DNA replication. 
Initial genetic studies were carried out on a large number of conditionally 
lethal mutants of HSV, found to be defective in DNA synthesis. 
Complementation studies revealed that mutants with defects directly 
affecting DNA replication fall into seven groups (Challberg, 1986 ; Wu et 
al., 1988). The complete set of viral genes that are required for viral DNA 
replication were identified by means of a transient complementation 
assay, in which cloned segments of HSV genome DNA were tested for 
their ability to support the replication of a co-transfected plasmid 
containing the HSV origin of replication (Challberg, 1986). The role of 
individual HSV DNA replication genes has also been examined using the 
recombinant baculovirus expression system. Infection of insect cells with 
baculovirus recombinants capable of expressing all the HSV-1 DNA 
replication proteins resulted in the viral origin dependent amplification of 
a transfected test plasmid (Stow, 1992). As mentioned above, early 
genetic studies on virus mutants revealed that seven HSV viral gene 
products were both necessary and sufficient for the replication of origin 
dependent DNA synthesis. Biochemical activities have now been
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ascribed to each of these proteins (McGeoch et ai., 1988 ; Wu et al., 
1988). The seven genes encode: a highly processive heterodimeric DNA 
polymerase (Purifoy et al, 1977 ; Crute and Lehman, 1989), a 
heterotrimeric helicase/primase (Crute et al, 1988,1989), a single­
stranded DNA binding protein (Weller et al, 1983) and an origin-binding 
protein (Elias et al, 1986 ; Olivo et al, 1988). The roles of each of these 
proteins in HSV DNA replication will be discussed individually.
HSV Origin Binding Protein.
(Gene product: UL9)
The origin binding protein was initially identified in extracts of HSV 
infected cells by the its ability to specifically bind to the HSV origins of 
replication. The protein termed UL9, was purified to homogeneity by 
DNA recognition site chromatography and shown to have a molecular 
weight of 83KDa by SDS PAGE (Elias et al, 1986 ; Elias and Lehman, 
1988). DNase I footprint analysis of the purified protein revealed that it 
bound to and protected two nearly identical sites (termed Box I and Box 
II) present in each arm of the palindrome region in Oris (Olivo et al, 
1988). Méthylation interference experiments combined with binding site 
affinity assays revealed that the protein bound to the recognition 
sequence GT(T/G)CG, contained within a 10 base-pair consensus 
sequence present in Boxes I and II. This recognition sequence is 
contained twice within the lObp consensus sequence, as inverted repeats. 
Furthermore, filter binding studies with single strand oligonucleotides 
corresponding to Boxes I and II demonstrated that UL9 bound to the left 
arm sequence (Box I) of the palindrome with an affinity 5-10 times 
greater than the binding site on the right arm (Box II). However, while 
there is general agreement that the left arm of the palindrome and its A/T 
rich central region are essential for Oris function, there are conflicting
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results on the requirement for the right arm sequence. Deb and Doelberg, 
(1988,1989) have reported that a plasmid lacking the right arm Oris can 
replicate equally as well as a control plasmid containing the intact origin. 
Additional support for this view came from work by Stow and Davison, 
(1986) on the related Varicella zoster virus (VZV). Their results 
demonstrated that HSV cells could support the replication of plasmids 
containing the VZV origin of replication, which only contains sequences 
homologous to the left arm and A/T rich regions of the HSV Oris 
palindrome. However, more recently combined mutational and binding 
site studies by Weir and Stow, (1990) have demonstrated that both sets of 
sequence are required for efficient DNA binding and origin function. The 
results from these recent studies suggest that there is some form of 
cooperative interaction between the UL9 proteins bound at the two 
binding sites. Direct evidence for this theory came from in vitro 
mutational studies investigating the effect of insertions into the central 
A/T rich region situated between the two UL9 binding sites. These 
studies demonstrated that the insertion of n additional A/T base-pairs into 
the A/T rich domain had a periodic effect on the efficiency of Oris in 
DNA replication. As n was increased from 0 to 8, replication was seen to 
first decrease to a minimum at n=3, then rise to a maximum at n=5, 
before decreasing again when n was greater than 6 (Lockshon and 
Galloway, 1988). This strongly suggests that a strict spatial constraint on 
the positioning of the UL9 binding sites exists which may be necessary to 
accommodate UL9-UL9 interactions critical for HSV origin function.
Analysis on the primary amino acid sequence of the UL9 protein 
has revealed the existence of two leucine zipper binding motifs; one near 
the N-terminus which has been shown to be required for origin 
cooperative binding (Elias et al, 1992) and the other closer to the C- 
terminus of the protein which seems to be involved in protein-protein
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interactions with other proteins involved in origin-specific initiation of 
HSV DNA replication. The UL9 protein is homodimeric and possesses 
both DNA-dependent nucleoside triphosphatase and DNA helicase 
activities (Dobson and Lehman, 1993 ; Boehmer et al, 1993). These 
enzymatic activities, along with its capacity to bind specifically origin 
DNA, are reminiscent of the SV40 T-antigen initiator protein. In the 
presence of ATP, T-antigen assembles into two double hexamers that 
untwist the SV40 DNA origin as a prelude to initiating DNA synthesis. In 
contrast, binding of the UL9 protein to Oris does not appear to be 
affected by ATP. Furthermore, it has recently been reported that the 
Herpes encoded single-stranded DNA-binding protein ICP8 can 
specifically stimulate the DNA helicase activity of the UL9 protein 
through a direct protein-protein interaction (Boehmer and Lehman, 
1993a). Again this is reminiscent of SV40, with T-ag and RF-A 
substituting for UL9 and ICP8.
HSV Single-Stranded DNA Binding Protein ICP8.
(Gene product: UL29)
ICP8 (infected cell polypeptide 8) was initially recognised several years 
ago as an abundant HSV-induced 128KDa protein present in infected 
cells (Bayliss et al, 1975). Early genetic studies using HSV temperature 
sensitive virus mutants revealed that the protein was absolutely required 
for viral DNA replication (Conley et al, 1981 ; Weller et al, 1983). This 
led to the reasonable assumption that the function of ICP8 was analogous 
to a group of replication proteins, e.g. E.coli SSB, T4 gene 32, RF-A, 
Ad.DBP, etc. known as single-stranded DNA binding proteins. Their 
primary function in DNA replication is to bind to single-stranded DNA 
formed at the replication fork by the helicase dependent unwinding of the 
parental strand in order to facilitate the use of these strands as templates
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for elongation by a replicative nucleoprotein complex. ICP8 has many of 
the characteristic properties associated with the SSB's: it binds to single­
stranded DNA (ssDNA), double-stranded DNA (dsDNA) and RNA in 
vitro ( reviewed in Chase and Williams, 1986 ; Stuiver, 1993) with at 
least a 5-fold preference for ssDNA over dsDNA; binding of ICP8 to 
ssDNA is cooperative at saturating concentrations and is independent of 
sequence. Using both site-directed mutagenesis and protease digestion 
assays the DNA binding region of ICP8 was mapped to a region spanning 
amino acids 564-869 (Leinbach and Heath, 1988 ; Wang and Hall, 1990). 
Further sequence analysis revealed that residues 499-512 within this 
region conformed to the consensus sequence for a "zinc finger" DNA 
binding motif (Gupte et al, 1991). Another consequence of DNA binding 
by SSB's is their ability to regulate gene expression. Analysis of viruses 
containing mutant ICP8 revealed an accumulation of mRNA’s from both 
early and late viral genes, indicating that ICP8 does plays a direct part in 
the regulation of HSV transcription (Godowski and Knipe, 1985 ; Gao 
and Knipe, 1991). As mentioned above, SSB's have the ability to assist in 
DNA synthesis by stimulating the proteins present in a viral replisome. 
ICP8 has been shown to stimulate the activities of all of the HSV viral 
gene products. Its interaction with the other viral products will be 
discussed individually:
ICP8-HSV DNA polymerase interaction.
Purified ICP8 has been shown to have a stimulatory effect on the HSV 
DNA polymerase activity in vitro using either primed ssDNA (activated 
DNA) and dsDNA as templates (Ruyechan and Weir, 1984 ; Hernandez 
and Lehman, 1990). It has also been found to stimulate the intrinsic 3'-5' 
exonuclease activity of the polymerase(0'Donnell et al, 1987a). Evidence 
for the stimulatory nature of ICP8 has also come from mutational studies
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with HSV-2 ICP8 temperature sensitive mutants. HSV DNA polymerase 
activity was found to be reduced in extracts from cells infected with ICP8 
temperature sensitive mutants at the non-permissive temperature. 
Additionally, some of the viral mutations were found to increase HSV 
DNA polymerase sensitivity to inhibitors like aphidicolin (Chiou et al, 
1985). This is reminiscent of the suspected Ad.DBP-Ad.DNA 
polymerase interaction in the adenovirus system (Mul and Van der Vliet, 
1993). The isolation of monoclonal antibodies against purified ICP8 and 
HSV DNA polymerase has produced detailed analysis on both of their 
intracellular localisation during infection (Bush et al, 1991). In vivo 
Immunofluorescence with these antibodies demonstrated that both ICP8 
and HSV DNA pol. colocalised in distinct cellular structures known as 
prereplicative sites and replication compartments. The localisation of 
HSV DNA polymerase to the nucleus was found to be independent of 
ICP8, but in its absence remained diffusely distributed throughout the cell 
nucleus. This suggests that the correct intranuclear distribution of the 
viral polymerase requires the presence of ICP8. The colocalisation of a 
viral SSB and viral DNA polymerase in distinct replication compartments 
has been shown in other viral replication systems, including adenovirus 
(Bosher et al, 1992). So clearly, similar compartmentalised functions 
exist throughout eukaryotes. No evidence supporting a direct interaction 
between ICP8 and the HSV DNA polymerase has been found to date. As 
with the adenovirus system, the SSB (ICP8) is thought to probably affect 
DNA polymerase activity through its ability to distort the secondary 
structure of the DNA it binds to.
ICP8-UL9 Interaction.
ICP8 can stimulate both the DNA-dependent ATPase and DNA helicase 
activities (Dobson and Lehman, 1993) of the origin binding protein, UL9.
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The stimulatory effect was specific for ICP8; neither E.coli SSB or 
Replication Factor A (RP-A) were able to substitute its function. These 
results suggested that there may be a direct interaction between ICP8 and 
UL9. ICP8 is believed to aide the UL9 protein in the physical separation 
of the DNA duplex, as it contains a helix-destabilising property similar to 
that of RP-A (Boehmer and Lehman, 1993b). ICP8‘s ability to bind 
ssDNA preferentially may also assist in this process by preventing the 
non-productive binding of UL9 to the single-stranded regions of the DNA 
substrate. A direct physical interaction between ICP8 and UL9 has 
recently been reported. Using protein affinity chromatography, Boehmer 
et al., (1993) demonstrated that baculovirus purified UL9 could bind to 
immobilised ICP8 and vice versa. The specific site of interaction has 
been localised to the 37KDa C-terminal domain of the UL9 protein, 
which has recently been shown to contain a leucine zipper binding motif 
(Deb and Deb, 1991), It is currently thought that the UL9-ICP8 
interaction is mediated through this leucine zipper structure.
ICP8-Helicase/Primase Interaction.
ICP8 is required for the complete unwinding of duplex DNA by the 
helicase/primase complex. In vitro DNA helicase assays by Crute and 
Lehman, (1991) demonstrated that both ICP8 and ATP were required to 
produce fully unwound DNA template. No biochemical evidence for a I
direct interaction exists. As in the case of the ICP8-UL9 interaction, it is i
believed that ICP8 may serve to stabilise regions of ssDNA generated by !
Ithe helicase.
HSV DNA polymerase + Processitivity subunit complex.
The HSV DNA polymerase was initially identified as a novel polymerase 
activity from HSV-infected cell extracts. The activity is readily
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distinguishable from host cell DNA polymerases on the basis of its 
sensitivity to various inhibitors (e.g. aphidicolin and acylovir) and its 
stimulation, rather than inhibition, by moderate salt concentrations 
(Powell and Purifoy, 1977). Further analysis on both temperature 
sensitive and drug resistant mutants clearly demonstrated that the 
polymerase was virally encoded. Careful mapping of the drug resistant 
mutants revealed that the HSV DNA polymerase contained domains of 
highly conserved amino acids important for its function (Larder et al., 
1987 ; Gibbs et al., 1988) e.g. the C-terminal amino acids 397-961 
contain a substantial number of these mutations, indicting that it may 
contain the nucleotide binding site of the polymerase. Interestingly, these 
domains seem to have homology with domains in the amino acid 
sequence of many DNA polymerases, both prokaryotic and eukaryotic 
(see later in this section). This idea has been reinforced recently by data 
from limited proteolysis mapping and fluorescence quenching studies on 
the polymerase (Weisshart et al, 1993). These biophysical techniques 
have revealed that the site in the centre of HSV DNA polymerase whose 
accessibility increases upon DNA binding is near or within the putative 
C-terminal nucleotide binding site between a.a.397-961. To date the 
136KDa HSV DNA polymerase has been purified from both HSV 
infected cell extracts and HSV recombinant baculovirus cell extracts.
Initial purification from HSV infected extracts revealed that the 
polymerase co-purified with a 62KDa protein which was subsequently 
shown to be the product of the UL42 gene, one of the genes found to be 
essential for DNA synthesis (Powell and Purifoy, 1977 ; Vaughan et al., 
1985). Further investigations revealed that this protein was, in fact, a 
processitivity factor that existed with the polymerase in a dimeric 
complex (Hernandez and Lehman, 1990), UL42 is required, along with 
ICP8, for the enhancement of processitivity of deoxynucleotide
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polymerisation by the HSV DNA polymerase subunit. UL42 can 
therefore be thought of as resembling the p-subunit of the E.coli DNA 
polymerase III holoenzyme. Biochemical analysis on UL42 free HSV 
DNA polymerase has shown it to be a trifunctional complex consisting of 
DNA polymerase, 3’-5* exonuclease and 5’-3' RNase H activities. The 
polymerase, despite its slow rate of DNA synthesis, is highly processive 
(Crute and Lehman, 1989 ; O’Donnell et al, 1987a), no doubt due to the 
presence of UL42 . Additionally, its rate of synthesis can be increased 
substantially in the presence of saturating concentrations of the ICP8. 
However, unlike in the case of the adenovirus SSB, Ad.DBP, ICP8's 
effect could be fully substituted by the E.coli SSB, There is indirect 
evidence from in vitro DNA-binding (O’Donnell et al, 1987b) and in vivo 
immunofluorescence (Bush et al, 1991) studies, that ICP8 can form a 
complex with the HSV DNA polymerase. To date no direct biochemical 
evidence exists that supports a physical interaction between the two. 
However, we can hypothesise that the increase in the rate of nucleotide 
incorporation observed in the presence of 1CP8 may be due to its ability 
to hold ssDNA in a configuration which increases the efficiency of the 
viral DNA's movement along the DNA chain.
As mentioned above, the HSV DNA polymerase also contains a 
3’-5' exonuclease and 5'-3‘ RNase H activity (Crute and Lehman, 1989). 
Both of these activities copurify with the DNA polymerisation function 
situated in the 136KDa polypeptide of the UL42-DNA polymerase 
complex. The 3'-5’ exonuclease activity is thought to have a proofreading 
function which it uses to increase the fidelity of DNA synthesis. The 5’-3’ 
RNase H activity is probably involved in the removal of RNA primers 
that initiate the synthesis on the lagging strand at a replication fork during 
HSV DNA replication.
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Helicase-Prîmase complex.
(Gene products: UL5; UL8 and UL52).
The helicase/primase complex was initially identified by its DNA 
helicase activity which was induced upon HSV infection of cells (Crute 
et al, 1988, 1989). It was purified to homogeneity and found to consist of 
three subunits with molecular weights of 120KDa, 97KDa and 70KDa. 
Immunochemical analysis of the enzyme revealed that the three subunits 
were products of the HSV UL52, UL5 and UL8 genes (Crute and 
Lehman, 1991). The DNA primase activity co-purified with the DNA 
helicase activity during purification, in vitro characterisation of the 
enzyme complex demonstrated that it could not fully unwind partial DNA 
duplexes without the presence of the HSV SSB, ICP8. These results led 
to the suggestion that ICP8 may serve to stabilise ssDNA generated as a 
consequence of the helicase activity in the complex. Alternatively, ICP8's 
function could be to localise the helicase-primase complex to the 
replication fork by preventing non-productive interactions with the newly 
synthesised ssDNA chains.
Although no cell-free system for HSV origin-dependent DNA 
replication exists, one can hypothesise about the roles of the seven viral 
gene products in DNA replication, when one compares their respective 
biochemical properties with replication proteins involved in other 
eukaryotic viral DNA replication systems.
10.3. A model for HSV DNA replication.
HSV DNA replication probably initiates when the UL9 protein assembles 
into a multimeric structure at the HSV origin, resulting in the untwisting 
of the central A/T rich region into a recognisable "open" complex. This 
"open" complex could be facilitated by the coupled DNA-dependent 
ATPase and DNA helicase activities of the UL9 protein, in a similar
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manner to the viral T-antigen of SV40. Complex formation would also 
require the presence of the single-stranded binding protein, ICP8, as it 
has been shown to stimulate the activity of the origin binding protein 
UL9. It also contains a helix-destabilising activity which could help in 
both the opening of duplex DNA and the stabilisation of regions of newly 
created ssDNA. This "open" complex would then require the presence of 
proteins involved in the initiation and elongation of the HSV genome.
The HSV DNA polymerase and helicase/primase are vital for these 
processes. They either recognise and bind to the "open" complex or are 
guided to it by ICP8, which is suspected of forming complexes with both. 
The assembly of the seven viral protein products at the origin can be seen 
as forming a replisome (as in E.coli), which with the aid of as yet 
unknown cellular factors, replicates the HSV DNA genome.
11. Eschericia coll chromosomal DNA replication.
Over the last 20 years three general methods have been utilised to help 
identify E.coli DNA replication functions: isolation of mutants; 
sensitivity of replication to chemical inhibitors and the biochemical 
isolation of proteins required for DNA replication in vitro.
E.coli DNA replication initiates (see figureS) bidirectionally at a 
specific sequence (Ori C) located at about 84 minutes on the genetic map 
(Yasuda and Hirota, 1977). The origin itself was originally identified by 
both biochemical and gene dosage experiments. OriC was subsequently 
cloned and found to support the replication of plasmids lacking a 
functional origin (Von Meyenburg et al, 1979).The minimal site required 
for replication on plasmids in vitro is a 245bp sequence (Oka et al, 1980) 
which is found to be highly conserved among enterobacteria. OriC has 
several important sequence elements; there are four 9bp sites, denoted 
R1-R4 that are highly conserved and arranged into two inverted repeats.
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This sequence known as Dna Box A was shown to be the binding site for 
Dna A, the E.coli initiator protein (Fuller et al, 1984 ; Matusi et al, 1985), 
To the left of the Dna A boxes are three direct repeats of a 13bp sequence 
(13mers) that are rich in A and T nucleotides (Bramhill and Komberg, 
1988a). DNA strand separation of the origin is initiated at these sites 
(Bramhill and Komberg, 1988b). The origin also contains specific 
binding sites for two small double-stranded DNA binding proteins, IHF 
and FIS. These proteins along with the non-specific binding protein HU 
("histone-like") function as accessory factors during the assembly of the 
many different protein-DNA complexes at the origin (Schmid et al.,
1990).
The major breakthrough in our understanding of the mechanism of 
initiation at OriC was elucidated by the development of a crude extract 
system that could synthesise DNA specifically on OriC containing 
plasmids in vitro (Fuller et al, 1981). Subsequent efforts have now 
outlined the steps necessaiy for initiation. The central and first step of 
initiation from OriC is the binding of Dna A to the origin. This binding 
reaction is highly cooperative and results in 10-20 monomers of Dna A 
forming a complex with the DNA (Fuller et al, 1984). Dna A, which has 
an ATPase activity, then binds ATP and becomes active for initiation.
The DnaA-ATP complex then promotes opening of the DNA in the 
region of the 13mers (Bramhill and Komberg, 1988a, 1988b). These 
"open" DNA complexes were detected through the sensitivity of the 
DNA in this region to cleavage by a single-stranded endonuclease. 
Opening of these complexes was demonstrated to occur sequentially from 
the rightmost 13mer leftward and required the presence of the proteins 
HU or IHF (Yung and Komberg, 1989). After the origin is opened, DnaB 
(a 5'-3' DNA helicase) is transferred to the exposed ssDNA as a DnaB- 
DnaC complex. DnaC functions as an escort protein as DnaB has a low
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Figure 5. Model of the initiation of replication at OriC 
The diagram does not suggest the stoichiometry of the proteins in the 
postulated complexes or the molecular structure of the individual proteins 
(taken from Baker and Wickner, 1993).
affinity for both single and double-stranded DNA in its absence. DnaA is 
also involved in bringing DnaB to the origin.It has been proposed that 
DnaC recognises DnaA at the origin and facilitates the binding of DnaB 
to the origin (Funnell et al., 1987). A direct role for DnaA and DnaC in 
loading DnaB is implied by the observation that DnaA also promotes the 
transfer of DnaB to any ssDNA, in a reaction that also requires DnaC 
(Wahle et al, 1989a). However, electron microscopy of the initiation 
complexes formed at OriC and tagged with gold-conjugated antibodies 
demonstrated the presence of DnaB, but failed to detect DnaC (Funnell et 
a l, 1987 ; Wahle et al, 1989b). This data along with other studies 
indicate that DnaC is in fact released from its complex with DnaB during 
transfer onto the template. It is believed that the release of DnaC activates 
DnaB for later steps, i.e. elongation (Allen et al, 1991). The next stage in 
initiation involves the unwinding of the DNA from the open OriC 
sequence by DnaB's helicase activity (Baker et al, 1987). This requires 
the presence of ATP, DNA gyrase (a Type I topoisomerase) and E.coli 
SSB. Once unwinding by DnaB has begun, DnaG primase, through its 
interaction with DnaB, syntheses primers which are then elongated by the 
replicative machinery which has been brought to the template by DnaB.
In the following section the characteristics of DnaB, DnaG primase, DNA 
polymerase III and E.coli SSB will be discussed, as they are principally 
responsible for full-length DNA replication in E.coli.
11.1. Elongation of E.coli chromosomal DNA replication.
Principal proteins involved in elongation are:
DnaB
Both biochemical and genetic analysis indicate that the 52KDa DnaB 
protein is the major helicase involved in E.coli DNA replication. Its 
helicase activity was first demonstrated in vitro by LeBowitz and
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MCMacken (1986) through the protein's ability to displace a ssDNA 
fragment from a partially duplex substrate in a reaction that required 
dNTP hydrolysis. By taking advantage of its substrate preference for 
dNTP hydrolysis, DnaB was shown to be the helicase involved in the 
unwinding (in vitro) of the OriC DNA template. The DNA helicase 
activity of DnaB has a 5'-3’ polarity, placing it on the lagging strand 
template during replication, ahead of the leading strand polymerase.
DnaB has also been shown to have a functional interaction with both the 
DnaG primase and DNA polymerase III holoenzyme proteins.
DnaG primase.
The 64KDa DnaG protein was identified as a primase based on the 
resolution and reconstitution of the enzymes required for the conversion 
of bacteriophage G4 ssDNA to its replicative form in vitro (Bouche et al., 
1978). In fact, DnaG is unable to synthesise primers on ssDNA that does 
not contain the highly specialised G4 ori sequence, unless DnaB is 
present. However, in a reaction termed general priming, DnaG, will in the 
presence of DnaB, synthesises primers on any naked ssDNA that can be 
used to prime subsequent DNA synthesis by the DNA polymerase III 
holoenzyme complex. Consequently, DnaB has been referred to as a 
"mobile promoter" of primer synthesis (Masai et al., 1990). The 
mechanism by which DnaG primase is activated by DnaB is unclear. 
However, the ATP binding function of DnaB does seem to be an essential 
step (Arai and Komberg, 1981). Although physical contact between 
DnaB and primase is usually assumed, no direct physical or genetic 
evidence exists to verify this. Therefore, DnaB may act by generating a 
special secondary stmcture in the DNA template that can subsequently 
promote DnaG binding.
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DNA polymerase III holoenzyme ( DNA pol ID HE ).
The DNA pol III HE was originally isolated on the basis of its 
requirement for the replication of phage ssDNA templates in the presence 
of the E.coli priming apparatus (McHenry, 1982,1991). DNA pol III HE 
is the largest multiprotein complex responsible for replicative DNA 
synthesis in E.coli. The enzyme contains 10 subunits with functions 
specialised for efficient replication of the E.coli chromosome. Early 
studies using standard fractionation procedures found that the 
holoenzyme actually separated into two main components: "core 
polymerase" and its "accessory factors". The catalytic DNA pol III core is 
composed of a heterotrimer of subunits that are not readily separable by 
chromatography. These include the 140KDa a  catalytic subunit (DnaE 
gene product ), the 23KDa e subunit (DnaQ gene product) which is a 
proof-reading 3’-5' exonuclease, and the lOKDa 0 subunit (DnaE gene 
product). Although this "core" complex has the enzymatic abilities of the 
holoenzyme it dissociates very quickly from the DNA template (Fay et 
al., 1981). The very low processive nature of the DNA pol III complex is 
specifically increased by the addition of the "accessory factors". These 
remaining subunits include: the 71KDa x subunit, which is thought to be 
responsible for the dimérisation of the core DNA pol III complex 
(Studwell-Vaughan et al., 1991), the yÔ complex which is composed of y 
(47KDa), Ô (35KDa), 8' (33KDa), % (15KDa) and \j/(12KDa) subunits 
and is involved in the ATP-dependent loading of the p subunit onto the 
primer terminus. The 38KDa p subunit imparts highly processive DNA 
synthesis to the core polymerase and is usually described as a "sliding 
clamp" that locks the enzyme onto the template (Stukenberg et al., 1991). 
Extending previous proposals that polymerases could function as dimers 
(Sinha et al., 1980). McHenry et al., (1991) have suggested that the
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complete DNA pol III HE exists as an asymmetric dimer with 
distinguishable leading and lagging strand polymerases.
E.coli single-stranded DNA binding protein ( E.coli SSB ).
E.coli SSB is a small (monomei^l8.8KDa), heat-stable protein that binds 
tightly to ssDNA as a tetramer (Sancar et al, 1981), forming a long chain 
of molecules which have a beaded appearance under the electron 
microscope (Chase and Williams, 1986). E.coli SSB also binds ssRNA 
with a 10-fold and dsDNA with a lO^-fold lower affinity than for 
ssDNA. Limited proteolysis indicates that the protein consists of several 
domains: an N-terminal fragment of 105 amino acids in length, which 
binds DNA at least as well as the intact protein and therefore most likely 
contains the DNA binding domain and information for tetramer 
formation; a less structured region spanning residues 106-165, possibly 
involved in protein-protein interactions with other replication proteins; 
and a C-terminal part (amino acids 166-177) which upon deletion leads to 
altered kinetics of DNA binding and increases the helix-destabilising 
activity of the protein (Chase and Williams, 1986).
In E.coli DNA replication, the SSB is thought to be involved in 
assisting helicases (especially DnaB) by helping in the assembly of what 
is known as the E.coli primosome, (DnaB helicase/DnaG primase) onto 
its correct position on the DNA origin (Marians, 1984), and by melting 
and then stabilising regions of newly created ssDNA, lowering the 
possibility of strand renaturation. This melting or helix-destabilisating 
activity of E.coli SSB also benefits the main DNA polymerase, DNA pol 
III HE. in vitro polymerisation assays have demonstrated that the SSB 
can increase the initial rate of polymerisation and fidelity of the DNA pol 
III HE enzyme (Kunkel et al, 1979). The increase in polymerisation is 
believed to be due to the SSB's ability to remove the secondaiy structure
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of DNA directly in front of the polymerase during replication (LaDuca et 
al., 1983). Alternatively, E.coli SSB could increase polymerisation by 
directly interacting with the accessory factors (yÔ complex) in DNA pol 
III HE, forming a stable replication structure capable of extensive DNA 
synthesis. However, to date no evidence for this type of direct interaction 
has been found. The E.coli SSB dependent increase in fidelity is thought 
to be due to enhanced base-selection by the DNA polymerase, resulting 
from an increase in the rigidity of the DNA template upon coating by the 
SSB.
DNA Gyrase.
On most natural DNA templates, replication fork movement requires a 
topoisomerase to remove the topological strain associated with 
unwinding the DNA duplex. Genetic evidence and in vivo studies with 
topoisomerase inhibitors indicate that this function is provided in E.coli 
by DNA gyrase (Baker et al., 1986 ; Funnell et al., 1986). In vitro DNA 
replication from OriC plasmid systems depend on the addition of DNA 
gyrase to function properly. The gyrase is ATP-dependent and functions 
in replication by unlinking the parental DNA strands as they are unwound 
by the DNA helicase, DnaB. It is thought to achieve this by reducing the 
net linkage between the parental strands by two turns during each 
enzymatic turnover; the mechanism involves a specialised double-strand 
break and a DNA passing event (Wang et al., 1985).
The discontinuous nature of DNA synthesis on the lagging 
strand necessitates the involvement of several additional proteins; the 
short nascent strands require processing of primer RNA's, gap-filling and 
ligation to convert them to a continuous strand. RNaseH, DNA 
polymerase I and E.coli DNA ligase have these functions (Funnell et al., 
1986 ; Ogawa et al., 1984).
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11.2. Model for Elongation of E.coli DNA.
After the initiation complex has been formed at OriC (see earlier in this 
section), DnaB very likely starts to generate a replication fork by opening 
the DNA duplex, while moving 5'-3' on the strand to which it is bound. 
This strand would be the lagging strand; DnaG/primase, by its presumed 
association with DnaB, could then synthesise the multiple primers needed 
during lagging strand synthesis. The dimeric DNA pol III HE would most 
probably interact simultaneously with both template strands. The leading 
strand polymerase would move in the same direction as DnaB, while 
copying the opposite strand. To synthesise the lagging strand, the DNA 
polymerase would have to work on the same strand bound by DnaB, but 
travel in the opposite direction. The discontinuous nature of replication at 
the lagging strand probably necessitates the participation of the E.coli 
SSB to melt secondaiy structure in the newly exposed single-stranded 
template. A model of a simple replication fork is shown in figure 6 to lay 
out the proposed organisation of the enzymes at the fork.
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Figure 6. Model of elongation at the replication fork of E. coli (taken from Baker and Wickner, 1993).
MATERIALS and MF.THODS.
1. Reagents.
Reagents were obtained from BDH Chemicals Ltd, Sigma Chemical 
Company Ltd, and Pharmacia. All chemicals were of analar grade. 
Acetonitrile and HPLC grade water were obtained from Rathmans Pic. 
Titriated sodium borohydride was obtained from ICN. All other 
radiochemicals were obtained from Amersham International Pic.
2. Restriction endonucleases and DNA modifying enzymes.
Enzymes were obtained from New England Biolabs, Bishop's Stortford, 
Herts., England and Boehinger Mannheim Ltd., Lewes, East Sussex, 
England. These were used according to the manufacturers directions.
3. Bacterial culture medium.
Bacteria were propagated in Luria Broth, lOg/1 bactotryptone (Difco labs, 
Detriot USA.) and 5g/l yeast extract (Difco) in lOmM NaCl, sterilised by 
autoclaving. M13 was propagated in JMlOl cells grown in 2x TYE, 16g/l 
bacotryptone, lOg/1 yeast extract, 5g/l NaCl and IM NaOH.
4. Virus stocks.
Recombinant baculoviruses containing the Ad.5 pTP and Pol genes were 
obtained from E.L.Winnaker (University of München). The recombinant 
baculovirus encoding the Ad.2 DBP gene was obtained from A.Webster 
(Monaghan et al., 1994) and the recombinant baculovirus encoding the 
NF-I DNA-binding domain was obtained from R.T.Hay (Bosher et al.,
1991).
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5. Plasmids.
The pEX series of plasmids containing deleted versions of the adenovirus 
type 2 inverted terminal repeats were as described in Hay and 
McDougall, (1986).
6. Oligonucleotides.
All oligonucleotides were synthesised on an Applied Biosystems 381 A. 
The 18mer and 39mer oligonucleotides used in the strand displacement 
assay contained the sequences 5'-GGTATATTATTGATGATG-3' and 5'- 
ATTGGCTTCAATCCAAAATAAGGTATATTATTGATGATG-3' 
respectively, and the 42mer oligonucleotide (oligo A), which was 
complementary to M13mpl9 DNA, had the sequence 5'- 
TCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGG- 
3’. Double stranded oligonucleotides containing the binding site for NF-I 
(Bosher et al., 1990) and NF-kB (Clark et al, 1990) were as described. 
Double stranded oligonucleotides containing the binding site for NF-III 
contained the sequence 5'-
GATCTGAGTTAATATGCAAATAAGGCGTGAG-3% (top strand).
7. Antibodies.
Monoclonal antibody a  72k B6-10 raised against Ad.2 DBP was obtained 
from A. Levine (Reich et al., 1983). The monoclonal IgG was purified 
via chromatography on a protein-G sepharose column equilibrated in 
PBS. Bound B6-10 antibody was eluted by extensive washing with 
lOOmM glycine, pH 2.5 and dialysed overnight against PBS (Harlow and 
Lane, 1988). The anti-ova monoclonal antibody was a kind gift from 
A.Green and was purified in a similar fashion.
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8. Preparation of single stranded (p M13 DNA.
mHRl (p M13 DNA was obtained from R.T.Hay (Hay, 1985). 
Transformation of bacteria and subsequent isolation of single stranded 
DNA was carried out as described in Sambrook et al., (1989).
9. Quantitation of DNA.
The concentrations of all aqueous solutions of DNA were determined by 
scanning the absorbance between 220nm and 280nm on a Perkin-Elmer 
Lambda U.V/Visible Spectrophotometer, One optical density unit at 
260nm was taken to correspond to 50pg/ml of double stranded DNA or 
20jLig/ml of single stranded oligonucleotide. Concentrations were double­
checked by separating DNA samples on agarose gels containing 0.5pg/pl 
ethidium bromide and comparing the intensity of the fluorescence with 
that of known standards.
10. Preparation of Adenovirus cores.
The Adenovirus cores used in the in vitro initiation assays were prepared 
as Coding and Russell, (1983).
11. Radiolabelling of oligonucleotides and restriction fragments.
Single stranded oligonucleotides were labelled using T4 polynucleotide 
kinase (New England Biolabs). DNA was incubated in a buffer 
containing 50mM Tris-HCl, pH 7.6, lOmM MgCl2,5mM DTT and 
0.1 mM EDTA, pH 8.0 with 5 Units of T4 polynucleotide kinase and 
30pCi of (y^ ^P) ATP (Amersham, specific activity 3000 Ci/mmol) at 
37°C for 45 mins. The reaction was terminated by addition of DNA dyes 
(20% glycerol, 50mM EDTA pH 8.0,0.01% bromophenol blue). 
Labelled oligonucleotide was separated from unincorporated (y^ ^P) ATP
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and unlabelled oligonucleotide by electrophoresis on a non-denaturing 
polyacrylamide gel. Labelled oligonucleotide in the wet gel was 
identified by autoradiography with x-ray film (Fuji RX) and the gel slice 
containing the single stranded oligonucleotide recovered. The labelled 
oligonucleotide was then passively eluted from the gel slice by the 
addition of TENioo buffer and eluted overnight at room temperature, 
before storage at 4^C.
Double stranded oligonucleotides and restriction fragments with 
overhanging 5' ends, were labelled by incubation with the Klenow 
fragment of E.coli DNA polymerase 1, dATP and a^^P dCTP. 50- 
l(X)ng of DNA was incubated in a buffer containing 50mM Tris-HCl,
(pH 7.5), 5mM MgCla, 0.1 mM DTT, lOOpg/ml BSA with 2 units 
Klenow, lOOpM dNTP's (cold) and 20pCi of an appropriate (a^^P) 
radiolabelled nucleotide. The reaction was incubated at 20^C for 15 mins, 
then lOOjxM of cold nucleotide was added to chase for an additional 20 
minutes at room temperature. The reaction was stopped by the addition 
of DNA dyes (20% glycerol, 50mM EDTA,pH 8.0 and 0.01 % 
bromophenol blue) and the labelled DNA purified by electrophoresis as 
above.
The radiolabelled DNA substrate used in the exonuclease assay was 
internally labelled using a " T7 Quick Prime" Kit (Pharmacia LKB). The 
labelling reaction and subsequent purification by gel filtration were 
carried out as described in the manufacturers instructions.
12. Purification of Adenovirus DNA replication proteins.
12.1 Preparation of single stranded calf thymus DNA.
Type 1 calf thymus DNA (Sigma) was dissolved in water at lOmg/ml by 
stirring overnight and sonicating using an MSE Soniprep 150 until the
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viscosity of the solution was reduced. The solution was then denatured by 
boiling for 15 minutes and cooled rapidly to 4°C.
12.2 Preparation of single stranded DNA-Sepharose.
100ml settled volume of Sepharose (Whatman CL-4B) was washed twice 
with one litre of ultra pure water, resuspended in 2(X)ml of water and 
stirred gently for 30 minutes. 1.5grams of CNBr was added dropwise to 
the Sepharose over one minute, followed by the addition of 9ml of 10ml 
NaOH, dropwise over 10 minutes. The reaction was stopped by the 
addition of one litre of ice cold water. The sluiiy was then transferred to a 
Buchner funnel and filtered with four litres of ice cold water, followed by 
two litres of lOmM potassium phosphate buffer (pH 8.0). lOOmg of 
single stranded calf thymus DNA was added and shaken gently with 
CNBr activated Sepharose for 12 hours at 20®C. The DNA-Sepharose 
was then washed with 100ml of IM ethanolamine (pH 8.0) and gently 
shaken for 4 hours at 20^C in IM ethanolamine (pH 8.0) followed by 
2x200ml washes with 50mM sodium phosphate buffer (pH 8.0), IM 
NaCl and finally with buffer containing lOmM Tris-HCl (pH 8.0), ImM 
EDTA, pH 8.0 and 0.3M NaCl.
12.3 Preparation of hydroxylapatite resin.
1ml of powdered hydroxylapatite was added to a high salt buffer, 150mM 
potassium phosphate (pH 7.0), 400mM potassium chloride, 10% 
glycerol.The mixture was shaken and left to settle.The supernatant was 
discarded and a low salt buffer, 5mM potassium phosphate (pH 7.0), 
400mM potassium chloride, 10% glycerol was added. This mixture was 
shaken and left to settle, the supernatant discarded and the slurry used in 
a chromatographic column.
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12.4 Expression and purification of Ad.5 pTP and Pol from 
Spodoptera fugiperda cells infected with recombinant baculovirus.
Spodoptera frugiperda insect cells were grown in liquid culture in TClOO 
medium supplemented with 10% foetal calf serum at 28^0 and infected 
with 10 p.f.u./cell of recombinant Autographe califomica nuclear 
polyhedrosis viruses containing the genes for Ad.5 pTP and Pol. The 
infected cells were incubated for a further 72 hours at 28®C in TCI00 
supplemented in 10% foetal calf serum. The cells were harvested by 
centrifugation at 2000g for 10 minutes and resuspended in 25mM Hepes- 
KOH (pH 8.0), 5mM KCl, 0.5mM MgCli, 0.5mM DTT and incubated for 
20 minutes. The resuspended cells were then disrupted by 15 strokes in a 
Dounce homogeniser using a type B pestle, NaCl was then added to 
bring the final concentration to 0.2M and the extract was incubated on ice 
for 30 minutes. The extract was then clarified by centrifugation at 
15,000g for 3 minutes and the supernatant was further clarified by 
centrifugation at 100,000g for 15 minutes to remove any insoluble 
protein.
Both Ad.5 pTP and Pol underwent the same method of purification. Clarified 
crude extract in 0.2M NaCl was applied to denatured calf thymus DNA-Sepharose 
equilibrated with 25mM HEPES-NaOH pH 8.0, ImM EDTA, 2mM DTT, 0.2M 
NaCl and 105 glycerol. After extensive washing with the equilibration buffer, bound 
proteins were eluted with the same buffer containing 0.6M NaCl. Fractions were 
then collected and their concentration estimated using the Bradford’s assay 
(Bradford, 1976). The peak fractions were pooled and dialysed overnight against two 
litres of 5mM KPO4 (pH 7), 400mM KCl, ImM DTT and 10% glycerol. The 
dialysate was then applied to an hydroxylapatite column equilibrated in the same 
buffer. After washing with the above buffer, bound protein was eluted with 50mM 
KPO4 (pH 7.0), ImM DTT, 0.4M KCl and 10% glycerol. The polypeptide 
composition of each fraction was monitored throughout the purification procedure
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by SDS-polyacrylamide gel (8%) electrophoresis. Fractions containing pTP and pol 
were dispensed in small amounts and stored at -7(K>C. pTP-pol heterodimers were 
formed by mixing molar equivalents of the two proteins in storage buffer (50mM 
KPO4 buffer pH 7.0, ImM DTT, 0.4M KCl and 10% glycerol) and incubating for 
20mins at CPC.
12.5 Expression and Purification of 72KDa and 39KDa DBF from Spodoptera 
frugiperda cells infected with a recombinant baculovirus.
Suspension cultures (500ml) of Sf9 cells were grown to a density of 8x10^ cells per 
ml. The cells were collected by centrifugation and infected at a multiplicity of 5 
p.f.u. per cell in 50ml of TClOO for 2 hours at 28^C before medium containing 5% 
foetal calf serum was added to 500ml and the infection was allowed to proceed for 
72 hours at 280C. Infected cells were collected by centrifugation at 2500 rpm for 15 
minutes and washed in phosphate-buffered saline.
The washed cell pellet from 500ml of Sf9 cells infected with the DBP 
recombinant baculovirus was resuspended in 8ml of ice-cold 50mM Tris/HCl pH8, 
50mM NaCl, ImM DTT, ImM EDTA, ImM PMSF, 0.5% NP40 and homogenised 
with 20 strokes of a Dounce homogeniser using a type B pestle. The nuclei were 
sedimented at low speed in a microcentrifuge and the supernatant clarified by 
centrifugation at 60000g for 30 minutes at 4^0. The resulting cytoplasmic extract 
was applied to a denatured DNA-Sepharose column (10ml) equilibrated with 50mM 
Tris/HCl pH8, ImM DTT, ImM EDTA,lmM PMSF, 0.2M NaCl (buffer A). The 
column was washed with 3 column volumes of buffer A and eluted with buffer A 
containing NaCl at a concentration of IM. Fractions containing DBP were pooled 
and applied (300fxl aliquots), to a S-75 Superdex HR 10/30 gel filtration column 
(Pharmacia) equilibrated with 25mM Tris-HCl, pH 8.0, lOOmM NaCl. DBP 
containing fractions were detected by absorbance at A260 nm and checked for purity 
on an SDS polyacrylamide gel. Purified DBP was dialysed against 25mM Tris/HCl
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pH8, lOOmM NaCl, ImM DTT, ImM EDTA, 20% glycerol, ImM PMSF and stored 
at -20OC.
Purified baculovirus expressed DBP (lOmg) prepared as described 
above was diluted to Img/ml in 25mM Tris/HCl pH8, ImM DTT, ImM 
EDTA, 20% glycerol and incubated with chymotrypsin (lOpg/ml) for 30 
minutes at room temperature. Digestion to the 39-kDa fragment was 
monitored by SDS-PAGE, the reaction was stopped by the addition of 
PMSF to 2mM and sample was dialysed against Buffer A made 0.2M 
with respect to NaCl. The 39-kDa DNA binding fragment was purified 
by single-stranded DNA-sepharose chromatography, dialysed and stored 
as described for the full length DBP above. Sequence analysis of the 39- 
kDa fragment was carried out by Biyan Dunbar at the SERC Protein 
Sequencing Facility (University of Aberdeen).
12.6 Expression and purification of Ad.2 72KDa DBF from 
adenovirus infected Hela cells.
Ad.DBP was purified from Hela cells infected at 100 p.f.u./cell for 22 
hours in the presence of hydroxyurea by submitting nuclear extracts to 
chromatography on D.E.A.E.-cellulose and denatured DNA-sepharose,
(Enomoto et al., 1981).
12.7 Expression and purification of Nuclear Factor I DNA-binding 
domain from Spodoptera frugiperda cells infected with a 
recombinant baculovirus.
The Nuclear Factor I DNA-binding domain was expressed and purified as 
described in Bosher et al., (1990).
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12.8 Affinity purification of bacterially expressed Nuclear Factor III 
DNA-binding domain using the pGEX-2T bacterial fusion protein 
expression system.
An E.coli JMlOl transformant containing the cDNA (a.a 270-582) for 
Nuclear Factor III DNA-binding domain (kind gift from P. O'Hare, Marie 
Curie Research Institute) was added to 500ml Luria Broth 
containinglOOpg/ml ampicillin and grown at 37^C until Agoo was 0.6, 
IPTG was added to 0.25mM and the incubation continued for 4 hours at 
25^C. Bacterial cells were then harvested by centrifugation in a Beckman 
JA-20 rotor at 13,000 rpm at 40C for 3 minutes and the supernatant 
discarded. The bacterial pellet was resuspended in lOmls of PBS, and 
disrupted by sonication on ice (4x20 seconds, MSE Soniprep 150). After 
the addition of Triton-x-100 (final concentration of 1%) to the bacterial 
lysate, the lysate was clarified by centrifugation in a Beckman JA-20 
rotor at 14,000rpm at 4^C for 25 minutes and the supernatant recovered 
and passed over a 3ml glutathione-agarose column pre-equilibrated in a 
PBS, 0.5M NaCl buffer. The column was then washed extensively with 
15mls of PBS, 0.5mM NaCl, then eluted with lOmM reduced 
glutathione, 50mM Tris-HCl, pH 8.0,0.5M NaCl and 0.25ml fractions 
collected. Fractions containing the fusion protein were identified by SDS 
polyacrylamide gel electrophoresis, pooled and the fusion protein cleaved 
by incubation with 8 units of human thrombin per mg of fusion protein at 
room temperature for 3 hours. The protease treated material was dialysed 
against PBS, 0.5M NaCl and reapplied to the glutathione column. 
Whereas the GST portion of the fusion protein bound to the column the 
NF-III portion failed to bind and was eluted with the above buffer.
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13. Preparation of substrates to determine strand displacement 
activity.
DNA substrates were prepared by labelling oligonucleotides, (5pmoles) at 
their 5' termini with [y32p] ATP , specific activity 3000 Ci / mmol, using T4 
polynucleotide kinase. Labelled oligonucleotides were isolated on an 8% 
non-denaturing polyacrylamide gel and by eluting overnight in lOmM Tris- 
HCl (pH8.0), ImM EDTA and lOOmM NaCl. DNA hybrids were formed 
by annealing 5 pmoles of 5'-32p-labelled oligonucleotides (or restriction 
fragments) with 1 pmole of complementary single stranded M13 mHRl 
DNA, (Hay, 1985) in 10 mM Tris-HCl (pH 8.0), ImM EDTA and 100 mM 
NaCl. Following three minutes at lOO^C, the mixture was slowly cooled to 
room temperature and 32p_iabelled M13 DNA hybrids separated from 
unannealed oligonucleotide by gel filtration on a Sepharose CL-4B column 
equilibrated in 10 mM Tris-HCl (pH8.0), ImM EDTA and lOOmM NaCl. 
The 18mer-M13 DNA and 100mer-M13 DNA substrates were used in 
assays with Hela DBP. All assays using baculovirus DBP used the 39mer- 
M13 DNA substrate.
14. Preparation of substrate for determination of directionality.
8 pmoles of the 42mer oligonucleotide (oligo A) was labelled at the 5'- 
end with T4 polynucleotide kinase and [')^ P^] ATP. The labelled 
oligonucleotide was annealed with 2 pmoles of single-stranded circular 
M13mpl9 DNA, by heating at lOO^C for three minutes and slowly 
cooled down to room temperature. Annealed DNA was then digested 
with Smal for three hours at 30^C and the 3 -OH termini of the DNA 
labelled in the presence of [a^^P] dCTP and five units of DNA 
polymerase 1 (large fragment). Annealed DNA was separated from
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unincorporated nucleotides by size exclusion on a 5ml Sepharose CL-4B 
column.
15. Preparation of linear double-stranded DNA templates.
DNA templates were prepared by digesting pEXA plasmids,(Hay and 
McDougall, 1986) with EcoRl and BamHl. The DNA was labelled with 
the Klenow fragment of DNA polymerase 1. DNA fragments released 
were labelled at their 3’ termini in the presence of [a 32p] dATP, [a ^^ P] 
dCTP, dGTP, dTTP (lOOpM) and 5 units of DNA polymerase 1 (large 
fragment), at 23^C for 20 mins. The dATP and dCTP concentrations 
were increased by the addition of unlabelled nucleotide to 100 pM and 
the incubation carried out for an additional 20 mins at 23^C. Labelled 
DNA fragments were isolated from a non-denaturing polyacrylamide gel 
and eluted overnight in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 100 
mM NaCl.
16. Strand displacement / DNA helicase assays.
Unless otherwise indicated, reactions (30pi) were performed at 37% for 
30 mins in 40mM Tris-HCl (pH 8.0), 5mMDTT, 1 mg/ml bovine serum 
albumin, containing 10 fmols of DNA substrate and the indicated 
concentrations of DBP. Reactions were terminated by the addition of 5pl 
of 33mM EDTA (pH 8.0), 6% sodium dodecyl sulfate, 25% glycerol, 
0.5% bromophenol blue, 0.5% xylene cyanol and the products separated 
through an 8% non-denaturing polyacrylamide gel. Following 
electrophoresis, gels were dried directly onto DE81 paper (Whatman) 
and exposed to x-ray film, in the presence of an intensifying screen at 
-70®C. Radioactivity in dried gel slices was determined by liquid 
scintillation counting in Ecosint A. DNA helicase assays were identical to
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the above except MgCb (5mM) and ATP (ImM) were included in the 
standard reaction mixture.
17. Quantitation of protein.
All protein concentrations were measured using the Bradford assay 
(1976). 5pl of a total protein sample was mixed with 1ml of Bradford's 
Reagent (lOOmg Coomassie blue G250,100ml orthophosphoric acid and 
50ml of ethanol made up to 1 litre with distilled water), incubated at 
room temperature for 5 minutes and absorbance readings taken at 595nm 
on an LKB Biochem. Ulrtaspec II spectrophotometer. Concentrations 
were calculated by comparison with a standard BSA protein curve.
18.. SDS-polyacrylamide gel electrophoresis.
For protein characterisation, denaturing SDS polyaciylamide gel 
electrophoresis based on the method of Laemmli (1970) was carried out 
in a mini-gel system (Biorad Mini Protean) under reducing and non­
reducing conditions.
19. Native polyacrylamide gel electrophoresis.
For gel electrophoresis DNA-binding assays and DNA unwinding assays, 
non-denaturing polyacrylamide gels (6% to 16%) were prepared using a 
29:1 ratio of acrylamide: N,N-methylene-bis aciylamide. Gels contained 
IxTBE buffer and were polymerised by the addition of 1/100 volume of 
25% (w/v) ammonium persulphate and 1/2000 volume of TEMED. Gels 
were cast 1.5mm thick and run at lOV/cm. 1/10 volume of sample buffer 
(50% glycerol (v/v) 0.2% (w/v) bromophenol blue, 0.2% (w/v) xylene 
cyanol, lOOmM EDTA), was added to samples prior to electrophoresis.
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20. Silver staining electrophoresis.
The Bio-Rad Silver stain was used when silver staining SDS PAGE gels 
and carried out according to the manufacturers instructions.
21. Agarose gel electrophoresis.
Gel slabs (100mm x 100mm) containing 1% (w/v) agrose, IxTBE and 
0.8|Xg/jil ethidium bromide in a total volume of 50ml, were run at 5 v/cm. 
One fifth volume of sample buffer (50% (v/v) glycerol, lOOmMEDTA, 
0.2% (w/v) bromophenol blue, 0.2% (w/v) xylene cyanol) was added to 
samples prior to electrophoresis.
22. Preparation of activated DNA.
Activated calf thymus DNA was prepared by the method of Pansier and 
Loeb, (1974). In assays containing PL? the activated DNA had Bicine 
substituted for Tris at the same pH and concentration.
23. Assay for DNA polymerase / residual DNA polymerase activities.
Purified adenovirus DNA polymerase or PLP inhibited polymerase were 
incubated with lOpg of activated calf thymus DNA, lOOpM dTTP, 
dGTP, dCTP, 20jxM dATP; IpCi (a^^P) dATP (specific activity 3000 
Ci/mmol), 5mM Tris, pH 8.0,5mM MgCb and lOmM DTT in a total 
volume of 50pl or lOOpl for 1 hour at 37^C.Reactions were terminated 
by the addition of 10% TCA, 0.5% sodium pyrophosphate. Insoluble 
radioactivity was captured on Whatman GF/C discs by filtration under 
vacuum. The disc was washed twice with 10% TCA / 0.5% sodium 
pyrophosphate, twice with 5% TCA, once with 70% ethanol, then air- 
dried and the radioactivity measured by scintillation counting.
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24. Assay for the modification of Ad. DNA polymerase with PLP.
Purified DNA polymerase was incubated with different concentrations of 
PLP at 370C(in light resistant eppendorf tubes), in a reaction mixture 
containing 20mM potassium bicine, pH 8.0,10% glycerol and ImM 
EDTA. The reaction was initiated by the addition of protein. After 
incubation, aliquots of the reaction mix, (40 j l i 1) were withdrawn at 
specific time intervals and reduced with a 10-fold excess of sodium 
borohydride (NaBH4). The reduced aliquots were allowed to stand an 
additional 15 minutes on ice, before being assayed for residual DNA 
polymerase activity. All assays were carried out in triplicate and a mean 
value obtained.
25. Assay for reversibility of PLP inhibition.
Purified polymerase was incubated in a reaction mixture (120pl) with 
lOOpM PLP, 20mM potassium bicine, pH 8.0 and 10% glycerol. At 
timed intervals, aliquots were withdrawn and reduced with excess NaBH4 
and assayed for residual DNA polymerase activity. These were 
compared to controls treated identically, except without PLP. After 12 
minutes, the reaction was split in half. To half, Tris-HCl pH 8.0 was 
added to lOOmM, to the other half NaBH4 was added to ImM. After 20 
minutes ImM NaBH4 was added to the first half and lOOmM Tris-HCl, 
pH 8.0, was added to the second half. All assays were carried out in 
triplicate and a mean value obtained.
26. Substrate protection experiments.
Purified polymerase was incubated with PLP (lOOpM) in the presence or 
absence of different substrates in a volume of 50pl. The reaction buffer 
used was 25mM potassium bicine, pH 8.0, with various concentrations 
of MgCla, as indicated. After 15 minutes, a small amount of sample
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(lOjil) was removed and assayed for residual DNA polymerase activity. 
These were compared to reactions prepared identically except containing 
no PLP. All assays were carried out in triplicate and a mean value 
obtained.
Percentage protection was defined as:
(Fraction of residual activity with substrates - fraction of residual activity 
without substrates) x 100.
(1- fraction of residual activity without substrates)
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27. Initial velocity analysis of PLP inhibition.
Reactions were performed using activated DNA as template-primer at 
different concentrations (as indicated) or with different concentrations of 
dNTP's (dNTP concentration was varied but the ratio of the four dNTP’s 
was maintained at 1:1:1:1) as indicated. DNA polymerase protein was 
incubated in lOmM MgCk, 25mM potassium bicine, pH 8.0, in the 
presence of different concentrations of PLP at 370C. Reactions were 
stopped at specific time intervals, by the addition of 10% TCA , 0.5% 
sodium pyrophosphate. All assays were carried out in triplicate and a 
mean value obtained.
Data was analysed by rearranging the Michaelis-Menten 
equation (see below) to obtain a double reciprocal plot known as a 
Lineweaver Burk plot :
Michaelis-Menten V =
Vmax . ( S ) 
Km + ( S )
( Inverted equation ) 1/v = Km + 1/VmaxVmax. ( S )
28. Glycerol gradient centrifugation.
A native (non SDS) gradient was created by layering 1ml glycerol 
solutions (10%, 15%, 20%, 30%) into a 5ml Beckman polycarbonate 
centrifuge tube. A gradient was foimed by incubating the tubes at 40C for 
3 hours, A 200iil protein sample containing purified polymerase was
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loaded onto the gradient and centrifuged at 49,000rpm in a Beckman 
SW40Ti rotor for 14 hours at 4^C, Fractions (50|rl) were collected by 
bottom puncture and then analysed for DNA polymerase and 
exonuclease activities. Fractions were also run on an SDS polyaciylamide 
gel for identification of proteins.
29. Assay for exonuclease activity.
Nuclease activity was measured as described in Field et al, (1984).
30. Assay for the transfer of dCMP to pTP.
Purified replication proteins were incubated in a reaction mixture (lOpl) 
containing 25mM Hepes KOH (pH 7.5), ImM DTT, 2mM MnCla, 0.2 
mg/ml BSA, 3mM ATP and 5|xCi ( dCTP), specific activity 
3000Ci/mmol, with lOOng of Adenovirus cores as the DNA template 
(Coding and Russell, 1983) for 90 minutes at 37^0. Reactions were 
stopped by heating at 70^C for 5 minutes and treated with 5 units of 
micrococcal nuclease in the presence of 2mM CaCla for 30 minutes at 
370c. 4pl of gel loading buffer containing 20% glycerol (v/v), 5% SDS 
(w/v), 570mM mercaptoethanol, 33mM Tris-HCl, pH6.7 and 0.2% 
bromophenol blue (w/v) was added and the samples denatured by heating 
at lOO^C for 2 minutes. Reaction products were resolved and visualised 
on a 10% SDS polyacrylamide gel, which was electrophoresed, dried and 
subjected to autoradiography at -70^C in the presence of an intensifying 
screen.
Adenovirus polymerase and preterminal protein were treated with PLP 
and NaBH4 before introduction into the in vitro initiation assay.
31. Radiolabelling of the adenovirus DNA polymerase active site 
using tritiated NaBHa.
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2.5 nmoles (350p,g) of Adenovirus DNA polymerase was incubated with 
25mM potassium bicine, pH 8.0,0.lmM MgC^ and 0.5mM PLP in the 
presence and absence of ImM dTTP and O.lmM poly dA-oligodTn-ig for 
15 minutes at 37^C, PLP was reduced by the addition of chilled tritiated 
NaBH4 (specific activity= 25mCi/mmol) to a final concentration of 
lOmM. After all the PLP was neutralised as judged by the disappearance 
of yellow colour, the reaction mixture was incubated for an additional 15 
minutes on ice. A small aliquot (15p.l) from each reaction mixture was 
removed and tested for DNA polymerase activity. The reaction mix was 
precipitated with 10% TCA and collected by centrifugation in a Beckman 
TLIOO at 100,(XX)g at 4^C for 20 minutes. The precipitate was washed 
twice, briefly with ice cold acetone before being air drying on ice. The 
dried protein pellet was then redissolved in 50pl of 8M urea, 0.4M 
ammonium bicarbonate buffer, the urea concentration reduced to 2M by 
dilution with water and the polymerase protein digested with 8|ig of 
bovine tiypsin at 37®C for 2 hours. Another 8pg (1/50 w/v) of trypsin 
was added to the mixture and the incubation allowed to proceed 
overnight. After tryptic digestion peptides were analysed by reverse 
phase chromatography using a Waters HPLC system with a Delta-Pak 
C18 column. Peptides eluted from the C18 column were collected over 
120 X 0.5ml fractions and lOpl aliquots from each fraction was added to 
5ml of Ecoscint A and scintillation counted. Suspected peak radioactivity 
HPLC fractions were identified and any corresponding peptides subjected 
to N-terminal amino acid sequencing.
32. Buffer solutions.
The following buffers were used routinely during these studies 
T.E.N. (lOmM Tris-HCl, pH7.5, ImM EDTA, pH8.0, lOOmM NaCl). 
P.B.S. (Phosphate buffered saline).
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RESIJI.TS.
Chapter 1. Purification and of Adenovirus DNA replication proteins.
The elucidation of protein-protein, protein-DNA interactions in 
adenovirus infected cells (in vivo) is difficult as proteins involved in 
DNA replication already exist in specific protein complexes, making it 
difficult to determine the properties of individual proteins. The use of 
recombinant baculoviruses that individually express the proteins solves 
this problem, as well as providing large quantities of protein for 
characterisation.
1.1. Purification of Ad.5 polymerase from recombinant baculovirus 
infected Spodoptera frugiperda cells.
Cell extracts were prepared as described in Materials and Methods from a 
500ml suspension culture of SF9 cells infected with a recombinant 
baculovirus containing the gene for Ad.5 DNA polymerase. Crude cell 
extract was adjusted to 0.2M NaCl, applied to denatured calf thymus 
DNA-sepharose and bound protein eluted with buffer containing 0.6M 
NaCl. The eluate was dialysed against 5mM KPO4 (pH 7), 400mM KCl 
and ImM DTT, applied to hydroxylapatite and bound protein eluted with 
buffer containing 50mM KPO4 (pH 7). Samples of each of these fractions 
containing AdDNA pol were denatured and analysed by SDS-PAGE, 
followed by staining with Coomassie brilliant blue. A distinct species of 
molecular weight 140KDa corresponding to Ad.pol was observed in the 
crude extract (Fig 1.1 A, L) and represented 70-80% of the total protein 
eluted from the s.s DNA-sepharose column (Fig 1.1 A, F4-20). The eluate 
from hydroxy lapatite consisted of near homogeneous pol (Fig I.IB, F3- 
5). The average yield from 500mls of infected SF9 cells was 4mg of 
protein.
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Figure 1.1 Purification of Ad.5 DNA pol from recombinant baculovirus 
infected insect cells. A recombinant baculovirus containing the gene for 
Ad.5 DNA pol was used to infect SF9 insect cells and the extract 
fractionated by denatured DNA affinity and hydroxy lapatite 
chromatography. 20pl of each fraction was analysed in 10% SDS-PAGE 
gels. Protein species were visualised by staining with Coomassie brilliant 
blue R-250. The following abbreviations were used for the various tracks 
in:- A. L, crude cell extract loaded onto the s.s.DNA-sepharose column; 
FT, flowthrough from column; W, 0.2M NaCl buffer wash; 2-20, 
fractions from the s.s. DNA-sepharose column eluted with 0.6M NaCl. B. 
M, molecular weight markers; L, 0.6M NaCl s.s.DNA-sepharose fraction 
loaded onto the hydroxy lapatite column; FT, flowthrough from column; 
W, 5mM KPO4 (pH 7) buffer wash; Fl-6, fractions eluted from 
hydroxy lapatite with 50mM KPO4 (pH 7).
A.
0.6M NaCl fractions
L FT WF2 4 6 8 10 12 14 16 18 20n Ad.Pol
B. 50mM KP04 fractionsI IM L FTWFl 2 3 4 5 6
20li Ad.Pol
29KDa«-ISKDa-»,14KDa-»>
1.2. Purification of Ad.2 DBF and its 39KDa C-terminal domain 
from recombinant baculovirus infected Spodoptera frugiperda and 
full-length DBF from adenovirus infected Hela cells.
Cell extracts were prepared as described in Materials and Methods from 
SOOmls of Spodoptera frugiperda cells infected with recombinant 
baculovirus expressing the gene for Ad.2 DBF (Monaghan et al., 1994). 
Crude cell extract was adjusted to 0.2M NaCl, applied to denatured calf 
thymus DNA-sepharose and bound protein eluted from the column with 
buffer containing IM NaCl. Peak fractions were applied to an S-75 
Superdex gel filtration column equilibrated in 25mM Tris-HCl (pH 8), 
O.IM NaCl. Eluted protein was detected by absorbance at 260nm. 
Samples of crude cell extract, column flowthrough, wash and eluted 
fractions from the denatured DNA-sepharose were analysed by 
electrophoresis on an SDS-PAGE gel, followed by staining with 
Coomassie brilliant blue. A distinct species of apparent molecular weight 
70KDa corresponding to DBP was observed in the crude extract (Fig 
1.2A, L). The eluted fractions from the s.s. DNA-sepharose column 
consisted of near homogeneous DBP (Fig 1.2A, lanes 3-14). The 
DBPwas further purified on an S-75 Superdex gel filtration column. 
Eluate fractions from the S-75 Superdex column were detected by 
absorbance at 260nm (Fig 1.2B) and analysed by electrophoresis on an 
SDS-PAGE gel (Fig, 1.2 C, F7-9). Eluted fractions contained full-length 
DBP and a small contaminating amount of proteolysed DBP.
Purified baculovirus expressed full-length DBP prepared as 
described above was incubated with chymotrypsin (lOpg/ml) for 30 mins 
at room temperature. After stopping the reaction with PMSF, the C- 
terminal proteolytic fragment was purified by single-stranded DNA- 
sepharose chromatography. The purified chymotryptic fragment of DBP 
when analysed by SDS PAGE gave a molecular weight around 39KDa.
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iFigure 1.2. Purification of DBF from recombinant baculovirus 
infected insect cells and adenovirus infected Hela cells. A. an extract 
of SF9 ceils infected with a baculovirus containing the gene for Ad.2 
DBP was fractionated by denatured DNA affinity chromatography 
followed by gel filtration on an S-75 Superdex column (B and C). D.
Hela cell extracts were fractionated by D.E.A.B-Sephacel and denatured 
DNA chromatography. 20pl of each fraction was analysed by 10% SDS- 
PAGE gels. Protein species were visualised by staining with Coomassie 
brilliant blue R-250 or silver stain in the case of Hela DBP. The 
following abbreviations were used for each of the tracks in ;- A. L, crude ^
cell extract loaded onto the s.s. DNA-Sepharose column; FT, flowthrough 
from column; W, wash with buffer containing 0.2M NaCl ; Fl-14, 
fractions eluted with IM NaCl, C. L, IM NaCl s.s DNA-Sepharose 
fractions loaded onto the S-75 Superdex column; F6-13, fractions eluted 
from S-75 Superdex, detected by absorbance at 260nm, D. M, protein 
molecular weight standards; F2-18, fractions from s.s DNA-Sepharose 
when eluted with IM NaCl . The positions of the molecular weight 
standard proteins are indicated.
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IM  NaCl fractions
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DBP was purified from adenovirus type 2 infected Hela cells as 
described in Materials and Methods.The crude cell extract from 10 litres 
of infected Hela cells was subjected to column chromatography on 
D.E.A.E'Sephacel and s.s. DNA-sepharose columns, respectively. Eluate 
fractions from the s.s.DNA-sepharose column were analysed by SDS- 
PAGE electrophoresis followed by silver staining and found to contain 
near homogeneous DBP (Fig 1.2 C, F4-12),
1.3 Purification of virally encoded Ad.5 pTP and the host encoded 
nuclear factor I and III DNA binding domains.
Ad.2 preterminal protein.
A recombinant baculovirus containing the gene for Ad.5 preterminal 
protein was expressed and purified in an identical manner to the Ad.5 
DNA polymerase. The eluate from hydroxy lapatite (figure 1.3, as 
indicated) consisted of near homogeneous pTP with a molecular weight 
of SOKDa.
Nuclear Factor I DNA-binding domain.
Previous studies on Adenovirus DNA replication have shown that only 
the purified baculovirus expressed NF-I DNA binding domain (N- 
terminal) was necessary for all replication functions (Bosher et al, 1991). 
NF-I B.D was expressed and purified as described in Materials and 
Methods. The purified protein was found to have a molecular weight of 
35KDa when analysed by SDS PAGE (figure 1.3, as indicated).
Nuclear Factor III DNA-binding domain.
For the expression of this protein it was decided to use the E.coli / 
pGEX-2T system, as the bacterial pGEX-2T expression vector had
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already been demonstrated to give efficient expression and easy 
purification of a range of eukaryotic protein species (Smith and Johnson, 
1988). Furthermore, an expression vector containing the cDNA for NF- 
III B.D (kind gift from P O'Hare) was available for use. An E.coli culture 
was grown to an optical density of 0.6 (600nm) at 37^0 before induction 
(using IPTG) of fusion protein expression. Purification of the fusion 
protein by glutathione agarose affinity chromatography was followed by 
thrombin cleavage of the fusion protein (see Materials and Methods). To 
purify the thrombin cleaved NF-III DNA binding domain protein from 
glutathione-s-transferase, the thrombin cleaved mixture was reapplied to 
a glutathione agarose column, washed and eluted witii PBS + 0.5M NaCl. 
SDS PAGE analysis of the purified protein (figure 1.3, as indicated) 
revealed that the protein species had a molecular weight of 43,000KDa. 
The protein preparation also had some contaminating glutathione-s- 
transferase present.
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Figurel.3. Purified recombinant Ad.2/5 DNA replication proteins.
Adenovirus pre-terminal protein, DNA polymerase, nuclear factor I ^
binding domain, full-length 72KDa DBP and 39KDa C-terminal DBP 
were all purified from the recombinant baculovirus infected insect cells,
(Materials and Methods). Nuclear factor III was expressed in the pGEX 
bacterial fusion expression system, (Materials and Methods). Sample 
(5pg) were analysed on a 10% SDS-PAGE gel followed by staining with 
Coomassie brilliant blue R-250. The following abbreviations were used:- 
Pol, Adenovirus type 5 DNA polymerase; pTP, adenovirus type 5 
preterminal protein; 72KDa DBP, adenovirus type 2 DNA binding 
protein; 39KDa DBP, C-terminal domain of the adenovirus type 2 DNA 
binding protein; NF-I B.D., N-terminal domain of nuclear factor I; NF- 
III B.D., nuclear factor III DNA-binding domain.
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Chapter 2. Characterisation of Adenovirus DNA replication proteins.
Prompted by reports that (p 29 DNA polymerase from bacteriophage (p 
29, whose genome replicates by a protein-primed mechanism similar to 
that of adenovirus, contained a helicase-like activity (Blanco et al., 1989) 
and through the previous lack of success in finding a helicase activity 
with Hela purified Adenovirus proteins (Field et al, 1984), the putative 
DNA helicase properties of recombinant baculovirus expressed 
adenovirus proteins, individually and in combination with each other was 
studied in more detail.
2.1 Lack of DNA helicase activity associated with purified 
recombinant baculovirus expressed adenovirus DNA replication 
proteins.
The requirement for a helicase was investigated through the use of an in 
vitro DNA helicase assay, originally developed by Matson et al., (1983), 
as it allows reaction products to be separated and quantitated (figure 2.1). 
The DNA substrate used consists of a radioactively labelled 
complementary strand of a restriction fragment (or an oligonucleotide) 
annealed to a circular single stranded DNA molecule. The newly made 
DNA substrate is purified from unannealed labelled oligonucleotide by 
size exclusion on a CL-4B sepharose column (see figures 2.2A and 2.2B). 
The substrate is incubated with a helicase, in the presence of NTP and 
MgCl2 and the products of the unwinding reaction resolved on a native 
polyacrylamide gel. The unwound labelled DNA fragment migrates faster 
in the gel than the substrate DNA, therefore the products of the reaction 
can be directly observed. The DNA substrate can also be altered in 
predictable ways, e.g. the length of the duplex region can be changed, the
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Figure 2.1. Scheme for measuring DNA helicase and DNA helix 
destabilising activities.
The standard DNA substrate consists of a radioactively labelled DNA 
strand of a restriction (or oligonucleotide) fragment annealed to its 
complementary sequence, a circular single stranded DNA molecule.
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Figure 2.2. Preparation of DNA helicase / DNA helix destabilising 
partial duplex substrates.
Annealed and unannealed labelled oligonucleotide (or restriction 
fragment) were separated by gel filtration on CL-4B Sepharose. Fractions 
were analysed by. A, scintillation counting and B, electrophoresis on an 
8% native polyacrylamide gel
substrate can be made linear, or non-homologous tails can be added onto 
the fragment that is to be displaced. In addition, a variation of this assay 
which utilises a linear molecule with labelled duplex regions at both ends, 
can be used to directly determine the polarity of unwinding.
The DNA substrate used in the initial studies consisted of an 18 
nucleotide long oligonucleotide (ISmer) annealed to a complementary 
single stranded M l3 DNA containing the inverted terminal repeat (ITR) 
of the adenovirus type 2 origin of DNA replication. When annealed they 
formed the minimal origin of replication for Ad.2. Results from Table 2.1 
show that no DNA helicase activity (using a standard partial DNA duplex 
substrate) was found associated with any of the recombinant proteins at 
the two indicated protein concentrations used.
2.2 Non-helicase / strand displacement activity of Hela Ad.2 DBP.
After initial attempts failed to show DNA helicase activity, experiments 
were repeated with the indicated recombinant proteins, present at 
concentrations used in the vitro initiation of adenovirus DNA replication 
assays. The possible interaction of Ad.DNA polymerase with DBP and its 
effect on helicase activity, if any was investigated more closely as 
previous studies had shown that DBP increased the processitivity of 
Ad.DNA polymerase (Lindenbaum et al, 1986). Two DNA substrates 
were used: the 18mer previously described, and a longer partial duplex 
DNA substrate containing a 100 nucleotides long strand encompassing 
the first 100 base pairs of the Ad.2 ITR when annealed to the ss M13 
DNA.
The results demonstrate, the presence of a DNA unwinding activity 
with both the 18mer (figure 2.3A, lanes,8-13) and lOOmer (figure 2.3B, 
lanes,3-4,7-8,11-12) substrates when Ad.5 Hela DBP was present in the 
reaction at a concentration (ITpmoles) sufficient to completely coat the
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Table 2.1. Lack of DNA helicase activity associated with the 
Adenovirus DNA replication proteins. The DNA substrate for 
measuring initial helicase activity consisted of a radioactively labelled 18 
nucleotide long oligonucleotide annealed to single stranded M13 DNA. 
After incubation with lOng and lOOng of each protein any displaced 
fragment was separated from those that remained annealed to the s.s.
M13 DNA by electrophoresis through an 8% native polyacrylamide gel. 
Helicase activity was measured as described under Materials and 
Methods. Complete reactions contained 40mM Tris-HCl (pH 7.5), 5mM 
MgCl2,5mM DTT, 1 mg/ml bovine serum albumin and 10 fmoles 3'-^^P- 
labelled (18 mer) partial duplex DNA.
TABLE 2.1
^ \P r o te in  species ^\(ng)
% D ispiacem eef^s^
NF-I B.D. Ad.POL Ad. pTP pTP.Pol Complex 
10 100
Ad.DBP
100 100 100 100 100
+ dNTP (ImM )
-dNTP 
( ImM)
+Mg
(SmM)
+EDTA ( SOmM )
+ NaCI
( 253,100 mM )
+rNTP(ImM)
-rNTP 
( ImM )
Figure 2.3. Hela DNA binding protein exhibits a non helicase DNA 
unwinding activity. Two DNA substrates for measuring the helicase 
activity of Hela DBP were constructed as in Materials and Methods. One 
consisted of an 18 nucleotide long oligonucleotide (IBmer) annealed to 
M13 single-stranded DNA as described above, the other was a 100 
nucleotide long single strand (from a restriction fragment) annealed to 
single stranded M13 DNA; A. native gel analysis of the reaction products 
after incubation of the IBmer substrate (10 fmoles) with the adenovirus 
replication proteins, in the presence and absence of saturating amounts 
(ITpmoles) of Ad.5 Hela DBP. Lane 1, heat denatured control; lanes, 
3,5,7 andl4, no protein; lanes, 2,4 and 6, lOng of preterminal protein 
(pTP), polymerase (Pol) and the preterminal-polymerase heterodimer 
complex (pTP-Pol), respectively, in the absence of DBP; lanes 8,10 and 
12, contain lOng of pTP, Pol and pTP-Pol respectively in the presence of 
DBP; lanes 9,11 and 13, contain DBP only, at saturating levels 
(ITpmoles).B. native PAGE analysis of the l(X)mer DNA helicase / DNA 
helix destabilising reaction products, in the presence and absence of 
ITpmoles DBP; Lane 1, heat denatured control; lanes, 5,9 and 13, no 
protein; lanes 2,6 and 10, lOng of pTP, pol and pTP-pol, respectively, in 
the absence of DBP; lanes, 3,7 and 11, contain lOng pTP, pol and pTP- 
pol in the presence of DBP (ITpmoles); lanes 5,9 and 12, contain DBP 
only at saturating levels (ITpmoles).
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single stranded region of the DNA substrate. With the ISmer, DBP 
unwound approximately 80-90% of the annealed DNA fragment with this 
figure falling to 50-60% with the larger template. The other protein 
species pTP, Pol, and the heterodimer pTP-Pol showed no activity with 
the ISmer (figure 2.3A, lanes, 2,4 and 6, respectively) or lOOmer 
template (figure 2.3B, lanes, 2,6 and 10, respectively).
2.3 Helix destabilisation activity of the recombinant baculovirus Ad.2 
DBP and 39KDa C-terminal DBF.
Although adenovirus type 2 DNA binding protein (DBP) can be purified 
in high yield from adenovirus infected HeLa cells it is not straightforward 
to genetically manipulate the DBP in this genetic background. The gene 
for DBP was therefore inserted into a modified baculovirus genome 
which was used to isolate recombinant baculovirus that would express 
DBP in infected insect cells. To further characterise the biochemical 
properties of DBP that might be involved in viral DNA replication, both 
baculovirus expressed full-length 72KDa DBP and the 39KDa 
chymotiyptic fragment of DBP were tested for their ability to unwind 
short stretches of double stranded DNA, as was the case for DBP isolated 
from adenovirus type 2 infected Hela cells.The substrate utilised to assay 
for this activity was a labelled 39mer oligonucleotide annealed to the 
single stranded form of M13 DNA.This substrate was incubated with 
concentrations of both 72KDa and 39KDa DBP that were sufficient to 
completely coat the M l3 single stranded DNA and the 2^p labelled DNA 
products of the reaction analysed on a native polyaciylamide gel after 
removal of bound protein by dénaturation in the presence of SDS. Both 
the 72KDa and 39KDa DBP proteins were capable of releasing the 39 
mer oligonucleotide from the M l3 DNA substrate, resulting in the 
appearance of free oligonucleotide (lanes 2 and 5, figure 2.4). Incubation
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Figure 2.4. DBP and 39KDa C-terminal DBP isolated from 
recombinant baculovirus infected insect cells exhibit a non helicase 
strand displacement activity.
The substrate used was a ^^P-labelled 39 base-pair oligonucleotide 
annealed to single stranded M13 DNA as described in Materials and 
Methods. The substrate, shown in the upper part of the figure was 
incubated with 72KDa and 39KDa DBP, present at a concentration 
sufficient to completely saturate the 39mer-M13 DNA substrate. 
Reaction products were analysed on a native polyacrylamide gel. Lanes 1 
and 4, heat denatured controls; Lanes 2 and 5, contain 34pmoles of 
72KDa and 39KDa DBP, respectively; lanes, 3 and 6, no protein.
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39 mer
DNA M13
72KDa £  39KDaS + —  S  + —
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of the substrate in the absence of DBP did not result in the release of 
labelled 39 mer oligonucleotide (lanes 3 and 6, figure 2.4) indicating that 
the DNA duplex was stable under the conditions employed for the 
reactions.
2.4 Characterisation of the strand displacement activity of 
recombinant baculovirus DBP.
One of the surprising properties of the DNA unwinding activity described 
above, and with Hela DBP, was that it appeared to take place in the 
absence of any added energy source. To investigate this further, reactions 
were incubated in the presence of a variety of nucleotide triphosphates or 
their analogues and DBP catalysed strand displacement quantitated after 
electrophoretic separation of the products. Strand displacement activity 
was not stimulated by the addition of ATP, CTP, UTP, dATP, dCTP or 
the presence of an ATP regeneration system and activity was not 
inhibited by the addition of the ATP analogue ATPyS (Table 2.2 ). 
Similarly, addition of EDTA or MgCk to 2mM was without consequence 
(Table 2.2 ). These data confirm that the strand displacement activity of 
DBP is independent of an energy source and does not require the 
presence of a divalent cation. In fact, addition of MgCk has a strong 
inhibitory effect on the strand displacement activity with 80% inhibition 
at BmM MgCk (figure 2.5C). Inclusion of NaCl in the reaction also 
reduces strand displacement activity of DBP with less than 30% of the 
activity remaining at lOOmM NaCl (figure 2.5 A). Titration of increasing 
amounts of both the 72KDa and 39KDa proteins into the reaction 
revealed that strand displacement only took place after the DNA was 
completely covered with bound protein (figure 2.5D). At saturating DBP 
concentrations the unwinding reaction is rapid with all of the 39 mer
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Table 2.2. Requirements for baculovirus derived 72KDa DBP strand 
displacement activity with 39mer-M13 DNA partial duplex substrate.
The displacement activity was measured as described in Materials and 
Methods, with the indicated additions, in the presence of 34pmoles of 
72KDa DBP. Complete reactions contained 40mM Tris-HCl (pH 8),
5mM DTT, 1 mg/ml bovine serum albumin, 34 pmoles 72KDa DBP and 
10 fmoles of 3 -^^P-labelled partial duplex DNA.
r
►
i
TABLE 2,2
Additions ConcentrationmM % Displacement
'■ -f
1 COMPLETE 827
COMPLETE + MgCl2 2 81
COMPLETE + EDTA 50 83>
i COMPLETE + ATP 1.5 79
COMPLETE + ATP Regeneration System — 81
COMPLETE + ATPS 1.5 78
> COMPLETE + ATP S and ATP I S Y 79
COMPLETE + CTP 1.5 78
>
COMPLETE + UTP 1.5 77
» COMPLETE + dATP 1.5 78
COMPLETE + dCTP 1.5 80
oligonucleotide released from the Ml3 DNA within 1 minute (figure 
2.5B).
2.5 Involvement of the C-terminal region of Ad.DBP in strand 
displacement.
To identify which region of the protein was involved in the strand 
displacement activity and to confirm that strand displacement was being 
catalysed by DBP rather than a copurifying contaminating protein, the 
DBP specific B6-10 monoclonal antibody (Reich et al, 1983) purified to 
homogeneity from a protein G-Sepharose column was included in the 
unwinding reaction. Eluted fractions (figure 2.6A, F1-5) were incubated 
overnight against PBS before addition to the unwinding reaction. While 
inclusion of purified IgO from a monoclonal antibody raised against 
ovalbumin had no effect on the unwinding activity of DBP, equivalent 
amounts of antibody specific for DBP strongly inhibited strand 
displacement activity (figure 2.6B). The epitope recognised by the B6-10 
antibody is present within the C-terminal chymotryptic fragment of DBP 
(Reich et al, 1983) and thus confirms that this region of the protein, 
which retains DNA binding activity, participates in the unwinding 
activity of DBP.
2.6. Directionality of strand displacement reaction.
The circular nature of the partial duplex routinely used as a helicase 
substrate (figure 2.1) does not allow the assignment of directionality to 
the DNA unwinding activity. A linear DNA substrate with short duplex 
regions at either end and a large internal single stranded region was 
therefore constructed (figure 2.6C upper level). The duplex regions of the 
substrate contain 2^p labelled DNA of 28 and 15 nucleotides such that if 
DBP bound to the single stranded region and migrated on the DNA in a 5'
112
Figure 2,5. Effect of ionic strength, protein concentration and time 
on the strand displacement activity. Using the standard assay as ^
described under Materials and Methods, 34pmoles 72KDa DBP was 
incubated with varying concentrations of, A. NaCl and C. MgCb. B.
Protein concentrations of 72KDa and 39KDa DBP ranging from 0-80 
pmoles were incubated with the substrate as above. D. the time 
dependence of strand displacement was measured in a reaction mixture 
(90|il) containing 200 pmoles of 72KDa DBP. Aliquots (lOpl) were 
withdrawn at the indicated times and loaded directly onto a native 
polyacrylamide gel for analysis.
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Figure 2.6. The 39KDa C-terminal subunit of Adenovirus DNA 
binding protein is responsible for strand displacement activity v^hich 
occurs with no directionality. A. Mouse ascitic fluid B6-10, containing 
monoclonal antibodies against the C-terminal of Ad.2 DBP, was purified 
on protein G-Sepharose. Bound antibody was eluted with lOOmM 
glycine, pH 2.5, collected in 1/20 volume IM sodium phosphate, pH 8 
and analysed on an 8% SDS-PAGE gel. 20pl of each fraction was 
analysed by SDS PAGE. Heavy chain (H.C.) and light (L.C.) were 
visualised by staining with Coomassie brilliant blue R-250, The 
following abbreviations were used for the various tracks:- L, ascitic fluid 
from mouse; FT, flowthrough from column; W, PBS pre-elution wash;
FI-17, fractions eluted with lOOmM glycine pH2.5 . B. 17 pmoles of 
72KDa DBP were incubated with increasing amounts of anti-DBP (anti- 
DBP B6-10) and anti-Ovalbumin monoclonal antibodies (anti-Ova). 
After 30 mins at O^ C the fractions were measured for DNA unwinding 
activity as described in Materials and Methods. C. 39KDa DBP (51-3.25 
pmoles) was incubated with a DNA substrate used to measure the 
direction of unwinding (as indicated at the top of the panel, prepared 
under Materials and Methods ).Lane 1, heat denatured control; lanes 2-6, 
substrate incubated with the indicated amounts of 39KDa DBP; lane 7, no 
protein.
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to 3' direction then the 28 nucleotide fragment would be displaced, 
whereas if DBP migrated in a 3’ to 5’ direction on the single stranded 
DNA then the 15 nucleotide fragment would be released (figure 2.6C).
In fact incubation of this substrate with the 39KDa DBP resulted in both 
fragments being displaced by DBP although the smaller fragment, being 
more easily unwound, was detected at a lower concentration of 39KDa 
DBP. Thus it appears that unlike ATP dependent helicases the strand 
displacement activity of adenovirus DBP is not strictly directional.
2.7. Ad.DBP promoted melting of linear duplex DNA.
In the assays described above the substrate used is largely single stranded 
with only a short stretch of double stranded DNA. Although DBP binds 
cooperatively and tightly to single stranded DNA it has also been shown 
that DBP can bind to double stranded DNA (Cleat & Hay, 1989; Stuiver 
et al., 1990). It was therefore of interest to determine if DBP could 
unwind a completely double stranded DNA fragment. A ^^ P labelled 27 
b.p double-stranded DNA fragment which contains base pairs 1-18 of the 
adenovirus type 2 origin of replication was incubated with both DBP and 
the 39KDa proteolytic fragment and the products separated on a native 
polyacrylamide gel which is capable of resolving single and double 
stranded DNA (figure 2.7). Both DBP and the 39KDa proteolytic 
fragment of DBP were capable of unwinding the short DNA duplex, 
although again it was noticed that the 39KDa fragment appeared to be 
more active in the assay than DBP with maximal activity being achieved 
at a twofold lower concentration of protein. Under the conditions of the 
assay the duplex was stable in the absence of DBP (figure 2.7, lanes 6 
and 12). To determine the size of double stranded DNA that could be 
unwound by DBP, a series of ^ P^ labelled double stranded DNA 
fragments of increasing size were prepared from deleted versions of the
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Figure 2.7. Ad.DBP promoted melting of linear duplex DNA.
Reactions were performed using the standard displacement assay. The 
indicated amounts of 39KDa and 72KDa DBP (34-0 pmoles) were 
incubated with a short ^^P-labelled 27 base-pair linear DNA molecule 
containing the first 18 base-pairs of the adenovirus type 2 origin of DNA 
replication. Duplex and single stranded DNA were separated by 
electrophoresis through a 16% native polyacrylamide gel. Positions of the 
native (d.s) and denatured (s.s) DNA's are shown. Lanes 1 and 7, heat 
denatured controls; lanes 2-6,72KDa DBP (34-0 pmoles); lanes 8-12, 
39KDa DBP (34-0 pmoles).
Ad. DBP ( pmoles) 1
2  34 17 8.5 4.25 ----
39KDa Fragment ( pmoles)I2 34 17 8.5 4.25 —
d.s
S.S
1 2 3 4 5 6 7 8 9 10 11 12
adenovirus type 2 origin of DNA replication (Hay and McDougall, 1986). 
Three linear templates, figure 2.8A, containing 27 (1-18 Ad2 origin), 45 
(1-36 Ad2 origin) and 67 (1-58 Ad2 origin) base-pairs of double-stranded 
DNA were incubated with DBP and the products of the reactions 
fractionated on native polyacrylamide gels. DBP unwound the 27 and 45 
base-pair templates, but not the 67 base-pair substrate. Larger DNA 
substrates of 100 b.p and 400 b.p. could not be unwound by Ad.DBP 
even at very high protein concentrations, (figure 2.8C). To determine if 
the observed strand displacement activity on completely double stranded 
DNA fragments was dependent on base composition of the DNA Ad 
DBP was incubated with two linear, duplex templates of similar size but 
different base composition. One DNA fragment of 23 base pairs 
representing the binding site for the transcription factor NF-kB (HIV-L) 
and had a G+C content of 58% while the other fragment of 27 base pairs 
contained the first 18 base pairs of the adenovirus type 2 origin 
(ADENO) and had a G+C content of 30%, were used as DNA substrates. 
While Ad. DBP could separate the strands of the DNA duplex with low 
G+C content (ADENO, figure 2.8B) it was unable to unwind the strands 
of the DNA duplex with high G+C content (HIV-L, figure 2.8B). DBP 
therefore appears to be unable to unwind completely double stranded 
DNA fragments of high structural stability.
2.8. Strand displacement of DNA duplexes by DBP is inhibited by 
bound proteins.
Prior to initiation of adenovirus DNA replication, the origin is bound by 
the sequence specific DNA binding proteins NFI and NFIII. It was thus 
of interest to determine if DBP could unwind DNA duplexes which were 
already bound by these proteins. DBP was therefore incubated with 
double stranded oligonucleotides containing the binding sites for NFI and
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Figure 2.8 Ad.DBP linear duplex DNA strand displacement is 
dependent on size and thermal stability. Reactions were performed as 
described under Materials and Methods. A. Varying amounts of 72KDa 
DBP (34-0 pmoles) were incubated with a series of ^ ^P-labelled double 
stranded DNA fragments of different size. The DNA templates used in A 
were 27 base pairs long containing base pairs 1-18 of the Ad.2 origin, 47 
base pairs long containing base pairs 1-36 of the Ad.2 origin and 67 base 
pairs long containing base pairs 1-58 of the Ad.2 origin, respectively. 
Positions of the native (d.s) and denatured (s.s) DNA's are shown. 27 
base pairs ; lane 1, heat denatured control; lanes 2-5,34-0 pmoles DBP; 
45 base pairs; lane 5, heat denatured control; lanes 1-4,34-0 pmoles 
DBP; 67 base pairs; lane 1, heat denatured control; lanes 2-5,34-0 
pmoles DBP. B. Varying concentrations of 72KDa DBP (34-0 pmoles) 
were incubated with two ^^P-labelled DNA fragments containing the 
binding site for the transcription factor HIV-L NF-kB (23 base pair 
template) and the adenovirus type 2 origin of replication (27 base pair 
template); HIV-L; lane 1, heat denatured; lanes 2-6, 34-0 pmoles DBP; 
ADENO; lane 1, heat denatured control; lanes 2-6,34-0 pmoles DBP. C. 
Reactions were carried out as in A, with larger linear substrates that 
contained the first 1(X) base pairs and 400 base pairs of the adenovirus 
type 2 genome. The lane set-up was the same for both templates; lane 1, 
heat denatured control, lanes 2-7,34-0 pmoles DBP.
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NFIII either in the absence or the presence of the cognate bound protein. 
To ensure that the specific binding sites were fully occupied by either 
NFI or NFIII, increasing quantities of the two proteins were incubated 
with the 32p-labelled double stranded oligonucleotide and the formation 
of DNA-protein complexes determined in a gel electrophoresis DNA 
binding assay. Amounts of NFI (1 pmole) and NFIII (3 pmoles) were 
therefore chosen that resulted in full site occupancy but higher order 
complexes, indicative of non-specific binding, were not detected (figure
2.9, A and B lower panels). DBP was incubated either with the double 
stranded oligonucleotides or with the double stranded oligonucleotides 
already bound to NFI or NFIII. While DBP can unwind the DNA 
duplexes it is unable to do so when either NFI or NFIII are bound to their 
cognate sites (figure 2.9 A and B, upper panels). Therefore, it seems 
unlikely that DBP alone could be responsible for helix opening at the 
origin prior to initiation of DNA replication.
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Figure 2.9. Bound NF-I and NF III inhibit 72KDa DBP promoted 
DNA unwinding. Reactions were performed as described under 
Materials and Methods. A. Upper panel; various concentrations of 
72KDa DBP (34-2.12 pmoles) added into the standard reaction 
containing an NF-I binding site template, in the presence and absence of 
saturating amounts of Nuclear Factor I (1 pmole). Lower panel; gel 
electrophoresis DNA binding assay as described under Materials and 
Methods, with the 33mer double-stranded oligonucleotide containing the 
binding site for NF-1. Lanes 1-7,10-0 pmoles NF-I. Positions of the 
DNA-protein complexes and free probe are indicated. B. Upper panel; 
various concentrations of 72KDa DBP (34-2.12 pmoles) added into the 
standard reaction containing an NF-III binding site template, in the 
presence and absence of saturating amounts of Nuclear Factor III (3 
pmoles). Lower panel; gel electrophoresis DNA binding assay, 
containing the 30mer double-stranded oligonucleotide containing the 
binding site for NF-III. Lanes 1-7,30-0 pmoles NF-III. Positions of 
DNA-protein complexes and free probe are indicated.
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Chapter 3. Pyridoxal-5’-phosphate (PLP) inhibition of the 
Adenovirus type 5 DNA polymerase.
Previous studies on Ad.2 DNA polymerase from adenovirus infected 
Hela cells has provided the basis of most of the characterisation on the 
enzyme (Field et al., 1984). Extensive sequence homology studies 
between both eukaryotic and prokaryotic DNA polymerases (both viral 
and cellular) has indicated the presence of a putative "active site" region 
in the C-terminal region of Ad.2 DNA polymerase (Larder et al., 1987). 
The role of this region in catalysis of the related Ad.5 DNA polymerase 
was examined through modification of the active site and inhibition of 
catalysis by pyridoxal-5'-phosphate (PLP).
3.1 Characterisation of recombinant baculovirus expressed Ad.5 
DNA polymerase.
Previous studies on the Ad.2 DNA polymerase from Hela infected cells 
demonstrated that optimal DNA polymerase activity, using activated 
DNA as a substrate, required the presence of all four 
deoxyribonucleoside triphosphates, DNA and Mg2+ salt (Lichy et al., 
1982 ; Field et al., 1984). Initial investigations on the baculovirus 
recombinant Ad.5 DNA polymerase therefore concentrated on 
establishing the conditions for optimal activity, A divalent metal cation 
(figure 3.1 A) was absolutely required for activity; the optima for MgCk 
and MnCla being 5mM and 0.5mM, respectively. The optimum pH 
(figure 3. IB) in 50mM Tris-HCl buffers was 8.0, the reaction rates at pH 
7 and 9 being 97 and 88%, respectively, of the rate at the optimum.
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Figure 3.1 Dependence of Adenovirus DNA polymerase activity on 
divalent metal cation and pH. A. 1.5|ig of Ad. 2 DNA polymerase 
incubated in the presence of the indicated concentrations of MgCli and 
MnCl2 as described in Materials and Methods, B. in the presence of Tris- 
HCl buffers varying from pH 7-10. All reactions were carried out in 
triplicate and a mean value obtained.
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3.2 Kinetics of Pyridoxai-5'-phosphate (PLP) inhibition of Ad.5 DNA 
polymerase.
Identification of amino acid side-chains involved at the catalytic centre 
of many enzymes has relied upon the use of chemical modifiers of amino 
acids, whose use is governed by two requirements: A, modification 
should be carried out under mild conditions; and B. only one type of 
amino acid group must be modified at a time (for review see, Price and 
Stevens, 1989). The catalytic site of Ad.5 DNA polymerase was 
investigated using the chemical modifier Pyridoxal-5-phosphate (PLP), a 
naturally occurring cofactor which has been shown to be an effective 
inhibitor of many enzymes which have binding sites for nucleoside 
triphosphate e.g. Reverse Transcriptase (Basu et al, 1989), DNA 
polymerase a  from Drosophilia melanogaster (Diffley, 1988) and E.coli 
DNA polymerase 1 (Basu and Modak, 1987). PLP inhibits through the 
chemical modification of lysine or ariginine amino acid side-chains. It 
contains a phosphate moiety important in the initial binding of the 
inhibitor at the phospho-ligand binding site, while the formyl moiety it 
contains at carbon position 4 is required for the formation of a covalent 
imine or Schiff base with a primary amino group, usually the e-amino 
group of lysine at this binding site. The initial covalent imine bond it 
forms is readily hydrolyzable and reversible in aqueous solution and 
needs to be reduced to a stable, secondary amine by the addition of at 
least a ten-fold excess of sodium borohydride (NaBH4). Inhibition of 
Ad.5 DNA polymerase with a molar excess of PLP should normally
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follow pseudo-first order kinetics;
Kh-1
►
K.i
E=Enzyme EI=Enzyme-I=Inhibito r Inhibitor
Complex
with the apparent first order forward rate constant defined as K+i; 
expected to increase linearly with increasing inhibitor concentration. 
However, when an inhibitor binds to a specific site on an enzyme, 
apparent first order rate constants plateau at higher inhibitor levels, 
exhibiting a saturation effect (Meloche et al, 1967), This is a 
characteristic property of an affinity label, indicating an initial, non- 
covalent interaction between the inhibitor and a specific site on an 
enzyme prior to the formation of a stable covalent bond. In the case of 
PLP inhibition, a reversible imine bond is formed prior to being reduced 
by sodium borohydride, forming a stable irreversible amine bond.
Ad.5 DNA polymerase was incubated in the absence of substrates 
with various concentrations of PLP in the presence (figure 3.2A) and 
absence (figure 3.2B) of MgCh. Data from figure 3.2A demonstrates that 
Ad.5 DNA polymerase is inhibited in a time-dependent manner, reaching 
a limit after several (8-12) mins. Apparent first order rate constants for 
inhibition at each PLP concentration, in both the presence and absence of 
Mg2+, were calculated and are shown in figure 3.2C. The results in figure
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Figure 3.2 Kinetics of PLP inhibition of Adenovirus type 5 DNA 
polymerase. A. 43jig (total) of purified Ad. 5 DNA polymerase 
incubated with PLP at final concentrations of 0,25,50,100,200pM in 
the presence of 20mM potassium bicine, pH 8,10% glycerol and ImM 
EDTA, pH 8 in a final volume of 400pl. At the times indicated, 40iil 
aliquots were removed and reduced with lOpl of 15mM NaBH4. After 
incubation at 0°C for 10 minutes, aliquots were assayed for residual DNA 
polymerase activity with activated DNA as described under Materials and 
Methods and compared to reactions treated identically, except containing 
no PLP, B. reactions were as above except in the absence of MgCli, C. 
values of K (mins) for PLP inhibition were determined from data in A 
and B. Rate values were calculated by measuring the gradient of the 
initial rate of the reaction slopes. All reactions were carried out in 
triplicate and a mean value obtained.
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3.2C demonstrate that PLP inhibition of the polymerase probably occurs 
through binding to a specific site(s) on the enzyme in both the presence 
and absence of Mg2+. The presence of Mg^ + also increases the ability of 
PLP to inhibit Ad.5 DNA polymerase activity .In fact, Mg^ + has been 
shown to have multiple roles in DNA polymerase reactions, which 
include the binding of both primer (Fisher and Kom, 1981) and dNTP’s 
(Mildvan and Loeb, 1979) to the active site, therefore its not surprising 
that Mg2+ stimulates the binding of PLP to the enzyme. This Mg^+- PLP 
chelate has been shown to be required for effective inhibition of other 
DNA polymerases (Basu and Modak, 1987 ; Basu et al., 1988).
3.3 Reversibility and pH dependence of PLP inhibition.
To demonstrate that PLP inhibition of Ad.5 DNA polymerase occurs via 
reversible imine bond formation, which can be rendered irreversible by 
reduction with NaBH^, use was made of the ability of primary amines 
such as Tris to inactivate free PLP via imine bond formation . After PLP 
inhibition of Ad.5 DNA polymerase was allowed to approach equilibrium 
(10 mins), the reaction mixture was split in half. One half was treated 
with an excess of Tris and then reduced with NaBH4. The other half was 
reduced by NaBH4 addition and then treated with excessTris and assayed 
for residual DNA polymerase activity. These were compared to reactions 
containing no PLP. Figure 3.3A demonstrates that the addition of Tris 
before reduction can reverse inhibition, while addition of Tris after 
reduction cannot reverse inhibition. Therefore it would seem that PLP 
inhibition of Ad.5 DNA polymerase activity occurs by reversible imine 
bond formation. During PLP inhibition this would involve nucleophilic 
attack by a nonprotonated amino group on the carbonyl group of PLP. 
This type of attack should cause a sharp rise in the rate of inhibition at 
some pH value, which can then be used to infer the pKa of the amino
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Figure 3.3 Reversibility and pH dependence of PLP inhibition.
A. lOOjig (total) of Ad.5 DNA polymerase incubated in ZOOpl with 50|xM 
PLP, 20mM potassium bicine, pH 8,10% glycerol and Img/ml BSA. At 
the times indicated aliquots (20pl) were withdrawn, reduced with lOjLil of 
15mM NaBH4 and assayed for residual DNA polymerase activity using 
activated DNA. These were compared to control reactions treated 
identically except without PLP. After 12min, the reaction was split in 
half. To half Tris-HCl, pH 8 was added to lOOmM, to the other, NaBH4 
was added to ImM. After 20 mins, ImM NaBH4 was added to the first 
half and lOOmM Tris-HCl, pH 8 was added to the second half; B. 60|iig 
(total) of purified Ad.5 DNA polymerase incubated with lOOjiM PLP in 
25mM potassium bicine at the indicated pH values in 280|xl. At 0 ,1,2 ,4 , 
8 and 10 mins, 40pl aliquots were withdrawn, reduced with 2mM NaBH4 
and assayed on activated DNA for residual DNA polymerase activity. 
Reactions identical to the above, except without PLP, were used as 
controls. Rate values were calculated by measuring the gradient of the 
initial rate of the reaction slopes. K(mins)‘l represent the initial rates of 
inhibition with PLP. All reactions were carried out in triplicate and a 
mean value obtained.
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group on the polymerase which forms the imine bond with PLP (Bull et 
al, 1975). Rate constants (K) for PLP inhibition of Ad.5 DNA 
polymerase were determined over a range of pH values. There is a sharp 
increase in the rate (K) between pH 7-9. An increase in the rate of PLP 
inhibition was seen for both E.coli RNA polymerase and DNA 
polymerase a  between pH 7.8 and 8.2 and was interpreted to mean that 
the critical amino group exhibited a pKa between 7.8 and 8.2 (Bull et al., 
1975 ; Diffley, 1988). In both cases the amino group was shown to be the 
e-amino group of a lysyl residue. Since the e-amino group of free lysine 
has a much higher pKa (pKa=10.79), it was suggested that this lysyl 
residue was unusually reactive and, therefore, probably in the active site 
of the enzyme. This could be the case with Ad.5 DNA polymerase as its 
rate of inhibition is highest between the to pH values above. Although 
increases in rate constants have been used to pinpoint crucial residues, it 
must be stressed that possible conformational changes in this pH range 
could artificially increase the rate of noncovalently binding of PLP to the 
polymerase and therefore an increase in covalent bond formation. 
However, the optimum pH for Ad.5 DNA polymerase, which is pH 8.0, 
is within the pH range were the rate of reaction increases.
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3.4 Effect of substrates on PLP inhibition.
If PLP inhibition of Ad.5 DNA polymerase is occurring via covalent 
bond formation at a substrate binding pocket, then occupation of this site 
by appropriate substrates should block PLP inhibition. This approach has 
been used to investigate, in detail, the Human immunodeficiency virus 
reverse transcriptase (Basu et al., 1988), Murine Leukemia virus reverse 
transcriptase (Basu et al., 1989) and Drosophilia melanogaster DNA 
polymerase a  (Diffley et al., 1988) activities. All of these enzymes seem 
to obey a rigidly ordered substrate binding mechanism, with a single 
stranded DNA template binding first, followed by the binding of the 
correct deoxyribonucleoside triphosphate. Two template-primer / dNTP 
binding systems were chosen to look at the substrate binding mechanism 
of Ad.5 DNA polymerase. In the first system, Ad.5 DNA polymerase was 
incubated in the presence and absence of activated DNA and all four 
dNTP's (as template-primer and nucleotide source, respectively) at three 
different Mg^+ concentrations, in the presence of 50|iM PLP. After 
incubation at 3?0C for 15 mins the reaction mixtures were treated with an 
excess of NaBH4, left to cool on ice, then assayed for residual DNA 
polymerase activity (see Materials and Methods) and compared with 
reactions which had no PLP added (figure 3.4), Percentage protection is 
defined as the percent of Ad.5 DNA polymerase activity protected by the 
indicated substrates (Material and Methods). The results from figure 3.4 
demonstrate that activated DNA alone affords little or no protection , 
whereas dNTP's alone affords protection only at ImM MgCla (25%) and 
lOmM MgCl2 (11%), respectively. Ribonucleoside triphosphates 
(rNTP's) were found to have the same basic pattern of protection as for 
dNTP's, the highest amount of protection occurred at ImM MgClz (19%), 
with reduced protection occurring at lOmM (9%) and no protection in the 
absence of MgCl2. Protection by dNTP and rNTP is optimal at a low
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Figure 3.4 Protection from PLP inhibition by various substrates.
lOjXg of purified Ad.5 DNA polymerase was incubated with 50pM PLP 
and the indicated concentrations of MgCl2 in the presence or absence of 
various nucleoside triphosphates and activated DNA in 25mM potassium 
bicine, pH 8, then reduced with an excess of NaBH4. Activated DNA and 
dNTP’s were added to a final concentration of 1 mg/ml and ImM, 
respectively. After 15 mins at 3?0C, lOjil aliquots from each reaction 
were assayed for residual DNA polymerase activity as described under 
Materials and Methods and compared to identical reactions containing no 
PLP .All reactions were carried out in triplicate and a mean value 
obtained. Percent protection is defined as:
(Fraction of residual activity with substrates-fraction of residual activity 
without substrates) x 100.
(1-Fraction of residual activity without substrates)
% Protection
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Mg2+ concentration and is probably due to PLP being less inhibitory as a 
result of the substrates competing for the Mg2+ ions in the reaction. 
Protection was highest when both DNA and dNTP’s were present at ImM 
MgCl2 (78%),with this figure dropping to 20% and 0% at lOmM and 
OmM MgCl2, respectively. Therefore the ability of template-primer and 
dNTP to protect Ad.5 DNA polymerase from PLP seems to be dependent 
upon the Mg2+ concentration. This can be demonstrated in a defined 
system using poly (dA).oligo (dT)i2-i8 as the template-primer, (table 3.1). 
Reactions were carried out at a Mg^+ concentration of O.lmM (10% of 
the optimal). Under these conditions, dTTP in the presence of poly 
(dA).oligo (dT) 12-18 is now seen to offer a significant amount of 
protection from PLP inhibition, (85%) while unmatched nucleotides, 
(30%, 24%, 26%, respectively for dGTP, dCTP, dATP) offer no more 
protection than primer-template alone (24%). Nucleotide alone (dTTP) 
showed little protection (12%). The values for percent protection (at 
these low Mg^ + concentrations) probably represent a slight underestimate 
of the actual protection since they were compared to control reactions 
without Mg2+. This was done to ensure that protection is not a result of 
the chelation of free Mg^ + by the substrates which would render PLP less 
inhibitory. These results suggest that (at suboptimal Mg2+ 
concentrations) template-primer and dNTP can bind in a potentially 
productive manner, but some aspect of catalysis is slowed, leaving the 
substrates in an abortive ternary complex which can protect the 
polymerase from PLP inhibition. To test this theory and to eliminate the 
possibility that PLP inhibited in a qualitatively different manner at low 
and high Mg^+ concentrations, the ability of a true dead-end ternary 
complex to protect Ad.5 DNA polymerase at two Mg^+was tested. Early 
characterisation studies on Ad.2 DNA polymerase (Lichy et al., 1982) 
had shown that the addition of a ddNTP inhibited almost 100% of the
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Table 3.1. Protection from PLP inhibition by substrates in a defined 
system. lOpg of Ad.5 DNA polymerase incubated with 50pM PLP,
25mM potassium bicine, pH 8, O.lmM MgCk in the presence of the 
indicated substrates. The final concentrations of each individual dNTP 
and poly (dA). oligo (dT)i2-i8 were ImM and O.lmM , respectively. 
Residual polymerase activity was assayed as above. All reactions were 
carried out in triplicate and a mean value obtained.
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Table 3.2, Protection from PLP inhibition by a ddNTP containing 
ternary complex. PLP inhibition and residual DNA polymerase activity 
assays were performed as in figure 3.4, except that only two MgCk 
concentrations (ImM and 1 OmM) were used. The concentration of 
nucleoside triphosphates and dideoxynucleoside triphosphates was ImM. 
All reactions were carried out in triplicate and a mean value obtained.
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polymerase activity. The ability of ddNTP's to protect polymerase 
activity through competitive inhibition with PLP was studied more 
closely. To investigate the possibility that the site of ddNTP inhibition 
coincided with that for PLP inhibition, PLP was incubated in the presence 
and absence of activated DNA, 3xdNTP's and one ddNTP at both ImM 
and 1 OmM MgCla (table 3.2). Addition of a ddNTP into the reaction at 
both Mg2+ concentrations resulted in nearly 100% protection . At the 
same Mg^+ concentrations, in the presence of dNTP's, protection was 
only 25% (lOmM) and 75% (ImM) respectively (see figure 3.4). Thus, 
the presence of activated DNA plus three dNTP's, dATP, dCTP, dGTP 
and any ddNTP seems to block PLP inhibition by binding to the same site 
on Ad.5 DNA polymerase as the ternary complex foimed with the noimal 
template-primer and dNTP. Presumably the ddNTP is immediately 
incorporated into the growing DNA chain, resulting in the formation of a 
dead-end ternary complex.
3.5 Effect of PLP on initial reaction velocities.
Ad.5 DNA polymerase substrates at optimal Mg^ + concentrations are 
ineffective in blocking PLP inhibition. Two possibilities exist to explain 
this problem: firstly, Ad.5 DNA polymerase can only leave a ternary 
complex by two pathways; A, either backward by ordered release of 
substrates; B, forward by catalysis and translocation of the newly formed 
3' end to the primer binding site and/or subsequent release of products. 
Secondly, since a dead-end ternary complex cannot follow this second 
pathway, a higher concentration of substrates may be required to occupy 
most of the polymerase as a ternaiy complex (therefore at infinite 
concentrations of one or all of the substrates, the normal ternary complex 
should protect from PLP inhibition); alternatively, a rate limiting step 
may exist in the polymerisation cycle between ternary complex formation
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Figure 3.5. Initial velocity analysis of PLP inhibition with respect to 
template-primer and dNTP concentration. A. Initial reaction velocities 
using the indicated concentrations of activated DNA as template-primer. 
5|Xg of Ad.5 DNA polymerase, lOmM MgClz, 25mM potassium bicine, 
pH 8, in the presence of 0,10,20 and 40pM PLP, incubated at 37^0 for
1,2 ,4 ,6 , 8 and 10 mins and stopped by the addition of cold TCA as 
described under Materials and Methods. B. initial reaction velocities were 
determined as above, except the dNTP concentration was varied (ratio of 
four dNTP's was maintained at 1:1:1:1) as indicated.The concentrations 
of PLP were the same as in figure 3.6 A, with the concentration of 
activated DNA constant at lOpg (total). All reactions were carried out in 
triplicate and a mean value obtained.
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and the nucleotide binding step.Therefore, if PLP binds to Ad.5 DNA 
polymerase in an inhibitory fashion during this time, then even infinite 
concentrations of substrate will not protect from PLP inhibition. The two 
alternatives can be distinguished by looking at the effect PLP has on the 
initial velocities of Ad.5 DNA polymerase reactions. If the first of the 
possibilities is correct, then inhibition by PLP should be competitive with 
one or more of the substrates, while with the second possibility, 
inhibition by PLP, should not be competitive with any substrate. Initial 
reaction velocity studies using PLP have been carried out with a number 
of enzymes (Modak, 1976 ; Diffley, 1988). In figure 3.5 reciprocal plots 
show that PLP inhibition is not competitive with either: A, activated 
DNA or B, total dNTP (using activated DNA as a template-primer). This 
is consistent with the results presented in figure 3.4, in which both 
template-primer and dNTP's alone were ineffective in protecting the 
polymerase from PLP inhibition.The kinetic data above suggests that the 
second possibility most accurately describes the PLP inhibition of Ad.5 
DNA polymerase. That is, only the template-primer and dNTP ternary 
complex can protect the polymerase from PLP inhibition, with PLP only 
capable of inhibiting the polymerase at a rate limiting step in the 
polymerisation reaction occurring after the formation of the ternary 
complex and before the binding of the next nucleotide.
3.6. Specificity of PLP inhibition.
In order to determine the specificity of inhibition by pyridoxal-5'- 
phosphate, four other chemically related compounds were tested for 
inhibitory effects on Ad.5 DNA polymerase (table 3.3). The results 
indicate that the pyridoxine derivatives, pyridoxine, pyridoxal, 
pyridoxamine and pyridoxamine-5’-phosphate (at a concentration 
oflOOjuM) have no effect on the DNA synthesis of Ad.5 DNA
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Table 3.3. Effects of various pyridoxine derivatives on the activity of 
Ad. 5 DNA polymerase. 3pg of purified Ad.5 DNA polymerase 
incubated with the indicated concentrations of pyridoxine derivatives. 
After incubation at 37^0 for 1 hour, reactions were stopped by the 
addition of cold TCA and DNA polymerase activity measured as 
described in Materials and Methods. All reactions were carried out in 
triplicate and a mean value obtained.
Table 3.3
PYRIDOXINE
DERIVATIVE(IOOuM)
NUCLEOTIDE INCORPORATION 
(pmol/hr )_______________ %INHIBmON
NONE 77
ÇHO
H .X J  “
PYRIDOXAL-5-PHOSPHATE
26 67
CHjOH
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CH^ NHjCHgOH
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HO CHjNH, pO-PO OH3C - N-
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polymerase. Pyridoxal-5’-phosphate at the same concentration inhibited 
inhibition by up to 67%. PLP inhibition of Ad.5 DNA polymerase 
therefore seems to be highly specific.
3.7. Ad.5 DNA polymerase associated nuclease activity.
Previous studies had shown that a 3-5' exonuclease activity is associated 
with the Ad.2 DNA polymerase (Field et al, 1984). To test whether 
recombinant baculovirus Ad.5 DNA polymerase contained this same 
activity, a preparation of Ad.5 DNA polymerase was fractionated by 
glycerol gradient centrifugation. Fractions were collected, analysed by 
SDS PAGE (figure 3.6A) and DNA polymerase and exonuclease 
activities determined (figure 3.6B). A contaminating band present just 
below the 140KDa DNA polymerase in the glycerol gradient fractions 
which corresponds to proteolysed polymerase was also found to be 
present. Alignment of the fractions from the glycerol column with 
optimal polymerase and exonuclease activities indicated that fractions 31 
40 (F31-40) contained both activities. The results indicate that 
baculovirus derived Ad.5 DNA polymerase contains an extrinsic 
exonuclease activity which co-sedimentates with the DNA polymerase 
activity.
3.8. Effect of PLP on Ad.5 DNA polymerase and its associated 3'-5’ 
exonuclease activities.
Sequence homology studies have indicated that the DNA polymerase 
and exonuclease activities of a-like DNA polymerases (of which Ad.5 
DNA polymerase is a member) are located on different domains of the 
protein. To test whether the two functions shared the same catalytic site, 
purified Ad.5 DNA polymerase was incubated with 0, 25, 50, 100,150, 
200pM PLP (figure 3.7) The results show a progressive decrease in the
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Figure 3.6 Co-sedimentation of an 3'-5’ exonuclease activity with the 
140KDa Adenovirus 2 DNA polymerase. 300pg of purified Ad.5 DNA 
polymerase loaded onto a native 5%-30% glycerol gradient and 
centrifuged at 49,000rpm on an SW40i rotor for 4 hours. Fractions were 
collected and analysed by SDS PAGE (A) and assayed for exonuclease 
and polymerase activities (B) as described in Materials and Methods. All 
reactions were carried out in triplicate and a mean value obtained.
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Figure 3.7 Effect of pyridoxal-5-phosphate (PLP) on the DNA 
polymerase / exonuclease activities of Ad.5 DNA polymerase. ITjig 
Ad.5 DNA polymerase was incubated with the indicated concentrations 
of PLP in 50mM potassium bicine, pH 8, lOmM MgCla at 31^C for 15 
mins. The reaction mixtures were slowly cooled to O^C and a chilled 
solution of NaBH4 added to give a final concentration of 2mM. After 15 
mins on ice a small aliquot (20|il) was assayed for polymerase and 
exonuclease activities. Percentage inactivation for the Ad.5 DNA 
polymerase and exonuclease activities are shown. All reactions were 
carried out in triplicate and a mean value obtained.
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polymerase activity with increasing PLP concentrations, while 
exonuclease activity was not significantly affected. These results indicate 
that the DNA polymerase and exonuclease domains of Ad.5 DNA 
polymerase are likely to be on different parts of the protein.
3.9. PLP inhibition of the transfer of dCMP to pTP.
Previous studies had pointed to a direct transfer mechanism being 
involved in the transfer of dCMP onto pTP, the first residue in the 
nascent DNA chain, (Lichy et al, 1982). The transfer is thought to 
directly involve the adenovirus DNA polymerase whilst in the pTP-Pol 
heterodimer complex. To demonstrate whether the dCMP transfer and 
catalytic sites were one and the same, PLP inhibition of both Ad.5 DNA 
pol and pTP was carried out before introduction into the standard 
initiation assay. Figure 3.8 (lanes 1-5) demonstrates that PLP (present at 
25, 50,100|iM) inhibition of the Ad.5 DNA polymerase before addition to 
the in vitro initiation assay results in a noticeable decrease in the level of 
the 80KDa pTP-dCMP protein complex. Inhibition of pTP, however, 
shows no affect on the level of the 80KDa pTP-dCMP complex, (lanes 6- 
9). Therefore, PLP seems to inhibit pTP-dCMP complex formation only 
when the polymerase component of the heterodimer has been previously 
inhibited. This result, when taken in conjunction with the kinetic results 
above, suggests that PLP is inhibiting at a site common to both the 
catalytic and dCMP transfer activities of the Ad.5 DNA polymerase.
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Figure 3.8. Inhibition of dCMP transfer by PLP. Purified Ad.5 DNA 
polymerase and preterminal protein were incubated with 0, 50,100 and 
200|iM PLP (as indicated) at 37^0 for 15 mins. PLP was reduced by the 
addition of cold NaBHU (final concentration of 2mM). The reaction 
mixture was left at O^C for an additional 15 mins before addition into the 
standard in vitro initiation assay (Material and Methods). The formation 
of the pTP-dCMP 80KDa complex, indicative of initiation was visualised 
as described under Materials and Methods.
Chapter 4. Attempted demonstration of the presence of reactive 
lysine(s) in the putative Ad.5 DNA polymerase active site.
The results presented in chapter 3 demonstrated that pyridoxal-5'- 
phosphate (PLP) inhibited the catalytic (polymerisation) function of the 
DNA polymerase at its active site. To identify the targets of 
pyridoxylation and to map the regions containing the putative lysine 
residue(s) involved in dNTP binding to the active site, differential 
labelling with tritiated sodium borohydride followed by comparative 
tryptic mapping using reverse-phase HPLC was performed.This approach 
had been used successfully to investigate important lysine residues 
involved in catalysis of various DNA polymerases (Modak et al, 1976; 
Basu and Modak, 1987).
4.1 m Sodium borohydride affinity labelling of lysine residues in the 
putative active site of Ad.5 DNA polymerase.
Differential labelling (Koshland et al, 1959) using PLP as an affinity 
label was the experimental approach taken to obtain more evidence on 
the structure of the active site of Ad.5 DNA polymerase. PLP was ideal 
to use as the imine bond (Schiff base) it can form with lysine residues 
may be radioactively labelled by reduction with tritiated NaBH4 (see 
figure 9 in discussion). An outline of the %  differential labelling 
procedure is shown in figure 4.1.
4.2 Comparative tryptic mapping of PLP treated and substrate 
protected Ad.5 DNA polymerase.
Peptides from the trypsin digested %  affinity labelled Ad.5 DNA 
polymerase protein in the presence and absence of substrates were
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^ 350fig Ad.5 DNA polymerase
*Incubation with and without teinplate-prinier ( poly (dA).oligo W T),2.,8at O.lniM ) and dNTP (dTTP) a t ImM in the presence of lOOpM PLP.
After incubation a t 37 C for 15 mins, PLP reduced by chilled 
H N aBI^at a final concentration of 1.5mM. Reaction mixture 
left on ice for an additional 15 mins.
Protein precipitated by addition of TCA to 10%.
Protein pellet redissolved in SOpl NB^H.CO^buffer / 8M urea. 
Solution diluted down to 200pl with water / 2M urea. 
Solution digested with 8pg trypsin for 24 hrs at 37 C.
Tryp tic peptides separated by reverse phase HPLC on a 018 column 
with a 0 to 98% acetonitrile gradient. Fractions were assayed for 
radioactivity.
Figure 4.1 Outline of sodium borohydride labelling / substrate 
protection scheme for lysine residues in the active site of baculovirus 
purified Ad. 5 DNA polymerase.
Given above is the outline of the active site substrate protection scheme 
used to label 350pg (2.5 nmoles) of purified Ad.5 DNA polymerase 
protein.
fractionated by reverse phase HPLC chromatography using a Waters 
HPLC system with a Delta Pak C l8 column, eluted from the column 
with 0-98% acetonitrile gradient (Materials and Methods) and collected 
over 105 x 0.5ml fractions. Eluted fractions were monitored at 325nm 
for reduced Schiff base characteristic absorbance (figure 4.2A, no 
templates and figure 4.2B, templates present) andlOpl aliquots of each 
fraction dissolved in 5ml of Ecoscint A and scintillation counted. The 
plot of %  radioactivity (in the absence and presence of templates), versus 
fraction number (figure 4.2C) showed a relatively simple pattern of 
radioactive peptides in the HPLC eluate. A large peak of radioactivity 
was found between fraction numbers 5-10 in both cases, which most 
probably corresponds to unreacted tritiated NaBH4 as this elution time 
corresponds to column flowthrough. Further comparison of the HPLC 
traces reveals that only one distinct peak of radioactivity can be seen, 
only in the absence of templates, between fraction numbers 23-27. This 
peak was subjected to N-terminal Edman degradation. Unfortunately it 
was not possible to identify a unique sequence with the isolated peptide.
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Figure 4.2. Reverse-phase HPLC separation of tryptic peptides of 
Ad.5 DNA polymerase.
The tryptic peptides derived from the PLP modified enzyme were 
resolved on a Vydac C l8 column and equilibrated with 0.06% 
trifluoroacetic acid. Peptides were eluted by increasing the concentration 
of solution B (98% acetonitrile containing 0.06% trifluoroacetic acid) as 
follows: 0-37% B (0-60 mins), 37-75% B (60-90 mins) and 75-98% (90- 
105 mins).The tiyptic maps shown here correspond to, (A) Ad.5 DNA 
polymerase modified by PLP in the presence of dTTP and poly d (A), 
oligo d (T) 12-18, (B) Ad.5 DNA polymerase modified by PLP in the 
absence of template-primer and dNTP and (C) radioactivity of eluate 
fractions from both (A □ — □  ) and (B ■— ■  ) above.
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DISCI ISSTON.
Adenoviruses replicate their genomes via a specialised "protein-priming" 
mechanism. In this system of DNA replication, it is believed that specific 
initiator protein(s) interact with the viral origin of replication, giving rise 
to the unwinding of the double-helix , leading to the creation of an 
exposed region of ssDNA which is used to elongate the rest of the 
genomic DNA. In adenovirus type 2 and 5 DNA replication, these 
proteins form a nucleoprotein complex consisting of five proteins; pTP, 
Ad.pol, Ad.DBP (all virally encoded), NF-I and NF-III (cellular 
proteins). The lack of any detectable helicase activity associated with any 
of the proteins (Lindenbaum et al., 1986) presents a problem when trying 
to understand the mechanism of DNA replication in the virus. The 
mechanism of DNA unwinding and its role in DNA replication has been 
studied in a large number of prokaryotic and eukaryotic reconstituted 
replication systems. This has led to the discovery of various DNA 
helicases that are essential for viral replication (Matson and Kaiser- 
Rogers, 1990 ; Matson et al., 1994). The results presented in chapter 2 
attempt to clarify the process of DNA unwinding that takes place during 
the replication of the Adenovirus genome.
All the purified replication proteins present in the nucleoprotein 
complex were tested individually for DNA helicase activity (see results 
section chapter 2, Table 2.1). No detectable helicase activity was found in 
any of these proteins when tested at low concentrations in a standard in 
vitro DNA helicase assay. However, when different combinations of the 
proteins were tested at concentrations equivalent to those used in vitro 
initiation assays, DNA unwinding of substrate was detected. The activity 
was detected only when the viral protein Ad.DBP was present at 
concentrations which could completely saturate the DNA substrates.The
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protein was termed as having helix-destabilising properties. In depth 
characterisation of this activity was carried out in results chapter 2.
1. Helix-destabilising property of the adenovirus DNA-binding 
protein.
The adenovirus DBF has been shown to possess the properties of a helix 
destabilising protein. When templates contain a large amount of single 
stranded DNA, the double stranded portion is efficiently unwound in a 
highly cooperative reaction. Completely double stranded templates are 
also unwound but this reaction is restricted by the length and G+C 
content of the DNA fragment. Like other helix destabilising proteins, 
DBF promoted unwinding requires neither ATF nor MgC^ (chapter 2, 
table 2.2). In fact, the latter is inhibitory to the process as are other 
agents, such as NaCl, which increase the stability of duplex DNA 
molecules (chapter 2, figure 2.5). Very similar properties have recently 
been ascribed to both the HeLa and herpes simplex virus coded single 
strand specific DNA binding proteins, which appear to be involved in 
cellular and viral DNA replication (Goergaki et al., 1993 ; Boehmer et al., 
1993). Two possibilities therefore exist to explain the ability of DBF to 
unwind completely double stranded DNA. In one model DBF could 
utilise its ability to first bind to double stranded DNA (Cleat and Hay, 
1989 ; Stuiver and van der Vliet, 1990), invade the DNA duplex and bind 
in a stable fashion to the exposed single strands. An alternative model is 
that DBF binds to transiently single stranded regions of DNA that are 
exposed during "breathing" of short double stranded DNA molecules. 
What is clear however is that when the double stranded DNA fragments 
are tightly bound by either NFI or NFIII at their cognate recognition sites 
DBF is unable to unwind the DNA. This could be due to the bound 
proteins stabilising the DNA duplex or alternatively the bound proteins
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may interfere with the ability of DBF to form a continuos protein chain 
on the DNA. Unlike DNA helicases which translocate unidirectionally 
on DNA, there does not appear to be a strict directionality to the 
unwinding reaction catalysed by DBF. In the experiment designed to 
address this point (chapter, figure 2.6C) it was noted that the smaller 
fragment was released from the template at lower concentrations of DBF 
than the larger DNA fragment. While this is interpreted as being a 
consequence of the lower Tm of the smaller fragment, it cannot be ruled 
out that initial binding of a single molecule of DBF is followed by 
unidirectional polymerisation of the protein on the single stranded DNA. 
Determination of the three dimensional structure of DBF by X-ray 
crystallography (Tucker et al., 1993) has suggested a mechanism for the 
cooperative binding of DBF to single stranded DNA. It is thought that an 
extension at the C-terminus of one DBF molecule "hooks" into a 
complementary surface on an adjacent DBF molecule and in doing so 
initiates formation of a protein chain of DBF molecules. The ability of 
DBF to impose a rigid structure on DNA has recently been shown to be 
responsible for the ability of DBF to also promote renaturation of 
complementary single strands (Zijderveld et al., 1993). However, 
whereas the dénaturation reaction described here is inhibited by high 
concentrations of monovalent and divalent cations, the renaturation 
reaction described above is highly resistant to their presence (Zijderveld 
et al., 1993).
The ability of DBF to destabilise double stranded DNA duplexes 
could be utilised at a number of points in the viral replicative cycle.
While DBF has been shown to stimulate the initiation of Ad2 DNA 
replication in vitro by decreasing the Km for transfer of dCMF onto pTF 
and by increasing the binding of NFI to the replication origin, neither of 
these reactions are likely to involve the melting of duplex DNA.
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Figure 7. Strand opening and formation of a preinitiation complex at the 
adenovirus origin.Representations of known and potential DNA-protein 
and protein-protein interactions are shown.
However, DBF may stimulate the initiation of DNA replication by 
additional means and it has previously been demonstrated that Ad4 DBF 
dramatically stimulates initiation of DNA replication. In this case the 
extent of stimulation is independent of the concentrations of NFI and 
dCTF (Temperley and Hay, 1991). One possibility is that DBF may 
participate with other replication proteins in the unwinding of the DNA 
double helix that is expected to take place at the termini of the genome 
prior to initiation (chapter!, see figure 7). Numerous experiments have 
indicated that TF( Fronk et al., 1992, Fronk and van der Vliet, 1993), NF- 
I (De Vries et al., 1987 , Mul and van der Vliet, 1992) and NF-III 
(Verrijzer et al., 1991) can all distort adenovirus genomic DNA to some 
extent. Along with DBF's ability to distort and unwind short fully duplex 
DNA, this could provide a mechanism by which the adenovirus 
replication proteins can destabilise and eventually open the origin DNA. 
The requirement for DBF during progress of the replication fork has been 
well established and it is likely to be a consequence of DBF stabilising 
displaced single strands and altering the properties of the viral DNA 
polymerase. In the latter case DBF has been shown to convert pol into a 
form that is capable of strand displacement and highly processive DNA 
synthesis (Field et al,, 1984 ; Lindenbaum et al., 1986). Both of these 
activities may well be a consequence of the ability of DBF to transiently 
destabilise double stranded DNA at the advancing replication fork.
2. PLP inhibition of the Ad.5 DNA polymerase.
Initial sequence homology studies on eukaryotic and prokaryotic DNA 
polymerases indicated the presence of clusters of highly conserved amino 
acids, posing the question as to whether the conservation was in any way 
a reflection of the functional importance of these regions to the 
polymerases. Thus far, two main groups of DNA polymerases have been
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Figure 8. Homology segments among several DNA polymerases of 
prokaryotic and eukaryotic origin. Alignment was carried out as 
described in Bemad et al., (1987). Numbers at the left indicate the first 
residue in each sequence. A residue was considered consensus if it was 
present in more than half of the polypeptides considered. Consensus 1 
indicates the consensus residues between DNA polymerases of terminal 
protein containing genomes. Consensus 2 indicates the consensus 
residues between all DNA polymerases. Consensus 3 indicates the 
consensus residues between the remaining DNA polymerases.
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distinguished on the basis of their amino acid sequence relatedness: 1. 
E.coli Pol I and phage T7 DNA polymerase; 2. a-like DNA polymerases, 
which include both prokaryotic and eukaryotic, protein-primed and RNA- 
primed DNA replicases, probably sharing a common polymerisation 
mechanism. The adenovirus DNA polymerases are contained in the 
second group, the a-like DNA polymerases. Limited structural 
characterisation on the Ad.2 DNA polymerase (Field et al., 1984 ; Chen 
and Horwitz, 1989 ; Joung et al, 1991) and computer-generated analysis 
of related eukaryotic gene sequences (Larder et al, 1987a ; Wang et al, 
1988) suggests that the catalytic domain of the Ad.5 DNA polymerase is 
likely to be located in the C-terminal region of the protein, between 
amino acid residues 687-726 (see figure 8). These amino acids 
correspond to a conserved region of sequence homology (Region III)
which contains the consensus sequence "K N _ _ YG", found
between different viral DNA polymerases (Larder et al, 1987a). This 
evidence suggested that a lysine residue (K) could be important for 
catalytic activity.
Chemical modification agents can be used successfully to identify 
amino acid residues that are important for enzyme activity, provided that 
the following two criteria are fulfilled: firstly, chemical modification of 
the residues must result in a loss of enzyme activity and secondly, this 
inactivation must be prevented by substrates or substrate analogues. 
Pyridoxal-5'-phosphate (PLP) is an ideal chemical modifier in this 
respect. The sensitivity of a number of prokaryotic (Modak, 1976 ; Basu 
and Modak, 1987), eukaryotic DNA polymerases (Diffley, 1988) to PLP 
prompted its use in this study. Inhibition kinetics with these different 
DNA polymerases indicated that it was a specific, substrate dNTP- 
binding site-directed reagent, that could be incorporated covalently into 
an enzyme's active site via borohydride reduction of the PLP-enzyme
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Figure 9. PLP inhibition reaction pathway. The foimation of the 
reversible imine bond with a lysine residue and its reduction to a 
secondary amine by sodium borohydride (radioactive) are shown.
complex formed during inhibition. PLP specifically modifies the amino 
acids, arginine and lysine. In all of the studies on the DNA polymerases 
mentioned above, a lysine residue in or near the active-site has been 
implicated as the residue involved in PLP mediated inhibition. The data 
presented in chapter 3 of this study characterises the PLP inhibition of 
Adenovirus type 5 DNA polymerase and lays down the groundwork for 
the use of this inhibitor in the affinity labelling of the catalytic DNA 
polymerase's active-site.
PLP inhibition of the Ad.5 DNA polymerase occurs via the 
formation of a metastable imine ("Schiff base") with an amino acid group 
(either arginine or lysine) on the enzyme. Nearly all of the polymerases 
inhibition can be reversed with primary amine (Tris-HCl) or substrate, 
indicating that the inhibition by PLP occurs via reversible imine bond 
formation. The rate of PLP inhibition of the polymerase, in the presence 
and absence of magnesium ions, does not increase linearly with 
increasing PLP concentration (chapter 3, figure 3.2). The rate reaches a 
plateau at high concentrations of PLP, exhibiting saturation kinetics. This 
argues that PLP is a specific inhibitor of the polymerase, binding to a 
specific site on the enzyme in a non-covalent fashion prior to the 
formation of a covalent bond, in this case a reversible imine (see figure 
9). This is an important property of an affinity label. The rate of PLP 
inhibition is increased two-fold in the presence of magnesium ions, 
indicating that PLP probably chelates with the Mg^+ ions and forms a 
more potent inhibitor for the polymerase. A magnesium ion chelate of 
PLP has been shown to be required for effective inhibition of the E.coli 
DNA polymerase I (Basu and Modak, 1987) and the murine leukemia 
virus reverse transcriptase (Basu et al, 1988).
The substrate protection data presented in chapter 3, along with the 
known order of substrate binding in related eukaryotic DNA
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polymerases, such as DNA polymerase a  from Drosophilia, suggests that 
PLP can inhibit Ad.5 DNA polymerase by binding to one site on the 
enzyme. Protection from this inhibition requires the presence of a dNTP 
and an appropriate template-primer, e.g. the presence of dTTP, will 
provide protection for Ad.5 DNA polymerase from PLP inhibition only 
when poly d(A).oligo d(T) is present (chapter 3, table 3.1). This data 
strongly suggests that the process of substrate binding in Ad.5 DNA 
polymerase is dependent on the prior binding of template-primer and that 
only dNTP which is complementary to the template strand can bind and 
be accepted by the active-site of the polymerase. Alternatively, the 
reversal of PLP mediated inactivation by the inclusion of template-primer 
and substrate dNTP may be argued to result from another PLP reactive 
site, which may be required for the translocation of the enzyme during 
polymerisation of dNTP's. If this catalytic site was modified, one may 
still expect perfect substrate binding although turnover of bound substrate 
may be affected. In E.coli DNA polymerase I and DNA polymerase a  
from Drosophilia melanogster, PLP-mediated inactivation has indeed 
been shown to occur via the reactivity of at least 2 lysine residues, one 
involved in substrate binding and the other in catalysis (Basu and Modak, 
1987 ; Basu et al., 1988 ; Diffley, 1988). However, this idea isn't 
consistent with the kinetic data in chapter 3 and the peptide mapping 
studies in chapter 4, which indicated that only one peptide containing 
PLP was present after digestion with trypsin (see chapter 4).
Initial velocity experiments demonstrate that PLP inhibition of the 
polymerase is not competitive with any substrate (chapter 3, figure3.5). 
Since essentially all the polymerase can be protected by the formation of 
the primer-template/dNTP ternary complex, these results indicate that 
PLP inhibition must occur at some point after the formation of this 
ternary complex in one polymerisation cycle and before the formation of
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a ternary complex in the next cycle. This is illustrated in figure 10. The 
results in chapter 3 argue that both the polymerase species, E and ETPn, 
can be inhibited by PLP binding, while the polymerase ternary complex 
species ETPn.N is protected from PLP inhibition. This in turn indicates 
that either the catalytic step, pyrophosphate release and/or translocation 
of the newly formed primer-binding site must be the rate-limiting step in 
the polymerisation cycle. During this rate-limiting step the dNTP-binding 
site would be accessible for PLP binding and inhibition. Alternatively, 
the 3'-5’ exonuclease associated with the adenovirus DNA polymerase 
could have its proof-reading (implicated) function exercised after 
catalysis and/or during translocation, making it the rate-limiting step 
predicted from PLP inhibition.
The associated 3'-5' exonuclease activity, which co-sediments with 
the DNA polymerase, exhibits negligible sensitivity to PLP (chapter 3, 
figure 3.7). This implies that there are two distinct active-site domains for 
the catalysis of these two activities. This is supported to some degree by 
sequence homology comparisons (see figure 11) on a wide range of 
prokaiyotic and eukaryotic (including Ad.2 DNA polymerase) DNA 
polymerases (Bemad et al., 1989). The conclusion from these studies was 
that the amino acids used for some of the different enzymatic activities 
required to catalyse the synthesis of DNA had been assembled in the 
same polypeptide to form a mutlifunctional DNA polymerase. If this 
hypothesis is correct, the organisation of the DNA polymerases into 
modular structures would imply a relative functional and structural 
independence of each catalytic domain. The results in chapter 3 argue 
that, fimctionally, this is the case with the adenovirus type 5 DNA 
polymerase. However, no x-ray crystal structure for any of the adenovirus 
DNA polymerases exists at the moment, so definitive studies cannot be 
carried out.
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Figure 10. The polymerisation cycle of Ad.5 DNA polymerase. The 
substrates, transition complexes and products are as indicated.
t»
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Figure 11. Relative arrangement of homologous regions among 
prokaryotic and eukaryotic DNA polymerases .Each DNA polymerase or 
exonuclease subunit is represented with the N terminus at the left hand 
side. Cross-hatched and thick-blackened regions indicate homology with 
the 5*-3' exonuclease, 3'-5' exonuclease and polymerase domains, 
respectively, of B.coli Pol I. Undetected or nonsignificant homology is 
represented by a straight line. Open boxes represent N-terminal 
homologous segments within the DNA polymerases and are proposed to 
be a general 3’-5' exonuclease active site. Filled circles indicate the 
homologous C-terminal segments present in a  like DNA polymerases 
(Larder, 1987).

To date, only in the case of E.coii DNA polymerase I have the different 
activities present in a DNA polymerase been ascribed to physically 
separate domains. Based on crystal analysis of its Klenow fragment (C- 
terminal region of the protein that contains both the DNA polymerase and 
3-5' exonuclease activities) with DNA, it has been proposed that one of 
the critical features for its role in ’editing" Okazaki fragments is that the 
polymerase and exonuclease active sites are separated, and are either 
located on a different subunit, as in the case of E.coii DNA pol III HE 
(Kong et al., 1992), or on a different structural domain, as in the case of 
E.coii DNA polymerase I (Ollis et al., 1985).
The last result in chapter 3 indicates that PLP inhibition of the 
Ad.5 DNA polymerase can influence its function in the initiation of 
adenovirus DNA replication. The polymerase is thought to initiate 
replication (pTP-dCMP complex formation) by directly catalysing the 
formation of a phosphodiester bond between the P-OH group of a serine 
residue in the preterminal protein (Lichy et al., 1982). Inhibition of Ad.5 
DNA polymerase by PLP, prior to its incubation in an in vitro initiation 
assay, resulted in a reduction of the pTP-dCMP complex signal. PLP 
inhibition of pTP had no effect on its initiation function. This argues that 
the initiation and polymerisation functions may share the same active- 
site. However, no mutational studies have been carried out on the 
conserved region III (putative dNTP binding site) of the polymerase to 
substantiate the above claim. Analysis has been carried out on conserved 
region I (putative metal-binding site) of the polymerase. Mutations in this 
region affected specific initiation and elongation reactions on different 
adenovirus templates (Joung et al., 1991). These results imply that region 
I is important in the process of dCMP transfer during initiation. However, 
more extensive studies on the related protein-priming <p29 DNA 
polymerase has revealed that its four most conserved regions are all
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critical in the initiation of its DNA replication process (Bemad et al.,
1990 ; Blasco et al., 1993). A site-directed mutagenesis approach has 
been used to describe the functional significance of all the conserved 
regions characterised by the motifs "KxsNSxYG", "YGDTDS", "KxY" 
and "Dx2SLYP"; all the mutant polymerases from these conserved 
regions showed normal 3* to 5' exonuclease activity but were affected in 
their synthetic activities (protein-primed initiation and/or DNA 
polymerisation). Motif "KxaNSxYG" has been proposed to be involved 
in template-primer binding and dNTP selection (Blasco et al., 1992b, 
1993) ; (j> 29 DNA polymerase residues Asp456 and Asp458 of conserved 
motif "YGDTDS" have been proposed to be involved in metal binding 
and catalysis (Bemad et al., 1990), and mutations in conserved motif 
"KxY" have been shown to affect primer recognition (Blasco et al., 
1992a). In addition, a mutant in residue Tyr254 of ^  29 DNA polymerase 
conserved motif "Dx2SLYP" has been described to be affected in Me^+- 
dNTP binding (Blasco et al., 1992b). Recently more extensive 
mutagenesis studies have been carried out on this conserved region 
(Blasco et al., 1993). Their results suggest that residue Asp^49 in the (j) 29 
DNA polymerase could have a direct role in catalysis. They have 
proposed that Asp249  ^together with Asp^56 and Asp^58  ^may be close 
to each other in the three-dimensional structure of ^  29 DNA polymerase, 
possibly contributing to catalysis by acting as metal ligands. Similar 
groups of acidic residues have been described to be critical for the 
maintenance of the synthetic activities in E.coii DNA polymerase I 
Klenow fragment (Polesky et al., 1990, 1992) and HIV-I reverse 
transcriptase (Larder et al., 1987b, 1989). More extensive mutational 
analysis needs to be carried out on all of the conserved regions in Ad.5 
DNA polymerase in an attempt to clarify the amino acid residues 
important in both initiation and elongation of DNA replication.
139
3. Identification of amino acid residues in the active site of the Ad.5 
DNA polymerase.
On the basis of comparative tryptic peptide mapping of Ad.5 DNA 
polymerase modified by PLP, in the presence and absence of template- 
primer and substrate dNTP, a single putative pyridoxylated peptide was 
identified. The peak was found only in the absence of substrates. The 
peak was identified as being pyridoxylated on the basis of: A. its 
absorbance pattern at 325nm (reduced "Schiff base" characteristic 
absorbance) and B. the distribution of radioactively reduced sodium 
borohydride in the tiyptic digest. However, amino acid composition and 
sequencing analyses revealed that the peak contained no detectable 
amounts of peptide. The lack of sequence data could be attributed to 
several things. The most likely of these is that not enough protein may 
have been used in the initial inhibition reaction with PLP. The inhibition 
reaction is followed by precipitation by trichloroacetic acid (TCA) and 
then HPLC on a C-18 peptide column. The combination of these two 
processes may have reduced the amount of PLP inhibited polymerase 
available for sequencing. Strong evidence for this comes from the fact 
that the amount of labelled material in the HPLC purified peptide peak is 
10-fold lower than the amount of protein initially added into the reaction. 
An alternative explanation is that the reduction of PLP by the radioactive 
sodium borohydride may simply not have worked. However, the foimer 
seems to be the case, as samples taken from the PLP inhibition reactions 
before TCA precipitation were found to be modified (no substrates) and 
unmodified (substrates present) when tested in a standard in vitro DNA 
polymerase activity assay.
In conclusion, the data presented in chapters 3 and 4 demonstrate 
that the polymerase activity of Ad.5 DNA polymerase can be inhibited by
140
PLP, Although direct physical evidence for the involvement of lysine 695 
in this process was not found, it seems likely that with larger quantities of 
the protein becoming available, an x-ray crystal structure for the protein 
will become a reality and pinpoint with accuracy the role of a lysine 
residue in catalysis.
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